0001213900-22-072004.txt : 20221114 0001213900-22-072004.hdr.sgml : 20221114 20221114141418 ACCESSION NUMBER: 0001213900-22-072004 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED ENERGETICS, INC. CENTRAL INDEX KEY: 0000879911 STANDARD INDUSTRIAL CLASSIFICATION: SEARCH, DETECTION, NAVIGATION, GUIDANCE, AERONAUTICAL SYS [3812] IRS NUMBER: 770262908 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14015 FILM NUMBER: 221383697 BUSINESS ADDRESS: STREET 1: 9070 S. RITA ROAD STREET 2: SUITE 1500 CITY: TUCSON STATE: AZ ZIP: 85747 BUSINESS PHONE: 520-628-7415 MAIL ADDRESS: STREET 1: 9070 S. RITA ROAD STREET 2: SUITE 1500 CITY: TUCSON STATE: AZ ZIP: 85747 FORMER COMPANY: FORMER CONFORMED NAME: IONATRON, INC. DATE OF NAME CHANGE: 20040429 FORMER COMPANY: FORMER CONFORMED NAME: US HOME & GARDEN INC DATE OF NAME CHANGE: 19950714 FORMER COMPANY: FORMER CONFORMED NAME: NATURAL EARTH TECHNOLOGIES INC DATE OF NAME CHANGE: 19930328 10-Q 1 f10q0922_appliedener.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended September 30, 2022

 

OR

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from __________ to __________

 

Commission File Number 001-14015

 

APPLIED ENERGETICS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   77-0262908
(State or Other Jurisdiction of
Incorporation or Organization)
  (IRS Employer
Identification Number)
     
9070 S. Rita Road, Suite 1500
Tucson, Arizona
  85747
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code (520) 628-7415

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer: Accelerated filer:
Non-accelerated filer: Smaller reporting company:
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange act. ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐   No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, par value $0.001 per share   AERG   OTCQB

 

As of November 8, 2022, there were 207,817,878 shares of the issuer’s common stock, par value $.001 per share, outstanding.

 

 

 

 

 

 

APPLIED ENERGETICS, INC.

QUARTERLY REPORT ON FORM 10-Q

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION
   
ITEM 1. Condensed Consolidated Unaudited Financial Statements 1
     
  Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 1
     
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021 (Unaudited) 2
     
  Condensed Consolidated Statements of Stockholders’ Equity for the nine months ended September 30, 2022 and 2021 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (Unaudited) 4
     
  Notes to Condensed Consolidated Unaudited Financial Statements 5
     
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
     
ITEM 4. Controls and Procedures 23
     
PART II – OTHER INFORMATION
   
ITEM 1. Legal Proceedings 24
     
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 24
     
ITEM 6. Exhibits 25
     
SIGNATURES 26

 

i

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

APPLIED ENERGETICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2022   2021 
     (Unaudited)     
Assets        
Current assets        
Cash and cash equivalents  $1,155,349   $3,662,615 
Accounts receivable   219,618    
-
 
Other assets   117,728    43,391 
Total current assets   1,492,695    3,706,006 
           
Long-term assets          
Property and equipment - net   220,765    206,810 
Deferred compensation   
-
    416,666 
Right of use asset - operating   460,705    544,670 
Security deposit   17,004    17,004 
Total long-term assets   698,474    1,185,150 
Total assets  $2,191,169   $4,891,156 
           
Liabilities and Stockholders’ Equity (Deficit)          
Current liabilities          
Accounts payable  $249,880   $195,381 
Notes payable   738,985    1,000,001 
Notes payable CARES Act PPP Loan   
-
    24,189 
Due to related parties   50,000    50,000 
Operating lease liability - current   104,117    76,227 
Accrued expenses   10,807    21,870 
Accrued dividends   48,079    48,079 
Subscription payable   585,000    
-
 
Total current liabilities   1,786,868    1,415,747 
           
Long-term liabilities          
Operating lease liability - non-current   425,339    507,188 
Total long-term liabilities   425,339    507,188 
Total liabilities   2,212,207    1,922,935 
           
Stockholders’ Equity (Deficit)          
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at September 30, 2022 and December 31, 2021 (Liquidation preference $340,050 and $340,050, respectively)   14    14 
Common stock, $.001 par value, 500,000,000 shares authorized; 207,817,878 and 207,562,461 shares issued and outstanding at September 30, 2022 and at December 31, 2021, respectively   207,817    207,562 
Additional paid-in capital   101,728,483    100,452,862 
Accumulated deficit   (101,957,353)   (97,692,217)
Total Stockholders’ Equity (Deficit)   (21,038)   2,968,221 
           
Total Liabilities and Stockholders’ Equity (Deficit)  $2,191,169   $4,891,156 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

1

 

 

APPLIED ENERGETICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   For The Three
Months Ended
September 30,
   For The Nine
Months Ended
September 30,
 
   2022   2021   2022   2021 
                 
Revenue  $572,766   $
-
   $763,688   $
-
 
Cost of revenue   127,668    
-
    142,835    
-
 
                     
Gross profit   445,098    
-
    620,853    
-
 
                     
Operating expenses                    
General and administrative   1,249,132    1,304,875    4,365,823    3,412,603 
Selling and marketing   56,416    83,173    231,528    235,897 
Research and development   65,364    61,968    286,365    192,783 
Total operating expenses   1,370,912    1,450,016    4,883,716    3,841,283 
                     
Operating loss   (925,813)   (1,450,016)   (4,262,863)   (3,841,283)
                     
Other income/(expense)                    
Other income   637    
-
    637    81,218 
Interest expense   (1,227)   (1,794)   (2,910)   (3,542)
Total other income/(expense)   (590)   (1,794)   (2,273)   77,676 
                     
Net Loss before provision for income taxes   (926,404)   (1,451,810)   (4,265,136)   (3,763,607)
                     
Provision for income taxes   
-
    
-
    
-
    
-
 
                     
Net loss   (926,404)   (1,451,810)   (4,265,136)   (3,763,607)
                     
Preferred stock dividends   (8,501)   (8,502)   (25,504)   (25,504)
                     
Net loss attributable to common stockholders  $(934,905)  $(1,460,312)  $(4,290,640)  $(3,789,111)
                     
Net loss attributable to common stockholders per common share - basic and diluted
  $(0.00)  $(0.01)  $(0.02)  $(0.01)
                     
Weighted average number of common shares outstanding   207,794,526    203,857,408    207,726,711    198,786,305 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

2

 

 

APPLIED ENERGETICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

(Unaudited)

 

   Preferred Stock   Common Stock   Additional Paid-   Accumulated   Total
Stockholders’
(Deficit)
 
   Shares   Amount   Shares   Amount   In Capital   Deficit   Equity 
Balance at December 31, 2021   13,602   $14    207,562,461   $207,562   $100,452,862   $(97,692,217)  $2,968,221 
RSU restricted Stock   -    
-
    130,417    130    (130)   
-
    
-
 
Stock-based compensation   -    
-
    -    
-
    554,877    
-
    554,877 
Net loss for the quarter ended March 31, 2022   -    
-
    -    
-
    
-
    (1,781,190)   (1,781,190)
Balance at March 31, 2022   13,602    14    207,692,878    207,692    101,007,609    (99,473,407)   1,741,908 
Stock-based compensation   -    
-
    -    
-
    449,508    
-
    449,508 
Common stock issued on exercise of option   -    
-
    100,000    100    12,900    
-
    13,000 
Net loss for the quarter ended June 30, 2022   -    
-
    -    
-
    
-
    (1,557,542)   (1,557,542)
Balance at June 30, 2022   13,602   $14    207,792,878   $207,792   $101,470,017   $(101,030,949)  $646,874 
Stock-based compensation   -    
-
    -    
-
    257,241    
-
    257,241 
Common stock issued on exercise of warrants             25,000    25    1,225    
-
    1,250 
Net loss for the quarter ended September 30, 2022   -    
-
    -    
-
    
-
    (926,404)   (926,404)
Balance at September 30, 2022   13,602    14    207,817,878   $207,817   $101,728,483   $(101,957,353)  $(21,038)

 

   Preferred Stock   Common Stock   Additional Paid-   Accumulated   Total
Stockholders’
(Deficit)
 
   Shares   Amount   Shares   Amount   In Capital   Deficit   Equity 
Balance at December 31, 2020   13,602   $14    190,529,320   $190,529   $93,778,591   $(92,266,764)  $1,702,370 
RSU restricted Stock   -    
-
    31,250    31    4,519    
-
    4,550 
Stock-based compensation   -    
-
    -    
-
    170,029    
-
    170,029 
Common stock issued on cashless exercise of options and warrant   -    
-
    1,005,682    1,006    (1,006)   
-
    
-
 
Common stock issued on exercise of options and warrant   -    
-
    600,000    600    41,400    
-
    42,000 
Common stock issued on exercise of convertible note   -    
-
    158,329    158    47,340    
-
    47,498 
Sale of common stock   -    
-
    7,056,250    7,056    2,250,944    
-
    2,258,000 
Net loss for the three months ended March 31, 2021   -    
-
    -    
-
    
-
    (1,086,438)   (1,086,438)
Balance at March 31, 2021   13,602    14    199,380,821    199,380    96,291,817    (93,353,202)   3,138,010 
                                    
Stock-based compensation   -    
-
    -    
-
    318,818    
-
    318,818 
Common stock issued on cashless exercise of options and warrant   -    
-
    259,741    260    (260)   
-
    
-
 
Common stock issued on exercise of options and warrant        
-
    450,010    450    28,550    
-
    29,000 
Net loss for the three months ended June 30, 2021   -    
-
    -    
-
    
-
    (1,225,360)   (1,225,360)
Balance at June 30, 2021   13,602   $14    200,090,572   $200,090   $96,638,926   $(94,578,562)  $2,260,468 
Stock-based compensation   -    
-
    -    
-
    354,880    
-
    354,880 
Common stock issued on cashless exercise of options and warrant   -    
-
    957,143    957    (957)   
-
    
-
 
Common stock issued on exercise of stock options and warrants   -    
-
    600,000    600    36,400    
-
    37,000 
Sale of common stock   -    
-
    4,054,665    4,054    3,036,946    
-
    3,041,000 
Net loss for the quarter ended September 30, 2021   -    
-
    -    
-
    
-
    (1,451,810)   (1,451,810)
Balance as of September 30, 2021   13,602   $14    205,702,380   $205,701   $100,066,194   $(96,030,372)  $4,241,539 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

3

 

 

APPLIED ENERGETICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited) 

 

   For the Nine Months Ended
September 30,
 
   2022   2021 
Cash Flows from Operating Activities        
Net loss  $(4,265,136)  $(3,763,607)
Adjustments to reconcile net loss to net cash used in operating activities:          
Noncash stock-based compensation expense   1,261,626    848,277 
Amortization of ROU assets   83,965    
-
 
Depreciation and amortization   50,499    18,021 
PPP loan forgiveness   
-
    (81,550)
Amortization of future compensation payable   416,666    625,000 
Amortization of prepaid assets   162,760    122,660 
    Loss on disposal of equipment   14,540    
-
 
Changes in assets and liabilities:          
Accounts receivable   (219,618)   
-
 
Other assets   
-
    2,880 
ROU liabilities   (53,959)   24,216 
Prepaids and deposits   (237,097)   (48,218)
Accounts payable   53,863    (28,051)
Accrued interest   
-
    696 
Accrued expenses and compensation   (11,063)   29 
Net cash used in operating activities   (2,742,953)   (2,279,649)
           
Cash Flows from Investing Activities          
Purchase of equipment   (78,996)   (206,198)
Net cash used in investing activities   (78,996)   (206,198)
           
Cash Flows from Financing Activities          
Repayment on note payable   (460,002)   (1,102,113)
Proceeds from sale of common stock   
-
    5,299,000 
Proceeds from note payable   175,435    
-
 
Proceeds from subscription payable   585,000    
-
 
Proceeds from exercise of stock options and warrants   14,250    108,000 
Net cash provided by financing activities   314,682    4,304,887 
           
Net change in cash and cash equivalents   (2,507,267)   1,819,042 
           
Cash and cash equivalents, beginning of year   3,662,615    3,323,290 
Cash and cash equivalents, end of period  $1,155,349   $5,142,332 
           
Supplemental disclosure of cash flow information          
Cash paid for interest  $1,683   $1,421 
Cash paid for taxes  $
-
   $
-
 
           
Non-cash investing and financing activities          
Insurance financing for prepaid insurance  $175,435   $117,209 
Implementation of ASC 842  $
-
   $617,569 
Forgiveness of PPP loan  $
-
   $81,449 
Equipment investing in accounts payable  $
-
   $64,107 
Common stock issued for repayment of convertible notes  $
-
   $47,499 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

4

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

NOTE 1 – ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2021, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.

 

Going Concern

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

 

For the nine months ended September 30, 2022, the company incurred a net loss of $4,265,136, had negative cash flows from operations of $2,742,953 and may incur additional future losses due to limited contract activity. At September 30, 2022, the company had total current assets of $1,492,695 and total current liabilities of $1,786,868, resulting in a working capital deficit of $294,173. At September 30, 2022, the company had cash of $1,155,349.

 

Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from a government grant and contract, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. 

 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.

 

The ongoing COVID-19 pandemic and pandemic-related trade conditions, such as exacerbated port congestion, supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company’s financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the company will be successful in its effort to secure additional equity financing. During the three months ended September 30, 2022, the company received funds in the amount of $585,000 as part of a pending placement of equity which it has recognized as a subscription payable. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.

 

5

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other relevant matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities and valuation of debt discount related to beneficial conversion features.

 

Net Loss Attributable to Common Stockholders

 

Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 24,424,550 and 32,019,604 for the nine months ended September 30 2022 and 2021, respectively.

 

Significant Concentrations and Risks

 

We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2022, $905,349 was uninsured.

 

NOTE 2 – NEW ACCOUNTING STANDARDS

 

The company has reviewed all issued accounting pronouncements and plans to adopt those that are applicable to it. The company does not expect the adoption of any other pronouncements to have an impact on its results of operations or financial position.

 

In December 2019, the FASB issued amended guidance in the form of ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU is intended to simplify various aspects of accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarifying certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for annual periods beginning after December 15, 2020, and interim periods within those annual periods, with early adoption permitted. An entity that elects early adoption must adopt all the amendments in the same period. Most amendments within this ASU are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The company has evaluated the impact of this new standard and notes the guidance did not have a material impact on our financial statements.

 

6

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

On August 5, 2020, the FASB issued ASU No. 2020-06 which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 simplifies the guidance in U.S. GAAP on the issuer’s accounting for convertible debt instruments and preferred stock. Such guidance includes multiple disparate sets of classification, measurement, and derecognition requirements whose interactions are complex. ASU 2020-06 is effective for annual periods beginning after December 15, 2021, and interim periods within those annual periods, with early adoption permitted. An entity that elects early adoption must adopt all the amendments in the same period. Most amendments within this ASU are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The company adopted this standard on January 1, 2022. The adoption of this standard did not have a material impact on the company’s financial statements.

 

NOTE 3 – NOTES PAYABLE

 

On May 24, 2019, the company entered into an Asset Purchase Agreement (the “APA”) with Applied Optical Sciences, LLC (“AOS”) to acquire certain assets. As consideration for the APA, the company entered into a promissory note issued to the shareholders of AOS for $2,500,000. The note is non-interest bearing and payable in equal installments. The company made the first three payments of $500,000 on February 10, 2021, May 24, 2021, and November 19, 2021, respectively. The Promissory Note was amended on May 23, 2022 as modification of debt to extend the maturity date by one year to, May 24, 2023, and restructure the payment to time up to the adjusted maturity date. The remaining balance of $1,000,000 as of June 30, 2022 is to be paid in ten equal installments of $100,000 over a period of ten month with the final installment to paid on April 24, 2023. In accordance with the terms of the promissory note, the company made three payments of $100,000, for an aggregate total repayment of $300,000. As of September 30, 2022, $700,000 in principle was outstanding on this loan.

 

Paycheck Protection Program

 

On April 28, 2020, the company entered into a loan agreement with Alliance Bank of Arizona, N.A. for a loan in the amount of $132,760 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act enacted on March 27, 2020 (the “CARES Act”). This loan is evidenced by a promissory note, dated April 27, 2020, and matured two years from the disbursement date. This loan bears interest at a rate of 1.00% per annum, with the first six-months ended of interest deferred. Principal and interest are payable monthly commencing six-months ended after the disbursement date and may be prepaid by the company at any time prior to maturity with no prepayment penalties. This loan contains customary events of default relating to, among other things, payment defaults or breaches of the terms of the loan. Upon the occurrence of an event of default, the lender may require immediate repayment of all amounts outstanding under the note.

 

Under the terms of the PPP, up to the entire amount of principal and accrued interest may be forgiven to the extent loan proceeds are used for qualifying expenses as described in the CARES Act and applicable implementing guidance issued by the U.S. Small Business Administration (“SBA”) under the PPP. The company partially used the loan amount for designated qualifying expenses and received notice from the SBA on June 30, 2021, that the company would not be required to repay $81,550 in proceeds. As a result, the company received partial forgiveness of the PPP amounting to $80,594 in principal and $956 in interest which is reflected within PPP forgiveness and other income on the statements of operations. During the six months ended June 30, 2020, the company paid the remaining balance of the loan in the aggregate of $23,553 in four equal payments, with loan formally repaid on April 20, 2022. As a result, as of September 30, 2022, no principal or interest was outstanding on this loan.

 

7

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

Premium Financing

 

On April 8, 2022, the company entered into an agreement with Oakwood D&O Insurance to provide financing in an amount of $234,367 for the insurance premium associated with two D&O policies. Both policies commenced March 12, 2022, and provided coverage for the next 12 months, expiring March 12, 2023. The loan bears interest at a fixed rate of 5% per annum and required the company to prepay $58,932 and appears on the balance sheet as a current asset. On April 12, 2022, the company commenced monthly principal and interest payments of $19,901, which was the first payment of nine remaining months due of $175,435, the last payment of which is scheduled to be made on December 31, 2022. As of September 30, 2022, the outstanding balance on the note was $38,985 and was recorded as notes payable, a currently liability, in the company’s condensed consolidated balance sheet.

 

Notes Payable Reconciliation

 

The following reconciles notes payable as of September 30, 2022, and December 31, 2021:

 

   September 30,
2022
   December 31,
2021
 
Beginning balance  $1,024,190   $2,681,157 
Notes payable   175,435    117,209 
Accrued interest   (640)   1,385 
Payments on notes payable   (460,002)   (1,646,513)
Extinguishment of debt   
-
    (81,550)
Converted into common stock   
-
    (47,498)
Total   738,985    1,024,190 
Less-Notes payable – current   738,985    1,024,190 
Notes payable – non-current  $
-
   $
-
 

 

Future principal payments for the company’s Notes as of September 30, 2022, are as follows:

 

2022  $338,985 
2023   400,000 
Thereafter   
 
 
Total  $738,985 

 

The company’s note payable balance of $738,985 is due within the next twelve months, in accordance with the terms of note payable. $700,000 of the outstanding notes payable balance at September 30, 2022 will be paid in seven equal installments of $100,000 over the next seven months, with the final installment to paid on April 24, 2023.

 

8

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

NOTE 4 – DEFERRED COMPENSATION

 

On May 24, 2019, the company entered into the APA with AOS to acquire certain assets. As consideration for the APA, the company entered into a promissory note issued to the shareholders of AOS for $2,500,000. The company also recorded a debt discount, which is reported on the balance sheet as deferred compensation, in the amount of $2,500,000, in relation to the transaction which is being amortized over the life of the loan as compensation expense. The amortization of deferred compensation for the nine months ended September 30, 2022, and 2021 was $416,666 and $625,000, respectively.

 

NOTE 5 – DUE TO RELATED PARTIES

 

It has come to the board’s attention that on July 31, 2018, our now deceased CEO deposited $50,000 into the company’s account. Although it has been suggested that the funds may have been intended for use toward Mr. Dearmin’s healthcare, the board does not know for certain what the purpose of the funds were or the nature of any intended investment. Accordingly, the board is investigating the appropriate disposition of the funds which will likely be to the estate of Mr. Dearmin. Until such a determination is made, the board does not intend to use these funds for any corporate purpose. For reporting purposes, the company has treated the deposit as a due to related party.

 

NOTE 6 – STOCKHOLDERS’ EQUITY

 

Authorized Capital Stock

 

During the nine months ended September 30, 2021, the company issued 7,056,250 shares of common stock in a private placement to accredited investors for $0.32 per share or $2,258,000 of net cash proceeds, in the aggregate.

 

During the nine months ended September 30, 2021, the company issued 158,329 shares of common stock upon the conversion of $47,499 of convertible notes (see Note 3).

 

During the nine months ended September 30, 2021, the company issued 31,250 shares of common stock in relation to a restricted stock agreement with a value of $4,550.

 

During the nine months ended September 30, 2021, the company issued 800,000 shares of common stock upon the exercise of 800,000 warrants at an exercise price of $0.07 a share.

 

During the nine months ended September 30, 2021, the company issued 250,000 shares of common stock upon the exercise of 250,000 warrants at an exercise price of $0.06 a share.

 

9

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

During the nine months ended September 30, 2021, the company issued 259,741 shares of common stock upon the exercise of 500,000 options at an exercise price of $0.37 a share. This exercise was performed on a cashless basis.

 

During the nine months ended September 30, 2021, the company issued 1,760,000 options to purchase common stock at an exercise price of $0.40 a share. The options vest over a period of three years from the date of the amendment.

 

During the nine months ended September 30, 2021, the company issued 4,054,665 shares of common stock in a private placement to accredited investors for $0.75 per share or $3,041,000 of net cash proceeds, in the aggregate.

 

During the nine months ended September 30, 2021, the company issued 50,000 shares of common stock upon the exercise of 50,000 warrants at an exercise price of $0.06 a share. During the nine months ended September 30, 2021, the company issued 100,000 shares of common stock upon the exercise of 100,000 warrants at an exercise price of $0.07 a share.

 

During the nine months ended September 30, 2021, the company issued 200,000 shares of common stock upon the exercise of 200,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 125,000 shares of common stock upon the exercise of 125,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 60,000 shares of common stock upon the exercise of 60,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 65,000 shares of common stock upon the exercise of 65,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 475,000 shares of common stock with an exercise of 500,000 options. 25,000 shares of common stock were withheld with the exercise. This exercise was performed on a cashless basis.

 

During the nine months ended September 30, 2021, the company issued the company issued 482,143 shares of common stock with an exercise of 500,000 options. 17,857 shares of common stock were withheld with the exercise. This exercise was performed on a cashless basis

 

During the nine months ended September 30, 2022, the company issued 130,417 shares of common stock for previously vested and expensed shares in relation to a restricted stock agreement. For the nine months ended September 30, 2022, the Company recorded $0 in relation to these shares.

 

During the nine months ended September 30, 2022, the company issued 100,000 shares of common stock upon the exercise of 100,000 options at an exercise price of $0.13 a share. As a result, the company received $13,000 in cash proceeds as part of the transaction.

 

During the nine months ended September 30, 2022, the company issued 25,000 shares of common stock upon result of the two warrant exercises of 12,500 shares each, or 25,000 shares of common stock in the aggregate, at an exercise price of $0.05 a share. The company received $1,250 in cash proceeds as part of the transaction.

 

Effective August 1, 2022, the Company entered into an Executive Employment Agreement with Mr. Donaghey who was appointed the Company’s Chief Financial Officer ("CFO"). As part of the Executive Employment Agreement, the Company granted 1,000,000 options to purchase shares of common stock at an exercise price of $2.36 per share. The options vest over a period of four years and expire ten years from the date of the grant.  Mr. Donaghey was also granted 400,000 shares of restricted to units as part of his Executive Employment Agreement (see “Share-Based Payments” below). Further, Mr. Donaghey forfeited unvested options to purchase 950,000 shares of common stock which he had previously received for his service on the Company’s Board of Advisors. The forfeiture of the unvested options resulted in the reversal of previously recorded stock-based compensation expense in the amount of approximately $176,000.

 

As of nine months ended, September 30, 2022, the company recognized a subscription payable for $585,000 from the sale of common stock as a current liability on its balance sheet, reflecting the receipt of $585,000 in cash proceeds as part of a pending private equity placement transaction.

 

During the nine months ended September 30, 2022 and 2021, the company recognized stock-based compensation in the amount of $1,261,626 and $848,277, respectively.

 

10

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

Preferred Stock

 

As of September 30, 2022, and December 31, 2021, there were 13,602 shares of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Stock”) issued and outstanding, respectively. The company has not paid the dividends commencing with the quarterly dividend due August 1, 2013. Dividend arrearages as of June 30, 2022, including previously accrued dividends included in our balance sheet are approximately $314,546. Our Board of Directors suspended the declaration of the dividend, commencing with the dividend payable as of February 1, 2015, since we did not have a surplus (as such term is defined in the Delaware general corporation Law) as of December 31, 2014, until such time as we have a surplus or net profits for a fiscal year.

 

Our Series A Preferred Stock has a liquidation preference of $25.00 per Share. The Series A Preferred Stock bears dividends at the rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. Dividends may be paid in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement and the company’s common stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance or (iii) any combination of the foregoing. If the company fails to make a dividend payment within five business days following a dividend payment date, the dividend rate shall immediately and automatically increase by 1% from 6.5% of the liquidation preference per offered share of Series A preferred stock to 7.5% of such liquidation preference. If a payment default shall occur on two consecutive dividend payment dates, the dividend rate shall immediately and automatically increase to 10% of the liquidation preference for as long as such payment default continues and shall immediately and automatically return to the Initial dividend rate at such time as the payment default is no longer continuing.

 

Each share of Series A Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the liquidation preference (plus any unpaid dividends for periods prior to the dividend payment date immediately preceding the date of conversion by the holder) divided by the conversion price (initially $12.00 per share, subject to adjustment in the event of a stock dividend or split, reorganization, recapitalization or similar event). If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.

 

If a change of control occurs, each holder of shares of Series A Convertible Preferred Stock that are outstanding immediately prior to the change of control shall have the right to require the corporation to purchase, out of legally available funds, any outstanding shares of Series A Convertible Preferred Stock at the defined purchase price. The purchase price is defined as: per share of Preferred Stock, 101% of the liquidation preference thereof, plus all unpaid and accumulated dividends, if any, to the date of purchase thereof. The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.

 

If the Corporation pays all or a portion of the Purchase Price in Common Stock, no fractional shares of Common Stock will be issued; instead, the company will round the applicable number of shares of Common Stock up to the nearest whole number of shares; provided that the Corporation may pay the Purchase Price (or a portion thereof), whether in cash or in shares of Common Stock, only if the Corporation has funds legally available for such payment and may pay the Purchase Price (or a portion thereof) in shares of its Common Stock only if (i) the Common Stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance and (ii) a shelf registration statement covering the issuance by the Corporation and/or resales of the Common Stock issuable as payment of the Purchase Price is effective on the Payment Date unless such shares are eligible for immediate resale in the public market by non-affiliates of the Corporation.

 

The company pays an annual dividend on its preferred stock of approximately $34,000. For the nine months ended September 30, 2022 and 2021, the company has recorded $25,004 and $25,504 respectively as preferred stock dividends on its condensed consolidated statements of operations in relation to its annual dividend. Dividends on our Preferred Stock are payable quarterly on the first day of February, May, August and November, in cash or shares of Common Stock, at our discretion.

 

11

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

Share-Based Payments

 

Effective November 12, 2018, the Board of Directors of Applied Energetics, Inc. adopted the 2018 Incentive Stock Plan. The plan provides for the allocation and issuance of stock, restricted stock purchase offers and options (both incentive stock options and non-qualified stock options) to officers, directors, employees and consultants of the company. The board reserved a total of 50,000,000 shares for possible issuance under the plan.

 

We have, from time to time, also granted non-plan options to certain officers, directors, employees and consultants. Total stock-based compensation expense for grants to officers, employees and consultants was $1,261,626 and $848,277 for the nine months ended September 30, 2022, and 2021, respectively, which was charged to general and administrative expense.

 

Stock-based compensation for the year ended December 31, 2021, was comprised of 140,000 shares under a restricted stock agreement the company entered into in May of 2021. The restricted stock awards were valued at $84,000 of which the full $84,000 was recognized as of September 30, 2022. The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.

 

As part of his Executive Employment Agreement dated July 13, 2022 the company granted 400,000 shares issued as restricted stock units to the Chief Financial Officer. The restricted stock units were valued at $928,000 of which $50,780 was recognized as of September 30, 2022. The shares vest in equal annual installments over four years. If either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date. The Restricted Stock Units are issued pursuant to a Restricted Stock Unit Agreement, dated as of July 13, 2022.

 

Stock based compensation for the nine months ended September 30, 2022, was comprised of 250,000 shares issued pursuant to the restricted stock unit agreement, dated July 13, 2022. The restricted stock units were valued at $580,000 of which $42,297 was recognized as of September 30, 2022. The shares vest with 25% being vested at the end of year one and two respectively, with the remaining 50% being expensed at the end of year three. If either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.

 

The $1,261,626 stock-based compensation for the nine months ended September 30, 2022, was comprised of $930,077 option expense, $108,549 expense from the vesting of the restricted stock and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.

 

The company recognized no related income tax benefit because our deferred tax assets are fully offset by a valuation allowance.

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model.

 

As of September 30, 2022, the company has $4,998,280 of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of approximately six years.

 

12

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

The following table summarizes the activity of our stock options for the nine-months ended September 30:

 

   Shares   Weighted
Average
Exercise Price
   Weighted
Average
Contractual Term
Outstanding
   Intrinsic
Value
 
Outstanding at December 31, 2021   28,415,000   $0.1859    5.84   $50,673,665 
Granted   2,390,000    2.2130    9.48    17,378,564 
Exercised   (100,000)   (0.1300)   6.09    (961,438)
Forfeited or expired   (7,950,000)   
-
    
-
    (75,400,831)
Outstanding at September 30, 2022   22,755,000    0.3378    6.66    208,131,088 
                     
Outstanding and exercisable at September 30, 2022   20,308,888    0.1751    6.34    189,061,250 

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model applying the assumptions in the following table:

 

    Nine-Months Ended
September 30,
 
    2022     2021  
Assumptions:            
Risk-free interest rate     1.26-1.30 %     .05-0.07 %
Expected dividend yield     0 %     0 %
Expected volatility     126 %     128-130 %
Expected life (in years)     5       2-3  

 

The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the nine months ended September 30, 2022, was as follows:

 

   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
         
Outstanding at December 31, 2021   215,000   $0.52 
Granted – restricted stock units and awards   650,000    2.32 
Granted – performance-based stock units   
-
    
-
 
Canceled   
-
    
-
 
Vested and converted to shares   
-
    
-
 
Outstanding at September 30, 2022   865,000   $1.8708 

 

13

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

As of September 30, 2022, and December 31, 2021, there was $1,414,923 and $15,355 respectively in unrecognized stock-based compensation related to unvested restricted stock agreements, net of estimated forfeitures.

 

As of September 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $501,750, respectively, was amortized for the nine months ended September 30, 2022, and 2021.

 

Warrant stock activity for the nine-months ended September 30, 2022, was as follows:

 

   Warrant Activity 
   Shares   Weighted Average
Exercise Price
   Weighted Average remaining Contractual Term (years) 
Outstanding at December 31, 2021   1,775,000   $0.0599    7.43 
Granted   
-
    
-
    
-
 
Exercised   (25,000)   0.0500    
-
 
Forfeited   
-
    
-
    
-
 
Outstanding and exercisable at September 30, 2022   1,750,000   $0.0600    6.78 

 

   Warrants Outstanding   Warrants Exercisable 
Range of Exercise Prices  Shares
Outstanding
   Weighted
Avg.
Remaining
Contractual
Life in Years
   Weighted Avg.
Exercise
Price
   Shares
Exercisable
   Weighted Avg.
Exercise
Price
 
$0.05 - $0.07   1,750,000    0.01   $0.0600    1,750,000   $0.0600 
    1,750,000    0.01   $0.0600    1,750,000   $0.0600 

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model applying the assumptions in the following table:

 

   Nine-months Ended
September 30,
 
   2022   2021 
Assumptions:        
Risk-free interest rate   0%   0%
Expected dividend yield   0%   0%
Expected volatility   0%   0%
Expected life (in years)   0    0 

 

14

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

NOTE 7 – REVENUE RECOGNITION

 

The Company derives revenue from technical research detailing the findings of its investigations to its customers under contract for specific projects. Under Topic 606, revenue is recognized when control of promised goods and services is transferred to customers, and the amount of revenue recognized reflects the consideration to which an entity expects to be entitled to in exchange for the goods and services transferred. A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The Company’s contracts require significant integrated services and are accounted for as a single performance obligation, and revenue is recognized by the Company over the contract term at a fixed contract price.

 

Concentrations

 

During the nine months ended September 30, 2022, the company earned revenue from two contracts with two separate customers. One customer accounted for $648,905 or 85% of revenue recognized during the period. As of September 30, 2022. The company has $219,618 of accounts receivable recorded as current assets on the balance sheet. As of September 30, 2022, one customer accounted for $162,226 or 74% of accounts receivable. The company had no revenue during the nine months ended, September 30, 2021.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Operating Leases

 

In March 2021, the company signed a five-year lease for a 13,000 square foot laboratory/office space in Tucson. The initial base rent was $6.7626 per rentable square foot for year one, and escalated to $9.2009 in year two, $11.4806 in year three, $13.1740 in year four and $14.9306 in year five, plus certain operating expenses and taxes.

 

The company incurred lease expense for its operating leases of $193,326 which was included in general and administrative expenses in the statements of operation for the periods ended September 30, 2022. During the nine months ended September 30, 2022, the company made cash lease payments in the amount of $166,501.

 

At September 30, 2022, we had approximately $128,000 in future minimum lease payments due in less than a year. The below table presents the future minimum lease payments due reconciled to lease liabilities.

 

   Operating Lease 
For the fiscal years ending December 31, 2022:    
2022  $30,752 
2023   143,325 
2024   168,577 
2025   191,779 
2026   66,536 
Thereafter   
-
 
Total undiscounted lease payments   600,969 
Present value discount, less interest   71,512 
Lease Liability  $529,426 

 

15

 

 

APPLIED ENERGETICS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2022

(Unaudited)

 

Guarantees

 

The company agrees to indemnify its officers and directors for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The maximum amount of future payments that the company could be required to make under these indemnification agreements is unlimited. However, the company maintains a director’s and officer’s liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. As a result, it believes the estimated fair value of these indemnification agreements is minimal because of its insurance coverage, and it has not recognized any liabilities for these agreements as of September 30, 2022 and 2021.

 

Litigation

 

On July 3, 2019, Gusrae, Kaplan & Nusbaum and its partner, Ryan Whalen filed a complaint in the United States District Court for the Southern District of New York against the company, its directors, officers, attorneys and a consultant. The action alleged libel, securities fraud and related claims. The company filed a motion to dismiss the complaint on October 24, 2019. On December 13, 2019, Gusrae Kaplan and Mr. Whalen filed an opposition to the company’s motion. On January 10, 2020, the company filed a reply brief. On August 5, 2021, the plaintiffs filed a Notice of Voluntary Dismissal of the action without prejudice.

 

On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr. Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties are currently engaged in discovery. No trial date has been set.

 

On September 7, 2021, Gusrae Kaplan & Nusbaum and its partner Ryan Whalen filed a complaint in the New York Supreme Court against the company, its directors, officers, attorneys and a consultant, alleging a single claim for defamation per se based on the same conduct underlying their claim of libel in their voluntarily dismissed federal court action. The company filed a motion to dismiss the complaint on October 29, 2021, to which Gusrae Kaplan & Nusbaum and Mr. Whalen filed an opposition on January 13, 2022, and the company filed its reply brief on February 17, 2022.

 

On May 23, 2022, the New York Supreme Court held a hearing on the motion to dismiss, and Judge Hagler ruled from the bench, granting all defendants’, including Applied Energetics’, motions to dismiss the claim, in its entirety, with prejudice. While he noted that defendants’ arguments regarding the claim being time-barred and the court lacking personal jurisdiction over certain defendants may have merit, he elected not to rule on those issues as he believed it appropriate to reach the merits. The judge declined to award sanctions requested by the defendants in this claim. The plaintiffs have filed a notice of intent to appeal the dismissal but have not filed their actual appeal brief, which is due on December 21, 2022.

 

As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.

 

We may, from time to time, be involved in legal proceedings arising from the normal course of business.

 

NOTE 9 – SUBSEQUENT EVENTS

 

The company’s management has evaluated subsequent events occurring after September 30, 2022, the date of our most recent balance sheet, through the date our financial statements were issued.

 

Subsequent to September 30, 2022, the Company received $2,931,000 in cash proceeds from a pending placement of common stock at a price of $2.20 per share, as amended in November 2022 per agreement between the company and the investors.

 

As of October 20, 2022, the Company issued incentive stock options to purchase up to 50,000 shares of common stock to an employee. The options are exercisable at a price of $2.30 per share.

 

As of November 4, 2022, the Company issued incentive stock options to purchase up to 50,000 shares of common stock to an employee. The options are exercisable at a price of $2.24 per share.

 

16

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Our discussion and analysis of the financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the related disclosures included elsewhere herein and in the Management’s Discussion and Analysis of Financial Condition and Results of Operations included as part of our Annual Report on Form 10-K for the year ended December 31, 2021, and Quarterly Report on Form 10-Q from the nine months ended September 30, 2022.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the securities laws. Forward-looking statements include all statements that do not relate solely to the historical or current facts and can be identified by the use of forward-looking words such as “may,” “believe,” “will,” “would,” “could,” “should,” “expect,” “project,” “anticipate,” “estimates,” “possible,” “plan,” “strategy,” “target,” “prospect,” or “continue,” and other similar terms and phrases. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial condition and may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause our actual results to differ materially from our expectations are described in Item 1A (Risk Factors) of our Annual Report on Form 10-K, for the year ended December 31, 2021. Although we believe that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to have been correct. We do not assume any obligation to update these forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking statements.

 

Applied Energetics, Inc., (sometimes referred to as the “company”) is a corporation organized and existing under the laws of the State of Delaware. Our executive office is located at 9070 S. Rita Road, Suite 1500, Tucson, Arizona 85747, (520) 628-7415. www.aergs.com

 

Applied Energetics, Inc., specializes in the development and manufacture of advanced high-performance lasers, advanced optical systems, and integrated guided energy systems for prospective defense, national security, industrial, biomedical, and scientific customers worldwide.

 

Technology, Capabilities and Patents

 

Applied Energetics, Inc. is recognized as a global leader in developing the next generation optical sources exhibiting ever-increasing output energy, peak power and frequency agility while also providing decreased size, weight, and cost of these systems for customers. Applied Energetics utilizes patented, dual-use technologies to advance critical industries. Leveraging our proprietary fiber-based architecture and wavelength- and pulse-agility capability, our Ultrashort Pulse (“USP™”) technology can enable users to achieve specific effects across different use cases with an unmatched blend of size, weight and power attributes. While initially designed to meet the emerging needs and priorities for the national security community, our directed energy technology also has commercial applications in both the biomedical and advanced manufacturing industries.

 

The Applied Energetics scientific team is continuously innovating and expanding our patent portfolio to cover these technological breakthroughs and further enhance our suite of solutions for threat disruption for the Department of Defense, the intelligence community, and for commercial, medical and space applications with optical sources operating from the deep ultraviolet to the far infrared portions of the electromagnetic spectrum.

 

17

 

 

Applied Energetics has developed, successfully demonstrated and holds all crucial intellectual property rights to a dynamic directed energy technology called Laser Guided Energy (“LGE®”) and Laser Induced Plasma Channel (“LIPC®”). LGE and LIPC are technologies that can be used in a new generation of high-tech directed energy systems. The Department of Defense (DOD) previously recognized only two key types of Directed Energy Weapon (“DEW”) technologies, High Energy Lasers (“HEL”), and High-Power Microwave (“HPM”). Neither the HEL nor the HPM intellectual property portfolio is owned by a single entity. The DOD then designated a third DEW technology, LGE. Applied Energetics’ LGE and LIPC technologies are wholly owned by Applied Energetics and protected by one or more of Applied Energetics’ 26 issued patents and 11 Government Sensitive Patent Applications (“GSPA”). These GSPA’s are held under secrecy orders of the US government, providing the company with greatly extended protection rights. The company also has seven provisional patent applications, and we continue to file patent applications as we deem appropriate.

 

Applied Energetics’ Directed Energy technologies are vastly different from conventional directed energy systems, i.e. HEL, and HPM. LGE uses Ultrashort Pulse (USP™) laser technology to combine the speed and precision of lasers with the overwhelming impact on targeted threats with high-voltage electricity. A key element of LGE is its novel ability to offer selectable and tunable properties that can help protect non-combatants and combat zone infrastructure. Applied Energetics’ proprietary fiber-based architecture is a key differentiator for our most recent technology demonstrators. Compared with traditional continuous wave technologies with their larger footprints, AE’s architecture enables orders of magnitude size-weight-power reductions on all deliverables, creating powerful, dual-use and agile systems that can fit a host of platforms while delivering very high intensity, ultrashort pulses of light to the required target. This unique directed energy solution allows extremely high peak power and energy, with target and effects tenability, and is effective against a wide variety of potential targets.

 

Applied Energetics’ unique optical fiber-based laser architectures enable unmatched wavelength agility as well as pulse duration agility. Using innovative and highly specialized frequency shifting techniques, wavelengths can be custom tuned from the deep ultraviolet to the far infrared. In addition, temporal outputs can be adjusted from continuous wave to sub-picoseconds. The technology enables the customer to adjust the lasers’ operating parameters, ultimately creating more flexibility to change wavelength and pulse width. This feature allows for optimization of laser performance for defense or commercial applications.

 

Our proprietary USP laser technology provides a significantly more compact solution than current continuous wave laser platforms while still delivering high peak power. Continuous wave laser systems are typically used to heat a target and, during continuous illumination, this heat transfer leads to melting or charring of the material. Using continuous wave output powers that now exceed 100 kilowatts (1kW = 1000 watts), it can take anywhere from seconds to minutes to impact a target. By contrast, Applied Energetics has delivered USP lasers to national security users that exceed five terawatts (1 TW = 1 trillion watts) in peak power, with the difference being that this peak power from a USP laser is delivered in a pulse that is less than a trillionth of a second. During this short pulse duration, and having such a high peak intensity, near-instantaneous ablation of the surface of the threat takes place. The net results of our innovative USP approaches are highly effective lasers with mountable footprints that require only a fraction of the size and weight of other directed energy technologies.

 

As Applied Energetics looks toward the future, our corporate strategic roadmap builds upon the significant value of the company’s USP capabilities and key intellectual property, including LGE and LIPC, to offer our prospective partners, co-developers and system integrators a variety of next-generation ultrashort pulse and frequency-agile optical sources, from the ultraviolet to the far infrared portion of the electromagnetic spectrum, to address numerous challenges within the national security, medical device, and advanced manufacturing market sectors.

 

Recent Developments

 

In May 2022, Applied Energetics was awarded a $3.89 million, two-year grant from the Department of the Navy, Office of Naval Research (ONR), to develop an optical system capable of defeating customer-specified threats for integration onto U.S. Marine Corps (USMC) platforms. We were awarded this grant to accelerate the development and testing of Infrared (IR) optical technology with an ultrashort pulse laser (USPL) system. The overall objective is to advance and ruggedize optical technologies that can be fielded on a variety of USMC platforms and are able to operate in harsh conditions.

 

We also executed a Phase I Small Business Technology Transfer (STTR) contract with the U.S. Army on June 2, 2022. The objective of the contract is the delivery of an ultra-broadband infrared (IR) source. Under this contract, Applied Energetics, will model novel approaches for the eye-safe delivery of ultra-broadband infrared laser pulses to electro-optic sensors. Electro-Optical/Infrared (EO/IR) sensors are imaging systems used for military applications. The STTR program is a federally funded initiative to incorporate small business technological innovation into government supported research and development programs. STTRs require the small business to team with a university or non-profit and are structured in three potential phases. Applied Energetics proposed to partner with the James C. Wyant College of Optical Sciences at the University of Arizona for Phase I.

 

We have begun work on each of these projects and anticipate producing all deliverables required under them in a successful and timely manner.

 

18

 

 

Effective August 1, 2022, our board of directors appointed Christopher Donaghey, age 50, to serve as Chief Financial and Chief Operating Officer. The company and Mr. Donaghey entered into an Executive Employment Agreement, pursuant to which he is to serve for an initial term of four years, with automatic renewal for additional one-year periods thereafter unless either party terminates the agreement. The agreement calls for salary of $350,000 per year, plus standard benefits and eligibility for a bonus at the discretion of the board. The company has also granted Mr. Donaghey additional options to purchase up to 1,000,000 shares of its common stock under its 2018 Incentive Stock Plan, which vest over four years and have an exercise price of $2.36 per share, and Restricted Stock Units representing up to 400,000 shares of the company’s common stock which also vest over four years. The Restricted Stock Units are issued pursuant to a Restricted Stock Unit Agreement, dated as of July 13, 2022. Mr. Donaghey forfeited unvested options to purchase up to 950,000 shares of common stock which he had previously received for service on the company’s Board of Advisors.

 

Mr. Donaghey is an experienced financial executive with a proven track-record in delivering profitable growth, including extensive experience within the defense industry. He joins Applied Energetics from Science Applications International Corporation (SAIC), a defense and government agency technology integrator, where he served as the senior vice president and head of corporate development. In this role, he was responsible for executing the company’s mergers and acquisitions (M&A) and strategic ventures strategy, working closely with the senior management team to support the development and implementation of SAIC’s strategic plan with an emphasis on M&A and external emerging technology investments to complement organic growth strategies and value creation. He joined SAIC in 2017, as senior vice president of finance for SAIC’s operations, and provided strategic leadership and business guidance to the organization. Mr. Donaghey is also a Founder and Executive Board member of the Silicon Valley Defense Group, a non-profit organization whose mission is to create the nexus of pioneering ideas, people, and capital that will unlock new sources of innovation for national security and power the digital evolution of the defense industrial base.

 

Prior to joining SAIC, Donaghey was vice president of Corporate Strategy and Development for KeyW Corporation, a national security solutions provider for the Intelligence, Cyber and Counterterrorism Communities, where he guided the overall corporate strategy, M&A, and capital markets activities.

 

Mr. Donaghey was also a senior research analyst for SunTrust Robinson Humphrey Capital Markets where he provided investment advice and insight to institutional investors covering public defense technology, government IT services, and commercial aerospace industries. During his tenure at SunTrust, Donaghey was ranked the number one defense analyst and number two analyst overall for stock selection by Forbes/Starmine in 2005 and was named in the Wall Street Journal Best on the Street survey in 2005, 2008, and 2009.

 

Mr. Donaghey served in the U.S. Navy Reserve where he provided scientific and technical analysis of missile guidance and control systems and advanced electronics for the Short-Range Ballistic Missile group at the Defense Intelligence Agency’s Missile and Space Intelligence Center. Donaghey earned his bachelor’s degree in mechanical engineering from Texas Tech University and served as an officer in the U.S. Navy.

 

Mr. Donaghey previously served on Applied Energetics’ Board of Advisors since April 30, 2019, providing input into the strategic direction of the company and assistance in building relationships in the defense markets.

 

Upon the successful examination, and with no opposition, the United States Patent and Trademark Office (USPTO) officially entered the marks LGE® (Reg. No. 6,289,892) and LIPC® (Reg. No. 6,316,069) on March 9, 2021, and April 6, 2021, respectively, in the principal register. Applied Energetics has applications pending before the USPTO for the marks USPTM, USPLTM, AERGTM and AETM and anticipates allowance and/or registration within the next six months. The company also has seven provisional patents, and we continue to file patent applications as we deem appropriate. 

 

In April 2022, we repaid the remaining balance on the Paycheck Protection Program loan, which we took out in 2020. The original loan was in the amount of $132,760, but our compliance with the guidelines set forth by the Small Business Administration regarding use of the proceeds of the loan qualified us for a waiver of a portion of this amount. We had been repaying the remaining balance in monthly installments at an annual interest rate of 1%.

 

Ongoing Business Development Activities

 

Over the past several quarters, we have submitted multiple proposals to, and attended briefings with, various defense and other various government agencies and attended briefings with various defense and other government agencies who have expressed an interest in our technology and applications. Due to the closures of multiple agencies and work-from-home orders during the Coronavirus pandemic, reviews and funding decisions on these proposals were delayed longer than anticipated as resources were focused on other matters within the government. We have received multiple notices from government agencies stating that “the vast number of proposals received, and the challenges posed by the COVID-19 pandemic, have impacted the government’s evaluation timelines.” Several of the government agencies that have received and are reviewing our proposals started to open their facilities to limited off-site briefings starting on June 1, 2021. and since that date, our team has been invited to, and completed, multiple briefings focused on our capabilities and submissions. Over time, the DOD has increased and reduced its facility occupancy limits and remote work requirements depending upon the local infection rates, and we have continued to make use of the time to submit proposals and attend briefings as and when permitted. We intend to continue developing and submitting proposals and to be available to attend on-site briefings to the extent possible.

 

19

 

 

In addition to these review-based delays, the US federal budget for 2022 was not approved by Congress by the October 1, 2021, start of the U.S. federal government fiscal year. The US government final fiscal year 2022 appropriations bill was signed into law by President Biden on the night of March 11, 2022 and includes increases in areas of particular interest to the company.

 

Two other significant pieces of legislation impacted Applied Energetics that were signed by the President on September 30, 2022. The first piece, bill S. 4900, the “SBIR and STTR Extension Act of 2022,” authorizes the Small Business Innovation Research (SBIR), Small Business Technology Transfer (STTR), and six related pilot programs through Fiscal Year 2025; requires agencies with an SBIR or STTR program to establish a due diligence program to assess the potential risk posed by program applicants’ foreign ties; requires certain departments and agencies to report on national security risks within their SBIR/STTR programs; and establishes increased minimum performance standards for firms that have won a certain number of awards during a specified period of time.

 

The other piece of legislation that we have seen multiple times in the past decade is the Continuing Resolution (CR), HR 6833, which provides fiscal year 2023 appropriations to federal agencies through December 16, 2022, for continuing projects and activities of the federal government and includes supplemental appropriations to respond to the Russian military action in Ukraine. This will provide for a continuation of funding for currently funded programs through December 16, but no new contracts until the 2023 fiscal year appropriations are approved by Congress. This CR allows for current Applied Energetics programs to continue.

 

Strategic Plan and Analysis

 

We plan to continue building our management team with highly qualified individuals. We intend to recruit additional personnel in the areas of R&D, science and simulation, marketing and finance, and, possibly add members to our Board of Directors and our Board of Advisors. We have worked to align key innovations with our roadmap to encourage and enable internal filing for a broad, strategic and robust intellectual property portfolio and continue surveying the literature for acquisitions of parallel intellectual property to that end. We also intend to pursue strategic corporate acquisitions in related fields and technology. We continue to explore any favorable equity financing opportunities.

 

Our goal with the Applied Energetics Strategic Plan is to increase the energy, peak power and frequency agility of USP optical sources while decreasing the size, weight, and cost of these systems. We are in the process of developing this breadth of very high peak power USP lasers and additional optical sources that have a very broad range of applicability for threat disruption for the Department of Defense, commercial, and medical applications. Although the historical market for Applied Energetics’ LGE and USP technology is the U.S. Government, the USP technologies are expected to provide numerous platforms for commercial additive and subtractive manufacturing and medical device and imaging markets, creating a substantially larger market for our products to address. Since 2020, the Applied Energetics team was able to develop partnership and teaming arrangements with the three leading laser and optics institutes in the United States, namely, the University of Arizona, the University of Central Florida, and the University of Rochester Laboratory for Laser Energetics. Our desire is to work on programs jointly where the strengths of each organization can assist in escalating knowledge and delivery of systems to the government sponsors, and to train the next generation of scientists and engineers to work in the directed energy fields.

 

Despite the challenges posed by COVID-19, we have continued to execute our business development plans, further our research and development program and submit filings for intellectual property and proposals for grants and contracts. During the past two fiscal years, we submitted multiple proposals and have been engaged in meetings on a daily and weekly basis with various agencies and departments both remotely and in person in Washington, DC and at various other government facilities. Having received a significant research grant and an STTR contract during the previous quarter, we believe the interest in our technology and applications remains high, and we continue to submit proposals for all appropriate opportunities and share our vision of the disruptive capabilities of USP optical sources for both near- and far-term threats and dual-use commercial applications.

 

Through our analysis of the market, and in discussions with potential customers, we remain convinced that customers are becoming more receptive and interested in directed energy technologies. According to the Department of Defense fiscal 2019 budget, its directed energy spending grew from approximately $500 million in 2017 to over $1 billion in 2019, an increase of 100%. The 2020 budget reflected directed energy spending of $1.2 billion, an additional increase of 20% over 2019, and from 2017 through 2020, the directed energy budget grew from approximately $500 million to approximately $1.2 billion, averaging approximately 40% per year. The government has allocated $1.4 billion for various directed energy programs in 2021, and market analysis and projections have estimated that this directed energy sector is anticipated to exceed $10.1 billion globally by 2026. The DOD budget for directed energy was essentially flat between 2021 and 2022, approaching $1.2 billion for each year. As a result, we continue to be optimistic about our future and the growing opportunities in directed energy applications. The Applied Energetics team anticipates a continuation of strong funding for the directed energy community. With our existing patent portfolio, and through further advancements of our technologies, we believe we have the substantial building blocks needed to become a significant and successful developer in our USP and LGE marketplaces.

 

20

 

 

Results of Operations

 

Comparison of Operations for the three months ended September 30, 2022 and 2021:

 

   2022   2021 
Revenue  $572,766   $ 
Cost of revenue   127,668     
General and administrative   (1,249,132)   (1,304,875)
Selling and marketing   (56,416)   (83,173)
Research and development   (65,364)   (61,968)
Other income   637     
Interest (expense)   (1,227)   (1,794)
Net loss  $(926,404)  $(1,451,810)

 

Revenue

 

Revenues increased by approximately $573,000 to approximately $573,000 as of September 30, 2022. We had no revenues as of September 30, 2021. This is due to a contract and grant that the company commenced in June 2022.

 

Cost of revenue

 

The cost of revenue increased by approximately $128,000 to approximately $128,000 as of September 30, 2022. We had no cost of revenues as of September 30, 2021. This is due to the costs directly associated with contract and grant that the company commenced in June 2022.

 

General and Administrative

 

General and administrative expenses decreased approximately $56,000 to approximately $1,249,000 for the three months ended September 30, 2022, compared to approximately $1,305,000 for the three months ended September 30, 2021, primarily due to the decrease of $246,000 of consulting services, an increase in salaries and employee benefits of approximately $123,000, in building costs of approximately $13,000, and in supplies and insurance of $25,000. 

 

Selling and Marketing

 

Selling and marketing expenses decreased $27,000, to approximately $56,000, for the three months ended September 30, 2022, compared to approximately $83,000 for the three months ended September 30, 2021, primarily due to the $27,000 decrease in expenses related to marketing consultant services.

 

Research and Development

 

Research and development expenses increased approximately $3,000 to approximately $65,000 for the three months ended September 30, 2022, compared to approximately $62,000 for the three months ended September 30, 2021.

 

Other Income

 

Other income increased approximately $1,000, to approximately $1,000 for the three months ended September 30, 2022, compared to $0 for the three months ended September 30, 2021. The other income for the three months ended September 30, 2022 was primarily due to the forgiveness of the company’s PPP loan.

 

Interest Expense

 

Interest expense decreased approximately $1,000 to $1,000 for the three months ended September 30, 2022 compared to approximately $2,000 for the three months ended September 30, 2021 primarily due the decrease in interest bearing notes payable.

 

Net Loss

 

Our operations for the three months ended September 30, 2022 resulted in a net loss of approximately $926,000, a decrease of approximately $526,000 compared to the approximately $1,452,000 net loss for the three months ended September 30, 2021, primarily due to the increase in revenue and decrease in general and administrative, selling and marketing expenses, partially offset by higher research and development expenses.

 

21

 

 

Comparison of Operations for the nine months ended September 30, 2022 and 2021:

 

   2022   2021 
Revenue  $763,688   $ 
Cost of revenue   142,835     
General and administrative   (4,365,823)   (3,412,603)
Selling and marketing   (231,528)   (235,897)
Research and development   (286,365)   (192,783)
Other income   637    81,218 
Interest (expense)   (2,910)   (3,542)
Net loss  $(4,265,136)  $(3,763,607)

 

Revenue

 

Revenues increased by approximately $764,000 to approximately $764,000 for the nine months ended September 30, 2022, as we had no revenues during the 2021 period. Revenues for the 2022 period were from a contract and a grant that we received and commenced performing in June 2022.

 

Cost of revenue

 

The cost of revenue increased by approximately $143,000 to approximately $143,000 for the nine months ended September 30, 2022, as we had no revenues, and therefore no costs of revenue during the 2021 period. September 30, 2022. This is due to the costs directly associated with contract and grant that the company commenced in June 2022.

 

General and Administrative

 

General and administrative expenses increased approximately $953,000 to approximately $4,366,000 for the nine months ended September 30, 2022, compared to approximately $3,413,000 for the nine months ended September 30, 2021, primarily due to an increase of approximately $403,000 in professional expenses, an increase in salaries and employee benefits of approximately $336,000, in IT costs of approximately $87,000, and in insurance of $42,000. 

 

Selling and Marketing

 

Selling and marketing expenses decreased approximately $4,000, to approximately $232,000 for the nine months ended September 30, 2022, compared to approximately $236,000 for the nine months ended September 30, 2021, primarily due to the continuation of business development activities through our Master Services Agreement with Westpark Advisors as well as other consultants in this field.

 

Research and Development

 

Research and development expenses increased approximately $94,000, to approximately $286,000 for the nine months ended September 30, 2022, compared to approximately $193,000 for the nine months ended September 30, 2021 primarily assets that were placed into service during the quarter that are actively being used to generate work in progress research and development of the company core technologies.

 

Other Income

 

Other income decreased approximately $81,000 to $1,000 for the nine months ended September 30, 2022 compared to approximately $81,000 for the nine months ended September 30, 2021 primarily due to the partial forgiveness of the company’s PPP loan.

 

Interest Expense

 

Interest expense decreased approximately $1,000 to $3,000 for the nine months ended September 30, 2022, compared to $4,000 for the nine months ended September 30, 2021, primarily due to a decrease in the aggregate outstanding debt the company had outstanding as of September 30, 2022, relative to September 30, 2021.

 

Net Loss

 

Our operations for the nine months ended September 30, 2022, resulted in a net loss of approximately $4,265,000, an increase of approximately $501,000 compared to the approximately $3,764,000 net loss for the nine months ended September 30, 2021, primarily due to increases in general and administrative and research and development expenses partially offset by higher revenue and decrease in selling and marketing.

 

Liquidity and Capital Resources

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the nine months ended September 30, 2022, the company incurred a net loss of approximately $4,265,000, had negative cash flows from operations of approximately $2,743,000 and may incur additional future losses due to the possible reduction in government contract activity and the expenses discussed under Results of Operations. In their report accompanying our financial statements for the year ended December 31, 2021, our independent auditors stated that our financial statements were prepared assuming that we would continue as a going concern and that they have substantial doubt as to our ability to do so based on our recurring losses from operations and need to raise additional capital. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

22

 

  

At September 30, 2022, the company had total current assets of $1,492,695 and total current liabilities of $1,786,868 resulting in negative working capital of $294,173. At September 30, 2022, we had $1,155,349 of cash and cash equivalents, a decrease of $ 2,507,266 from $3,662,615 at December 31, 2021.

 

During the first nine months of 2022, the net cash outflow from operating activities was $2,742,953. This amount was comprised primarily of our net loss of $4,265,136. This was offset by noncash stock-based compensation expense of $1,261,626, amortization of future compensation payable of $416,666, and the amortization of right of use assets of $83,965. Additionally, net cash used the changes in asset and liabilities totaled $409,283. This included an increase in accounts receivable $219,618, increase in prepaid and deposits of $178,506, increase in accrued expenses and compensation of $11,063, and an increase in accounts payable of $53,863. This is offset by the net decrease in operating lease liabilities of $53,959.  

 

During the first nine months of 2022, the net cash outflow from investing activities was $78,996. This was comprised of a $78,996 decrease from the acquisition of equipment.

 

During the first nine months of 2022, the net cash flows from financing activities was $314,685. This amount consisted of $175,435 in proceeds on a note payable for insurance premium financing, $14,250 from the exercise of options, and $585,000 of proceeds from subscription payable offset by $460,000 in conjunction with the monthly repayment of the note for the company’s insurance premium financing and AOS note. The proceeds from a subscription payable represent funding received as part of a pending private placement of equity.

 

Based on the company’s current business plan, we believe our cash balance as of the date of this report, along with anticipated revenues from our recently received ONR grant and STTR agreement, will be sufficient to meet the company’s anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable.

 

The company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting a significant portion of its efforts to developing additional business and raising capital, as needed, but cannot be certain that these efforts will be successful. Management’s business development efforts may not result in profitable operations. To fund its research and development and marketing efforts, the company’s management continues to explore possible financing opportunities through discussions with investment bankers and private investors. The company may not be successful in its effort to secure additional financing on terms it considers favorable. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern.

 

Additionally, the Russian military action in Ukraine and related economic sanctions around the globe could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company’s financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Budgeting for upcoming expenses and costs of supplies and equipment needed to perform our ONR grant, our STTR contract, both of which are described under “Recent Developments” above, and any other contracts or grants we receive in the future, requires that we estimate factors such as inflation and geo-political events that affect such expenses and costs. The cost of labor continues to increase across many sectors of the US and global economy which is likely to drive up our general and administrative expenses as well as the cost of personnel working directly and indirectly on our grants and contracts. This aspect of inflation is particularly difficult given the highly skilled nature of this work. Inflation is also likely to impact the price of supplies and materials we must purchase in order to perform grants and contracts, some of which may have been bid on based on cost structures which were submitted during periods of lower inflation. In addition, the war in Ukraine and other related geo-political events have further limited the number of countries from which we can source certain supplies and equipment. These limitations can range from outright prohibitions to strong discouragement based on potentially sensitive information. We continually monitor these events and the markets for needed supplies in order to make the best estimates possible, both in our internal budgeting and in any bids or proposals we submit.

 

ITEM 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2022. Based on that evaluation, our Principal Executive Officer has concluded that our disclosure controls and procedures as of September 30, 2022, are not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

  

Changes in Internal Controls Over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

23

 

  

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On July 3, 2019, Gusrae, Kaplan & Nusbaum and its partner, Ryan Whalen filed a complaint in the United States District Court for the Southern District of New York against the company, its directors, officers, attorneys and a consultant. The action alleged libel, securities fraud and related claims. The company filed a motion to dismiss the complaint on October 24, 2019. On December 13, 2019, Gusrae Kaplan and Mr. Whalen filed an opposition to the company’s motion. On January 10, 2020, the company filed a reply brief. On August 5, 2021, the plaintiffs filed a Notice of Voluntary Dismissal of the action without prejudice.

 

On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr. Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties are currently engaged in discovery. No trial date has been set.

 

On September 7, 2021, Gusrae Kaplan & Nusbaum and its partner Ryan Whalen filed a complaint in the New York Supreme Court against the company, its directors, officers, attorneys and a consultant, alleging a single claim for defamation per se based on the same conduct underlying their claim of libel in their voluntarily dismissed federal court action. The company filed a motion to dismiss the complaint on October 29, 2021, to which Gusrae Kaplan & Nusbaum and Mr. Whalen filed their opposition on January 13, 2022, and the company filed its reply brief on February 17, 2022.

 

On May 23, 2022, the New York Supreme Court held a hearing on the motion to dismiss, and Judge Hagler ruled from the bench, granting all defendants’, including Applied Energetics’, motions to dismiss the claim, in its entirety, with prejudice. While he noted that defendants’ arguments regarding the claim being time-barred and the court lacking personal jurisdiction over certain defendants may have merit, he elected not to rule on those issues as he believed it appropriate to reach the merits. The judge declined to award sanctions requested by the defendants in this claim. The plaintiffs have filed a notice of intent to appeal this dismissal but have not yet filed their actual appeal brief, which is due on December 21, 2022.

 

As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.

 

The company may, from time to time, be involved in legal proceedings arising from the normal course of business.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The company has reported all information pertaining to issuances of equity securities sold during the period covered by this Quarterly Report on Form 10-Q in previously filed reports on Forms 10-K, 10-Q and 8-K.

 

24

 

 

ITEM 6. EXHIBITS

 

EXHIBIT
NUMBER
  DESCRIPTION
31.1   Certification of Chief Executive Officer Pursuant to Exchange Act Rule 13a-14(a).
31.2   Certification of Chief Financial Officer Pursuant to Exchange Act Rule 13a-14(a).
32.1   Principal Executive Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Principal Financial Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

25

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  APPLIED ENERGETICS, INC.
     
  By: /s/ Gregory J. Quarles
    Gregory J. Quarles, President and
    Chief Executive Officer

 

  By: /s/ Christopher Donaghey
    Christopher Donaghey, Chief Financial Officer and Chief Operating Officer

 

Date: November 14, 2022

 

 

26

 

 

NONE 0.00 0.01 0.01 0.02 P3Y false --12-31 Q3 0000879911 0000879911 2022-01-01 2022-09-30 0000879911 2022-11-08 0000879911 2022-09-30 0000879911 2021-12-31 0000879911 2022-07-01 2022-09-30 0000879911 2021-07-01 2021-09-30 0000879911 2021-01-01 2021-09-30 0000879911 us-gaap:PreferredStockMember 2021-12-31 0000879911 us-gaap:CommonStockMember 2021-12-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000879911 us-gaap:RetainedEarningsMember 2021-12-31 0000879911 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000879911 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000879911 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000879911 2022-01-01 2022-03-31 0000879911 us-gaap:PreferredStockMember 2022-03-31 0000879911 us-gaap:CommonStockMember 2022-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000879911 us-gaap:RetainedEarningsMember 2022-03-31 0000879911 2022-03-31 0000879911 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0000879911 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000879911 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000879911 2022-04-01 2022-06-30 0000879911 us-gaap:PreferredStockMember 2022-06-30 0000879911 us-gaap:CommonStockMember 2022-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000879911 us-gaap:RetainedEarningsMember 2022-06-30 0000879911 2022-06-30 0000879911 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0000879911 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000879911 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000879911 us-gaap:PreferredStockMember 2022-09-30 0000879911 us-gaap:CommonStockMember 2022-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000879911 us-gaap:RetainedEarningsMember 2022-09-30 0000879911 us-gaap:PreferredStockMember 2020-12-31 0000879911 us-gaap:CommonStockMember 2020-12-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000879911 us-gaap:RetainedEarningsMember 2020-12-31 0000879911 2020-12-31 0000879911 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000879911 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000879911 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000879911 2021-01-01 2021-03-31 0000879911 us-gaap:PreferredStockMember 2021-03-31 0000879911 us-gaap:CommonStockMember 2021-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000879911 us-gaap:RetainedEarningsMember 2021-03-31 0000879911 2021-03-31 0000879911 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000879911 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000879911 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000879911 2021-04-01 2021-06-30 0000879911 us-gaap:PreferredStockMember 2021-06-30 0000879911 us-gaap:CommonStockMember 2021-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000879911 us-gaap:RetainedEarningsMember 2021-06-30 0000879911 2021-06-30 0000879911 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000879911 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000879911 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000879911 us-gaap:PreferredStockMember 2021-09-30 0000879911 us-gaap:CommonStockMember 2021-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000879911 us-gaap:RetainedEarningsMember 2021-09-30 0000879911 2021-09-30 0000879911 aerg:AppliedOpticalSciencesMember 2019-05-01 2019-05-24 0000879911 2021-02-10 0000879911 2021-05-24 0000879911 2021-11-19 0000879911 2022-01-01 2022-06-30 0000879911 2020-04-01 2020-04-28 0000879911 2021-06-01 2021-06-30 0000879911 aerg:PPPForgivenessMember 2022-09-30 0000879911 aerg:PPPForgivenessMember 2022-01-01 2022-09-30 0000879911 2020-01-01 2020-06-30 0000879911 2022-04-01 2022-04-08 0000879911 2022-04-08 0000879911 2022-04-12 0000879911 2022-04-01 2022-04-12 0000879911 2021-01-01 2021-12-31 0000879911 2019-05-01 2019-05-24 0000879911 srt:ChiefExecutiveOfficerMember 2018-07-01 2018-07-31 0000879911 us-gaap:PrivatePlacementMember 2021-01-01 2021-09-30 0000879911 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000879911 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0000879911 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000879911 us-gaap:WarrantMember 2021-09-30 0000879911 aerg:WarrantsOneMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantsOneMember 2021-09-30 0000879911 aerg:OptionsMember 2021-09-30 0000879911 aerg:OptionsMember 2021-01-01 2021-09-30 0000879911 aerg:OptionsOneMember 2021-09-30 0000879911 aerg:OptionsOneMember 2022-01-01 2022-09-30 0000879911 aerg:PrivatePlacement1Member 2021-09-30 0000879911 aerg:PrivatePlacement1Member 2021-01-01 2021-09-30 0000879911 aerg:WarrantTwoMember 2021-09-30 0000879911 aerg:WarrantThreeMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantThreeMember 2021-09-30 0000879911 aerg:WarrantFourMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantFourMember 2021-09-30 0000879911 aerg:WarrantFiveMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantFiveMember 2021-09-30 0000879911 aerg:WarrantSixMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantSixMember 2021-09-30 0000879911 aerg:WarrantSevenMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantSevenMember 2021-09-30 0000879911 aerg:OptionsTwoMember 2021-01-01 2021-09-30 0000879911 aerg:OptionsTwoMember 2021-09-30 0000879911 aerg:OptionsThreeMember 2021-01-01 2021-09-30 0000879911 aerg:OptionsThreeMember 2021-09-30 0000879911 aerg:OptionsTwoMember 2022-01-01 2022-09-30 0000879911 aerg:OptionsTwoMember 2022-09-30 0000879911 2022-08-01 0000879911 2022-07-25 2022-08-01 0000879911 us-gaap:ConvertiblePreferredStockMember 2022-09-30 0000879911 us-gaap:ConvertiblePreferredStockMember 2021-12-31 0000879911 srt:MinimumMember 2022-01-01 2022-09-30 0000879911 srt:MaximumMember 2022-01-01 2022-09-30 0000879911 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-09-30 0000879911 us-gaap:PreferredStockMember 2022-01-01 2022-09-30 0000879911 us-gaap:OperatingIncomeLossMember 2022-01-01 2022-09-30 0000879911 us-gaap:OperatingIncomeLossMember 2021-01-01 2021-09-30 0000879911 srt:ChiefFinancialOfficerMember 2022-09-30 0000879911 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0000879911 aerg:BusinessCombinationMember 2022-01-01 2022-09-30 0000879911 srt:MinimumMember aerg:FairValueOfOptionMember 2022-01-01 2022-09-30 0000879911 srt:MaximumMember aerg:FairValueOfOptionMember 2022-01-01 2022-09-30 0000879911 srt:MinimumMember aerg:FairValueOfOptionMember 2021-01-01 2021-09-30 0000879911 srt:MaximumMember aerg:FairValueOfOptionMember 2021-01-01 2021-09-30 0000879911 aerg:FairValueOfOptionMember 2022-01-01 2022-09-30 0000879911 aerg:FairValueOfOptionMember 2021-01-01 2021-09-30 0000879911 aerg:RestrictedStockOutstandingMember 2021-12-31 0000879911 aerg:RestrictedStockOutstandingMember 2022-01-01 2022-09-30 0000879911 aerg:RestrictedStockOutstandingMember 2022-09-30 0000879911 aerg:WarrantActivityMember 2022-09-30 0000879911 aerg:WarrantActivityMember 2022-01-01 2022-09-30 0000879911 aerg:ZeropoinzerofivetozeropointzerosevenMember 2022-01-01 2022-09-30 0000879911 aerg:ZeropoinzerofivetozeropointzerosevenMember 2022-09-30 0000879911 aerg:OneCustomerMember 2022-01-01 2022-09-30 0000879911 aerg:OneCustomerMember 2022-09-30 0000879911 aerg:SquareFoodLaboratoryMember 2021-01-01 2021-03-31 0000879911 aerg:SquareFoodLaboratoryMember 2021-03-31 0000879911 us-gaap:SubsequentEventMember 2022-10-20 0000879911 us-gaap:SubsequentEventMember 2022-11-04 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0922ex31-1_applied.htm CERTIFICATION

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)

 

I, Gregory J Quarles, the President and Chief Executive Officer of Applied Energetics, Inc., certify that:

 

1.I have reviewed this report on Form 10-Q of Applied Energetics Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Gregory J Quarles
  Gregory J Quarles
  President and Chief Executive Officer
   
  Date: November 14, 2022

 

 

 

EX-31.2 3 f10q0922ex31-2_applied.htm CERTIFICATION

EXHIBIT 31.2

 

 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)

 

I, Christopher Donaghey, the Chief Financial Officer Chief Operating Officer of Applied Energetics, Inc., certify that:

 

1.I have reviewed this report on Form 10-Q of Applied Energetics Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Christopher Donaghey
  Christopher Donaghey
  Chief Financial Officer and
  Chief Operating Officer
   
  Date: November 14, 2022

 

EX-32.1 4 f10q0922ex32-1_applied.htm CERTIFICATION

EXHIBIT 32.1 

 

CERTIFICATION OF PRINCIPAL EXECUTIVE

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the filing by Applied Energetics, Inc. (the “company”) of its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (the “Report”) I, Gregory J Quarles, Chief Executive Officer (and Principal Financial Officer) of the company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

(i)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the company.

 

This certificate is being made for the exclusive purpose of compliance by the principal executive officer of Applied Energetics, Inc. with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and may not be used for any other purposes. A signed original of this written statement required by Section 906 has been provided to Applied Energetics, Inc. and will be retained by Applied Energetics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

  /s/ Gregory J Quarles
  Gregory J Quarles
  President and Chief Executive Officer
   
  Date: November 14, 2022

 

 

EX-32.2 5 f10q0922ex32-2_applied.htm CERTIFICATION

EXHIBIT 32.2 

 

CERTIFICATION OF PRINCIPAL EXECUTIVE

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the filing by Applied Energetics, Inc. (the “company”) of its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (the “Report”) I, Christopher Donaghey, Chief Financial Officer and Chief Operating Officer of the company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

(i)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the company.

 

This certificate is being made for the exclusive purpose of compliance by the principal executive officer of Applied Energetics, Inc. with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and may not be used for any other purposes. A signed original of this written statement required by Section 906 has been provided to Applied Energetics, Inc. and will be retained by Applied Energetics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

  /s/ Christopher Donaghey
  Christopher Donaghey
  Chief Financial Officer and
  Chief Operating Officer
   
  Date: November 14, 2022

 

EX-101.SCH 6 aerg-20220930.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Organization of Business, Going Concern and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - New Accounting Standards link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Deferred Compensation link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Due to Related Parties link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Stockholders’ Equity link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Notes Payable (Details) - Schedule of reconciles notes payable link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Notes Payable (Details) - Schedule of future principal payments link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Deferred Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Due to Related Parties (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Stockholders’ Equity (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Stockholders’ Equity (Details) - Schedule of stock options link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stockholders’ Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stockholders’ Equity (Details) - Schedule of fair value of restricted stock and restricted stock units link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stockholders’ Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stockholders’ Equity (Details) - Schedule of range exercise prices warrants outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Revenue Recognition (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Commitments and Contingencies (Details) - Schedule of future minimum lease payments link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 aerg-20220930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 aerg-20220930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 aerg-20220930_lab.xml XBRL LABEL FILE EX-101.PRE 10 aerg-20220930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 08, 2022
Document Information Line Items    
Entity Registrant Name APPLIED ENERGETICS, INC.  
Trading Symbol AERG  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   207,817,878
Amendment Flag false  
Entity Central Index Key 0000879911  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-14015  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0262908  
Entity Address, Address Line One 9070 S. Rita Road  
Entity Address, Address Line Two Suite 1500  
Entity Address, City or Town Tucson  
Entity Address, State or Province AZ  
Entity Address, Postal Zip Code 85747  
City Area Code (520)  
Local Phone Number 628-7415  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Security Exchange Name NONE  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 1,155,349 $ 3,662,615
Accounts receivable 219,618
Other assets 117,728 43,391
Total current assets 1,492,695 3,706,006
Long-term assets    
Property and equipment - net 220,765 206,810
Deferred compensation 416,666
Right of use asset - operating 460,705 544,670
Security deposit 17,004 17,004
Total long-term assets 698,474 1,185,150
Total assets 2,191,169 4,891,156
Current liabilities    
Accounts payable 249,880 195,381
Notes payable 738,985 1,000,001
Notes payable CARES Act PPP Loan 24,189
Due to related parties 50,000 50,000
Operating lease liability - current 104,117 76,227
Accrued expenses 10,807 21,870
Accrued dividends 48,079 48,079
Subscription payable 585,000
Total current liabilities 1,786,868 1,415,747
Long-term liabilities    
Operating lease liability - non-current 425,339 507,188
Total long-term liabilities 425,339 507,188
Total liabilities 2,212,207 1,922,935
Stockholders’ Equity (Deficit)    
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at September 30, 2022 and December 31, 2021 (Liquidation preference $340,050 and $340,050, respectively) 14 14
Common stock, $.001 par value, 500,000,000 shares authorized; 207,817,878 and 207,562,461 shares issued and outstanding at September 30, 2022 and at December 31, 2021, respectively 207,817 207,562
Additional paid-in capital 101,728,483 100,452,862
Accumulated deficit (101,957,353) (97,692,217)
Total Stockholders’ Equity (Deficit) (21,038) 2,968,221
Total Liabilities and Stockholders’ Equity (Deficit) $ 2,191,169 $ 4,891,156
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Series A convertible preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Series A convertible preferred stock, shares authorized 2,000,000 2,000,000
Series A convertible preferred stock, shares issued 13,602 13,602
Series A convertible preferred stock, shares outstanding 13,602 13,602
Series A convertible preferred stock, liquidation preference (in Dollars) $ 340,050 $ 340,050
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 207,817,878 207,562,461
Common stock, shares outstanding 207,817,878 207,562,461
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue $ 572,766 $ 763,688
Cost of revenue 127,668 142,835
Gross profit 445,098 620,853
Operating expenses        
General and administrative 1,249,132 1,304,875 4,365,823 3,412,603
Selling and marketing 56,416 83,173 231,528 235,897
Research and development 65,364 61,968 286,365 192,783
Total operating expenses 1,370,912 1,450,016 4,883,716 3,841,283
Operating loss (925,813) (1,450,016) (4,262,863) (3,841,283)
Other income/(expense)        
Other income 637 637 81,218
Interest expense (1,227) (1,794) (2,910) (3,542)
Total other income/(expense) (590) (1,794) (2,273) 77,676
Net Loss before provision for income taxes (926,404) (1,451,810) (4,265,136) (3,763,607)
Provision for income taxes
Net loss (926,404) (1,451,810) (4,265,136) (3,763,607)
Preferred stock dividends (8,501) (8,502) (25,504) (25,504)
Net loss attributable to common stockholders $ (934,905) $ (1,460,312) $ (4,290,640) $ (3,789,111)
Net loss attributable to common stockholders per common share - basic and diluted (in Dollars per share) $ 0 $ (0.01) $ (0.02) $ (0.01)
Weighted average number of common shares outstanding (in Shares) 207,794,526 203,857,408 207,726,711 198,786,305
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net loss attributable to common stockholders per common share - basic and diluted (in Dollars per share) $ 0.00 $ (0.01) $ (0.02) $ (0.01)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 14 $ 190,529 $ 93,778,591 $ (92,266,764) $ 1,702,370
Balance (in Shares) at Dec. 31, 2020 13,602 190,529,320      
Stock-based compensation 170,029 170,029
Common stock issued on cashless exercise of options and warrant $ 1,006 (1,006)
Common stock issued on cashless exercise of options and warrant (in Shares)   1,005,682      
Common stock issued on exercise of convertible note $ 158 47,340 47,498
Common stock issued on exercise of convertible note (in Shares)   158,329      
Sale of common stock $ 7,056 2,250,944 2,258,000
Sale of common stock (in Shares)   7,056,250      
Net loss (1,086,438) (1,086,438)
Balance at Mar. 31, 2021 $ 14 $ 199,380 96,291,817 (93,353,202) 3,138,010
Balance (in Shares) at Mar. 31, 2021 13,602 199,380,821      
Common stock issued on exercise of stock options and warrants $ 600 41,400 42,000
Common stock issued on exercise of stock options and warrants (in Shares)   600,000      
RSU restricted Stock $ 31 4,519 4,550
RSU restricted Stock (in Shares)   31,250      
Balance at Dec. 31, 2020 $ 14 $ 190,529 93,778,591 (92,266,764) 1,702,370
Balance (in Shares) at Dec. 31, 2020 13,602 190,529,320      
Net loss         (3,763,607)
Balance at Sep. 30, 2021 $ 14 $ 205,701 100,066,194 (96,030,372) 4,241,539
Balance (in Shares) at Sep. 30, 2021 13,602 205,702,380      
Common stock issued on exercise of stock options and warrants (in Shares)   158,329      
Balance at Mar. 31, 2021 $ 14 $ 199,380 96,291,817 (93,353,202) 3,138,010
Balance (in Shares) at Mar. 31, 2021 13,602 199,380,821      
Stock-based compensation 318,818 318,818
Common stock issued on cashless exercise of options and warrant $ 260 (260)
Common stock issued on cashless exercise of options and warrant (in Shares)   259,741      
Net loss (1,225,360) (1,225,360)
Balance at Jun. 30, 2021 $ 14 $ 200,090 96,638,926 (94,578,562) 2,260,468
Balance (in Shares) at Jun. 30, 2021 13,602 200,090,572      
Common stock issued on exercise of stock options and warrants $ 450 28,550 29,000
Common stock issued on exercise of stock options and warrants (in Shares)   450,010      
Stock-based compensation 354,880 354,880
Common stock issued on cashless exercise of options and warrant $ 957 (957)
Common stock issued on cashless exercise of options and warrant (in Shares)   957,143      
Sale of common stock $ 4,054 3,036,946 3,041,000
Sale of common stock (in Shares)   4,054,665      
Net loss (1,451,810) (1,451,810)
Balance at Sep. 30, 2021 $ 14 $ 205,701 100,066,194 (96,030,372) 4,241,539
Balance (in Shares) at Sep. 30, 2021 13,602 205,702,380      
Common stock issued on exercise of stock options and warrants $ 600 36,400 37,000
Common stock issued on exercise of stock options and warrants (in Shares)   600,000      
Balance at Dec. 31, 2021 $ 14 $ 207,562 100,452,862 (97,692,217) 2,968,221
Balance (in Shares) at Dec. 31, 2021 13,602 207,562,461      
Stock-based compensation 554,877 554,877
Net loss (1,781,190) (1,781,190)
Balance at Mar. 31, 2022 $ 14 $ 207,692 101,007,609 (99,473,407) 1,741,908
Balance (in Shares) at Mar. 31, 2022 13,602 207,692,878      
RSU restricted Stock $ 130 (130)
RSU restricted Stock (in Shares)   130,417      
Balance at Dec. 31, 2021 $ 14 $ 207,562 100,452,862 (97,692,217) 2,968,221
Balance (in Shares) at Dec. 31, 2021 13,602 207,562,461      
Net loss         (4,265,136)
Balance at Sep. 30, 2022 $ 14 $ 207,817 101,728,483 (101,957,353) (21,038)
Balance (in Shares) at Sep. 30, 2022 13,602 207,817,878      
Balance at Mar. 31, 2022 $ 14 $ 207,692 101,007,609 (99,473,407) 1,741,908
Balance (in Shares) at Mar. 31, 2022 13,602 207,692,878      
Stock-based compensation 449,508 449,508
Common stock issued on exercise of option $ 100 12,900 13,000
Common stock issued on exercise of option (in Shares)   100,000      
Net loss (1,557,542) (1,557,542)
Balance at Jun. 30, 2022 $ 14 $ 207,792 101,470,017 (101,030,949) 646,874
Balance (in Shares) at Jun. 30, 2022 13,602 207,792,878      
Stock-based compensation 257,241 257,241
Net loss (926,404) (926,404)
Balance at Sep. 30, 2022 $ 14 $ 207,817 101,728,483 (101,957,353) (21,038)
Balance (in Shares) at Sep. 30, 2022 13,602 207,817,878      
Common stock issued on exercise of stock options and warrants   $ 25 $ 1,225 $ 1,250
Common stock issued on exercise of stock options and warrants (in Shares)   25,000      
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (4,265,136) $ (3,763,607)
Adjustments to reconcile net loss to net cash used in operating activities:    
Noncash stock-based compensation expense 1,261,626 848,277
Amortization of ROU assets 83,965
Depreciation and amortization 50,499 18,021
PPP loan forgiveness (81,550)
Amortization of future compensation payable 416,666 625,000
Amortization of prepaid assets 162,760 122,660
Loss on disposal of equipment 14,540
Changes in assets and liabilities:    
Accounts receivable (219,618)
Other assets 2,880
ROU liabilities (53,959) 24,216
Prepaids and deposits (237,097) (48,218)
Accounts payable 53,863 (28,051)
Accrued interest 696
Accrued expenses and compensation (11,063) 29
Net cash used in operating activities (2,742,953) (2,279,649)
Cash Flows from Investing Activities    
Purchase of equipment (78,996) (206,198)
Net cash used in investing activities (78,996) (206,198)
Cash Flows from Financing Activities    
Repayment on note payable (460,002) (1,102,113)
Proceeds from sale of common stock 5,299,000
Proceeds from note payable 175,435
Proceeds from subscription payable 585,000
Proceeds from exercise of stock options and warrants 14,250 108,000
Net cash provided by financing activities 314,682 4,304,887
Net change in cash and cash equivalents (2,507,267) 1,819,042
Cash and cash equivalents, beginning of year 3,662,615 3,323,290
Cash and cash equivalents, end of period 1,155,349 5,142,332
Supplemental disclosure of cash flow information    
Cash paid for interest 1,683 1,421
Cash paid for taxes
Non-cash investing and financing activities    
Insurance financing for prepaid insurance 175,435 117,209
Implementation of ASC 842 617,569
Forgiveness of PPP loan 81,449
Equipment investing in accounts payable 64,107
Common stock issued for repayment of convertible notes $ 47,499
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization of Business, Going Concern and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2021, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.

 

Going Concern

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

 

For the nine months ended September 30, 2022, the company incurred a net loss of $4,265,136, had negative cash flows from operations of $2,742,953 and may incur additional future losses due to limited contract activity. At September 30, 2022, the company had total current assets of $1,492,695 and total current liabilities of $1,786,868, resulting in a working capital deficit of $294,173. At September 30, 2022, the company had cash of $1,155,349.

 

Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from a government grant and contract, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. 

 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.

 

The ongoing COVID-19 pandemic and pandemic-related trade conditions, such as exacerbated port congestion, supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company’s financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the company will be successful in its effort to secure additional equity financing. During the three months ended September 30, 2022, the company received funds in the amount of $585,000 as part of a pending placement of equity which it has recognized as a subscription payable. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other relevant matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities and valuation of debt discount related to beneficial conversion features.

 

Net Loss Attributable to Common Stockholders

 

Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 24,424,550 and 32,019,604 for the nine months ended September 30 2022 and 2021, respectively.

 

Significant Concentrations and Risks

 

We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2022, $905,349 was uninsured.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
New Accounting Standards
9 Months Ended
Sep. 30, 2022
New Accounting Standards [Abstract]  
NEW ACCOUNTING STANDARDS

NOTE 2 – NEW ACCOUNTING STANDARDS

 

The company has reviewed all issued accounting pronouncements and plans to adopt those that are applicable to it. The company does not expect the adoption of any other pronouncements to have an impact on its results of operations or financial position.

 

In December 2019, the FASB issued amended guidance in the form of ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU is intended to simplify various aspects of accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarifying certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for annual periods beginning after December 15, 2020, and interim periods within those annual periods, with early adoption permitted. An entity that elects early adoption must adopt all the amendments in the same period. Most amendments within this ASU are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The company has evaluated the impact of this new standard and notes the guidance did not have a material impact on our financial statements.

 

On August 5, 2020, the FASB issued ASU No. 2020-06 which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 simplifies the guidance in U.S. GAAP on the issuer’s accounting for convertible debt instruments and preferred stock. Such guidance includes multiple disparate sets of classification, measurement, and derecognition requirements whose interactions are complex. ASU 2020-06 is effective for annual periods beginning after December 15, 2021, and interim periods within those annual periods, with early adoption permitted. An entity that elects early adoption must adopt all the amendments in the same period. Most amendments within this ASU are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The company adopted this standard on January 1, 2022. The adoption of this standard did not have a material impact on the company’s financial statements.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable
9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

 

On May 24, 2019, the company entered into an Asset Purchase Agreement (the “APA”) with Applied Optical Sciences, LLC (“AOS”) to acquire certain assets. As consideration for the APA, the company entered into a promissory note issued to the shareholders of AOS for $2,500,000. The note is non-interest bearing and payable in equal installments. The company made the first three payments of $500,000 on February 10, 2021, May 24, 2021, and November 19, 2021, respectively. The Promissory Note was amended on May 23, 2022 as modification of debt to extend the maturity date by one year to, May 24, 2023, and restructure the payment to time up to the adjusted maturity date. The remaining balance of $1,000,000 as of June 30, 2022 is to be paid in ten equal installments of $100,000 over a period of ten month with the final installment to paid on April 24, 2023. In accordance with the terms of the promissory note, the company made three payments of $100,000, for an aggregate total repayment of $300,000. As of September 30, 2022, $700,000 in principle was outstanding on this loan.

 

Paycheck Protection Program

 

On April 28, 2020, the company entered into a loan agreement with Alliance Bank of Arizona, N.A. for a loan in the amount of $132,760 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act enacted on March 27, 2020 (the “CARES Act”). This loan is evidenced by a promissory note, dated April 27, 2020, and matured two years from the disbursement date. This loan bears interest at a rate of 1.00% per annum, with the first six-months ended of interest deferred. Principal and interest are payable monthly commencing six-months ended after the disbursement date and may be prepaid by the company at any time prior to maturity with no prepayment penalties. This loan contains customary events of default relating to, among other things, payment defaults or breaches of the terms of the loan. Upon the occurrence of an event of default, the lender may require immediate repayment of all amounts outstanding under the note.

 

Under the terms of the PPP, up to the entire amount of principal and accrued interest may be forgiven to the extent loan proceeds are used for qualifying expenses as described in the CARES Act and applicable implementing guidance issued by the U.S. Small Business Administration (“SBA”) under the PPP. The company partially used the loan amount for designated qualifying expenses and received notice from the SBA on June 30, 2021, that the company would not be required to repay $81,550 in proceeds. As a result, the company received partial forgiveness of the PPP amounting to $80,594 in principal and $956 in interest which is reflected within PPP forgiveness and other income on the statements of operations. During the six months ended June 30, 2020, the company paid the remaining balance of the loan in the aggregate of $23,553 in four equal payments, with loan formally repaid on April 20, 2022. As a result, as of September 30, 2022, no principal or interest was outstanding on this loan.

 

Premium Financing

 

On April 8, 2022, the company entered into an agreement with Oakwood D&O Insurance to provide financing in an amount of $234,367 for the insurance premium associated with two D&O policies. Both policies commenced March 12, 2022, and provided coverage for the next 12 months, expiring March 12, 2023. The loan bears interest at a fixed rate of 5% per annum and required the company to prepay $58,932 and appears on the balance sheet as a current asset. On April 12, 2022, the company commenced monthly principal and interest payments of $19,901, which was the first payment of nine remaining months due of $175,435, the last payment of which is scheduled to be made on December 31, 2022. As of September 30, 2022, the outstanding balance on the note was $38,985 and was recorded as notes payable, a currently liability, in the company’s condensed consolidated balance sheet.

 

Notes Payable Reconciliation

 

The following reconciles notes payable as of September 30, 2022, and December 31, 2021:

 

   September 30,
2022
   December 31,
2021
 
Beginning balance  $1,024,190   $2,681,157 
Notes payable   175,435    117,209 
Accrued interest   (640)   1,385 
Payments on notes payable   (460,002)   (1,646,513)
Extinguishment of debt   
-
    (81,550)
Converted into common stock   
-
    (47,498)
Total   738,985    1,024,190 
Less-Notes payable – current   738,985    1,024,190 
Notes payable – non-current  $
-
   $
-
 

 

Future principal payments for the company’s Notes as of September 30, 2022, are as follows:

 

2022  $338,985 
2023   400,000 
Thereafter   
 
 
Total  $738,985 

 

The company’s note payable balance of $738,985 is due within the next twelve months, in accordance with the terms of note payable. $700,000 of the outstanding notes payable balance at September 30, 2022 will be paid in seven equal installments of $100,000 over the next seven months, with the final installment to paid on April 24, 2023.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Deferred Compensation
9 Months Ended
Sep. 30, 2022
Deferred Compensation [Abstract]  
DEFERRED COMPENSATION

NOTE 4 – DEFERRED COMPENSATION

 

On May 24, 2019, the company entered into the APA with AOS to acquire certain assets. As consideration for the APA, the company entered into a promissory note issued to the shareholders of AOS for $2,500,000. The company also recorded a debt discount, which is reported on the balance sheet as deferred compensation, in the amount of $2,500,000, in relation to the transaction which is being amortized over the life of the loan as compensation expense. The amortization of deferred compensation for the nine months ended September 30, 2022, and 2021 was $416,666 and $625,000, respectively.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Due to Related Parties
9 Months Ended
Sep. 30, 2022
Related Party Transactions [Abstract]  
DUE TO RELATED PARTIES

NOTE 5 – DUE TO RELATED PARTIES

 

It has come to the board’s attention that on July 31, 2018, our now deceased CEO deposited $50,000 into the company’s account. Although it has been suggested that the funds may have been intended for use toward Mr. Dearmin’s healthcare, the board does not know for certain what the purpose of the funds were or the nature of any intended investment. Accordingly, the board is investigating the appropriate disposition of the funds which will likely be to the estate of Mr. Dearmin. Until such a determination is made, the board does not intend to use these funds for any corporate purpose. For reporting purposes, the company has treated the deposit as a due to related party.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity
9 Months Ended
Sep. 30, 2022
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 6 – STOCKHOLDERS’ EQUITY

 

Authorized Capital Stock

 

During the nine months ended September 30, 2021, the company issued 7,056,250 shares of common stock in a private placement to accredited investors for $0.32 per share or $2,258,000 of net cash proceeds, in the aggregate.

 

During the nine months ended September 30, 2021, the company issued 158,329 shares of common stock upon the conversion of $47,499 of convertible notes (see Note 3).

 

During the nine months ended September 30, 2021, the company issued 31,250 shares of common stock in relation to a restricted stock agreement with a value of $4,550.

 

During the nine months ended September 30, 2021, the company issued 800,000 shares of common stock upon the exercise of 800,000 warrants at an exercise price of $0.07 a share.

 

During the nine months ended September 30, 2021, the company issued 250,000 shares of common stock upon the exercise of 250,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 259,741 shares of common stock upon the exercise of 500,000 options at an exercise price of $0.37 a share. This exercise was performed on a cashless basis.

 

During the nine months ended September 30, 2021, the company issued 1,760,000 options to purchase common stock at an exercise price of $0.40 a share. The options vest over a period of three years from the date of the amendment.

 

During the nine months ended September 30, 2021, the company issued 4,054,665 shares of common stock in a private placement to accredited investors for $0.75 per share or $3,041,000 of net cash proceeds, in the aggregate.

 

During the nine months ended September 30, 2021, the company issued 50,000 shares of common stock upon the exercise of 50,000 warrants at an exercise price of $0.06 a share. During the nine months ended September 30, 2021, the company issued 100,000 shares of common stock upon the exercise of 100,000 warrants at an exercise price of $0.07 a share.

 

During the nine months ended September 30, 2021, the company issued 200,000 shares of common stock upon the exercise of 200,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 125,000 shares of common stock upon the exercise of 125,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 60,000 shares of common stock upon the exercise of 60,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 65,000 shares of common stock upon the exercise of 65,000 warrants at an exercise price of $0.06 a share.

 

During the nine months ended September 30, 2021, the company issued 475,000 shares of common stock with an exercise of 500,000 options. 25,000 shares of common stock were withheld with the exercise. This exercise was performed on a cashless basis.

 

During the nine months ended September 30, 2021, the company issued the company issued 482,143 shares of common stock with an exercise of 500,000 options. 17,857 shares of common stock were withheld with the exercise. This exercise was performed on a cashless basis

 

During the nine months ended September 30, 2022, the company issued 130,417 shares of common stock for previously vested and expensed shares in relation to a restricted stock agreement. For the nine months ended September 30, 2022, the Company recorded $0 in relation to these shares.

 

During the nine months ended September 30, 2022, the company issued 100,000 shares of common stock upon the exercise of 100,000 options at an exercise price of $0.13 a share. As a result, the company received $13,000 in cash proceeds as part of the transaction.

 

During the nine months ended September 30, 2022, the company issued 25,000 shares of common stock upon result of the two warrant exercises of 12,500 shares each, or 25,000 shares of common stock in the aggregate, at an exercise price of $0.05 a share. The company received $1,250 in cash proceeds as part of the transaction.

 

Effective August 1, 2022, the Company entered into an Executive Employment Agreement with Mr. Donaghey who was appointed the Company’s Chief Financial Officer ("CFO"). As part of the Executive Employment Agreement, the Company granted 1,000,000 options to purchase shares of common stock at an exercise price of $2.36 per share. The options vest over a period of four years and expire ten years from the date of the grant.  Mr. Donaghey was also granted 400,000 shares of restricted to units as part of his Executive Employment Agreement (see “Share-Based Payments” below). Further, Mr. Donaghey forfeited unvested options to purchase 950,000 shares of common stock which he had previously received for his service on the Company’s Board of Advisors. The forfeiture of the unvested options resulted in the reversal of previously recorded stock-based compensation expense in the amount of approximately $176,000.

 

As of nine months ended, September 30, 2022, the company recognized a subscription payable for $585,000 from the sale of common stock as a current liability on its balance sheet, reflecting the receipt of $585,000 in cash proceeds as part of a pending private equity placement transaction.

 

During the nine months ended September 30, 2022 and 2021, the company recognized stock-based compensation in the amount of $1,261,626 and $848,277, respectively.

 

Preferred Stock

 

As of September 30, 2022, and December 31, 2021, there were 13,602 shares of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Stock”) issued and outstanding, respectively. The company has not paid the dividends commencing with the quarterly dividend due August 1, 2013. Dividend arrearages as of June 30, 2022, including previously accrued dividends included in our balance sheet are approximately $314,546. Our Board of Directors suspended the declaration of the dividend, commencing with the dividend payable as of February 1, 2015, since we did not have a surplus (as such term is defined in the Delaware general corporation Law) as of December 31, 2014, until such time as we have a surplus or net profits for a fiscal year.

 

Our Series A Preferred Stock has a liquidation preference of $25.00 per Share. The Series A Preferred Stock bears dividends at the rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. Dividends may be paid in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement and the company’s common stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance or (iii) any combination of the foregoing. If the company fails to make a dividend payment within five business days following a dividend payment date, the dividend rate shall immediately and automatically increase by 1% from 6.5% of the liquidation preference per offered share of Series A preferred stock to 7.5% of such liquidation preference. If a payment default shall occur on two consecutive dividend payment dates, the dividend rate shall immediately and automatically increase to 10% of the liquidation preference for as long as such payment default continues and shall immediately and automatically return to the Initial dividend rate at such time as the payment default is no longer continuing.

 

Each share of Series A Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the liquidation preference (plus any unpaid dividends for periods prior to the dividend payment date immediately preceding the date of conversion by the holder) divided by the conversion price (initially $12.00 per share, subject to adjustment in the event of a stock dividend or split, reorganization, recapitalization or similar event). If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.

 

If a change of control occurs, each holder of shares of Series A Convertible Preferred Stock that are outstanding immediately prior to the change of control shall have the right to require the corporation to purchase, out of legally available funds, any outstanding shares of Series A Convertible Preferred Stock at the defined purchase price. The purchase price is defined as: per share of Preferred Stock, 101% of the liquidation preference thereof, plus all unpaid and accumulated dividends, if any, to the date of purchase thereof. The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.

 

If the Corporation pays all or a portion of the Purchase Price in Common Stock, no fractional shares of Common Stock will be issued; instead, the company will round the applicable number of shares of Common Stock up to the nearest whole number of shares; provided that the Corporation may pay the Purchase Price (or a portion thereof), whether in cash or in shares of Common Stock, only if the Corporation has funds legally available for such payment and may pay the Purchase Price (or a portion thereof) in shares of its Common Stock only if (i) the Common Stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance and (ii) a shelf registration statement covering the issuance by the Corporation and/or resales of the Common Stock issuable as payment of the Purchase Price is effective on the Payment Date unless such shares are eligible for immediate resale in the public market by non-affiliates of the Corporation.

 

The company pays an annual dividend on its preferred stock of approximately $34,000. For the nine months ended September 30, 2022 and 2021, the company has recorded $25,004 and $25,504 respectively as preferred stock dividends on its condensed consolidated statements of operations in relation to its annual dividend. Dividends on our Preferred Stock are payable quarterly on the first day of February, May, August and November, in cash or shares of Common Stock, at our discretion.

 

Share-Based Payments

 

Effective November 12, 2018, the Board of Directors of Applied Energetics, Inc. adopted the 2018 Incentive Stock Plan. The plan provides for the allocation and issuance of stock, restricted stock purchase offers and options (both incentive stock options and non-qualified stock options) to officers, directors, employees and consultants of the company. The board reserved a total of 50,000,000 shares for possible issuance under the plan.

 

We have, from time to time, also granted non-plan options to certain officers, directors, employees and consultants. Total stock-based compensation expense for grants to officers, employees and consultants was $1,261,626 and $848,277 for the nine months ended September 30, 2022, and 2021, respectively, which was charged to general and administrative expense.

 

Stock-based compensation for the year ended December 31, 2021, was comprised of 140,000 shares under a restricted stock agreement the company entered into in May of 2021. The restricted stock awards were valued at $84,000 of which the full $84,000 was recognized as of September 30, 2022. The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.

 

As part of his Executive Employment Agreement dated July 13, 2022 the company granted 400,000 shares issued as restricted stock units to the Chief Financial Officer. The restricted stock units were valued at $928,000 of which $50,780 was recognized as of September 30, 2022. The shares vest in equal annual installments over four years. If either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date. The Restricted Stock Units are issued pursuant to a Restricted Stock Unit Agreement, dated as of July 13, 2022.

 

Stock based compensation for the nine months ended September 30, 2022, was comprised of 250,000 shares issued pursuant to the restricted stock unit agreement, dated July 13, 2022. The restricted stock units were valued at $580,000 of which $42,297 was recognized as of September 30, 2022. The shares vest with 25% being vested at the end of year one and two respectively, with the remaining 50% being expensed at the end of year three. If either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.

 

The $1,261,626 stock-based compensation for the nine months ended September 30, 2022, was comprised of $930,077 option expense, $108,549 expense from the vesting of the restricted stock and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.

 

The company recognized no related income tax benefit because our deferred tax assets are fully offset by a valuation allowance.

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model.

 

As of September 30, 2022, the company has $4,998,280 of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of approximately six years.

 

The following table summarizes the activity of our stock options for the nine-months ended September 30:

 

   Shares   Weighted
Average
Exercise Price
   Weighted
Average
Contractual Term
Outstanding
   Intrinsic
Value
 
Outstanding at December 31, 2021   28,415,000   $0.1859    5.84   $50,673,665 
Granted   2,390,000    2.2130    9.48    17,378,564 
Exercised   (100,000)   (0.1300)   6.09    (961,438)
Forfeited or expired   (7,950,000)   
-
    
-
    (75,400,831)
Outstanding at September 30, 2022   22,755,000    0.3378    6.66    208,131,088 
                     
Outstanding and exercisable at September 30, 2022   20,308,888    0.1751    6.34    189,061,250 

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model applying the assumptions in the following table:

 

    Nine-Months Ended
September 30,
 
    2022     2021  
Assumptions:            
Risk-free interest rate     1.26-1.30 %     .05-0.07 %
Expected dividend yield     0 %     0 %
Expected volatility     126 %     128-130 %
Expected life (in years)     5       2-3  

 

The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the nine months ended September 30, 2022, was as follows:

 

   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
         
Outstanding at December 31, 2021   215,000   $0.52 
Granted – restricted stock units and awards   650,000    2.32 
Granted – performance-based stock units   
-
    
-
 
Canceled   
-
    
-
 
Vested and converted to shares   
-
    
-
 
Outstanding at September 30, 2022   865,000   $1.8708 

 

As of September 30, 2022, and December 31, 2021, there was $1,414,923 and $15,355 respectively in unrecognized stock-based compensation related to unvested restricted stock agreements, net of estimated forfeitures.

 

As of September 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $501,750, respectively, was amortized for the nine months ended September 30, 2022, and 2021.

 

Warrant stock activity for the nine-months ended September 30, 2022, was as follows:

 

   Warrant Activity 
   Shares   Weighted Average
Exercise Price
   Weighted Average remaining Contractual Term (years) 
Outstanding at December 31, 2021   1,775,000   $0.0599    7.43 
Granted   
-
    
-
    
-
 
Exercised   (25,000)   0.0500    
-
 
Forfeited   
-
    
-
    
-
 
Outstanding and exercisable at September 30, 2022   1,750,000   $0.0600    6.78 

 

   Warrants Outstanding   Warrants Exercisable 
Range of Exercise Prices  Shares
Outstanding
   Weighted
Avg.
Remaining
Contractual
Life in Years
   Weighted Avg.
Exercise
Price
   Shares
Exercisable
   Weighted Avg.
Exercise
Price
 
$0.05 - $0.07   1,750,000    0.01   $0.0600    1,750,000   $0.0600 
    1,750,000    0.01   $0.0600    1,750,000   $0.0600 

 

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model applying the assumptions in the following table:

 

   Nine-months Ended
September 30,
 
   2022   2021 
Assumptions:        
Risk-free interest rate   0%   0%
Expected dividend yield   0%   0%
Expected volatility   0%   0%
Expected life (in years)   0    0 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition
9 Months Ended
Sep. 30, 2022
Revenue Recognition [Abstract]  
REVENUE RECOGNITION

NOTE 7 – REVENUE RECOGNITION

 

The Company derives revenue from technical research detailing the findings of its investigations to its customers under contract for specific projects. Under Topic 606, revenue is recognized when control of promised goods and services is transferred to customers, and the amount of revenue recognized reflects the consideration to which an entity expects to be entitled to in exchange for the goods and services transferred. A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The Company’s contracts require significant integrated services and are accounted for as a single performance obligation, and revenue is recognized by the Company over the contract term at a fixed contract price.

 

Concentrations

 

During the nine months ended September 30, 2022, the company earned revenue from two contracts with two separate customers. One customer accounted for $648,905 or 85% of revenue recognized during the period. As of September 30, 2022. The company has $219,618 of accounts receivable recorded as current assets on the balance sheet. As of September 30, 2022, one customer accounted for $162,226 or 74% of accounts receivable. The company had no revenue during the nine months ended, September 30, 2021.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Operating Leases

 

In March 2021, the company signed a five-year lease for a 13,000 square foot laboratory/office space in Tucson. The initial base rent was $6.7626 per rentable square foot for year one, and escalated to $9.2009 in year two, $11.4806 in year three, $13.1740 in year four and $14.9306 in year five, plus certain operating expenses and taxes.

 

The company incurred lease expense for its operating leases of $193,326 which was included in general and administrative expenses in the statements of operation for the periods ended September 30, 2022. During the nine months ended September 30, 2022, the company made cash lease payments in the amount of $166,501.

 

At September 30, 2022, we had approximately $128,000 in future minimum lease payments due in less than a year. The below table presents the future minimum lease payments due reconciled to lease liabilities.

 

   Operating Lease 
For the fiscal years ending December 31, 2022:    
2022  $30,752 
2023   143,325 
2024   168,577 
2025   191,779 
2026   66,536 
Thereafter   
-
 
Total undiscounted lease payments   600,969 
Present value discount, less interest   71,512 
Lease Liability  $529,426 

 

Guarantees

 

The company agrees to indemnify its officers and directors for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The maximum amount of future payments that the company could be required to make under these indemnification agreements is unlimited. However, the company maintains a director’s and officer’s liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. As a result, it believes the estimated fair value of these indemnification agreements is minimal because of its insurance coverage, and it has not recognized any liabilities for these agreements as of September 30, 2022 and 2021.

 

Litigation

 

On July 3, 2019, Gusrae, Kaplan & Nusbaum and its partner, Ryan Whalen filed a complaint in the United States District Court for the Southern District of New York against the company, its directors, officers, attorneys and a consultant. The action alleged libel, securities fraud and related claims. The company filed a motion to dismiss the complaint on October 24, 2019. On December 13, 2019, Gusrae Kaplan and Mr. Whalen filed an opposition to the company’s motion. On January 10, 2020, the company filed a reply brief. On August 5, 2021, the plaintiffs filed a Notice of Voluntary Dismissal of the action without prejudice.

 

On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr. Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties are currently engaged in discovery. No trial date has been set.

 

On September 7, 2021, Gusrae Kaplan & Nusbaum and its partner Ryan Whalen filed a complaint in the New York Supreme Court against the company, its directors, officers, attorneys and a consultant, alleging a single claim for defamation per se based on the same conduct underlying their claim of libel in their voluntarily dismissed federal court action. The company filed a motion to dismiss the complaint on October 29, 2021, to which Gusrae Kaplan & Nusbaum and Mr. Whalen filed an opposition on January 13, 2022, and the company filed its reply brief on February 17, 2022.

 

On May 23, 2022, the New York Supreme Court held a hearing on the motion to dismiss, and Judge Hagler ruled from the bench, granting all defendants’, including Applied Energetics’, motions to dismiss the claim, in its entirety, with prejudice. While he noted that defendants’ arguments regarding the claim being time-barred and the court lacking personal jurisdiction over certain defendants may have merit, he elected not to rule on those issues as he believed it appropriate to reach the merits. The judge declined to award sanctions requested by the defendants in this claim. The plaintiffs have filed a notice of intent to appeal the dismissal but have not filed their actual appeal brief, which is due on December 21, 2022.

 

As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.

 

We may, from time to time, be involved in legal proceedings arising from the normal course of business.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

The company’s management has evaluated subsequent events occurring after September 30, 2022, the date of our most recent balance sheet, through the date our financial statements were issued.

 

Subsequent to September 30, 2022, the Company received $2,931,000 in cash proceeds from a pending placement of common stock at a price of $2.20 per share, as amended in November 2022 per agreement between the company and the investors.

 

As of October 20, 2022, the Company issued incentive stock options to purchase up to 50,000 shares of common stock to an employee. The options are exercisable at a price of $2.30 per share.

 

As of November 4, 2022, the Company issued incentive stock options to purchase up to 50,000 shares of common stock to an employee. The options are exercisable at a price of $2.24 per share.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2021, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.

 

Going Concern At September 30, 2022, the company had total current assets of $1,492,695 and total current liabilities of $1,786,868, resulting in a working capital deficit of $294,173. At September 30, 2022, the company had cash of $1,155,349.

Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from a government grant and contract, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. 

 

The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.

 

The ongoing COVID-19 pandemic and pandemic-related trade conditions, such as exacerbated port congestion, supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company’s financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the company will be successful in its effort to secure additional equity financing. During the three months ended September 30, 2022, the company received funds in the amount of $585,000 as part of a pending placement of equity which it has recognized as a subscription payable. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.

 

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.

 

Use of Estimates

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other relevant matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities and valuation of debt discount related to beneficial conversion features.

 

Net Loss Attributable to Common Stockholders

Net Loss Attributable to Common Stockholders

 

Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 24,424,550 and 32,019,604 for the nine months ended September 30 2022 and 2021, respectively.

 

Significant Concentrations and Risks

Significant Concentrations and Risks

 

We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2022, $905,349 was uninsured.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable (Tables)
9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Schedule of reconciles notes payable
   September 30,
2022
   December 31,
2021
 
Beginning balance  $1,024,190   $2,681,157 
Notes payable   175,435    117,209 
Accrued interest   (640)   1,385 
Payments on notes payable   (460,002)   (1,646,513)
Extinguishment of debt   
-
    (81,550)
Converted into common stock   
-
    (47,498)
Total   738,985    1,024,190 
Less-Notes payable – current   738,985    1,024,190 
Notes payable – non-current  $
-
   $
-
 

 

Schedule of future principal payments
2022  $338,985 
2023   400,000 
Thereafter   
 
 
Total  $738,985 

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2022
Stockholders’ Equity [Abstract]  
Schedule of stock options
   Shares   Weighted
Average
Exercise Price
   Weighted
Average
Contractual Term
Outstanding
   Intrinsic
Value
 
Outstanding at December 31, 2021   28,415,000   $0.1859    5.84   $50,673,665 
Granted   2,390,000    2.2130    9.48    17,378,564 
Exercised   (100,000)   (0.1300)   6.09    (961,438)
Forfeited or expired   (7,950,000)   
-
    
-
    (75,400,831)
Outstanding at September 30, 2022   22,755,000    0.3378    6.66    208,131,088 
                     
Outstanding and exercisable at September 30, 2022   20,308,888    0.1751    6.34    189,061,250 

 

Schedule of black-scholes- merton option-pricing model applying the assumptions
    Nine-Months Ended
September 30,
 
    2022     2021  
Assumptions:            
Risk-free interest rate     1.26-1.30 %     .05-0.07 %
Expected dividend yield     0 %     0 %
Expected volatility     126 %     128-130 %
Expected life (in years)     5       2-3  

 

   Nine-months Ended
September 30,
 
   2022   2021 
Assumptions:        
Risk-free interest rate   0%   0%
Expected dividend yield   0%   0%
Expected volatility   0%   0%
Expected life (in years)   0    0 
Schedule of fair value of restricted stock and restricted stock units
   Restricted Stock Outstanding 
   Shares   Weighted
Average
Fair Value
per Share
at Grant Date
 
         
Outstanding at December 31, 2021   215,000   $0.52 
Granted – restricted stock units and awards   650,000    2.32 
Granted – performance-based stock units   
-
    
-
 
Canceled   
-
    
-
 
Vested and converted to shares   
-
    
-
 
Outstanding at September 30, 2022   865,000   $1.8708 

 

Schedule of unrecognized stock-based compensation related to a lockup agreement
   Warrant Activity 
   Shares   Weighted Average
Exercise Price
   Weighted Average remaining Contractual Term (years) 
Outstanding at December 31, 2021   1,775,000   $0.0599    7.43 
Granted   
-
    
-
    
-
 
Exercised   (25,000)   0.0500    
-
 
Forfeited   
-
    
-
    
-
 
Outstanding and exercisable at September 30, 2022   1,750,000   $0.0600    6.78 

 

Schedule of range exercise prices warrants outstanding and exercisable
   Warrants Outstanding   Warrants Exercisable 
Range of Exercise Prices  Shares
Outstanding
   Weighted
Avg.
Remaining
Contractual
Life in Years
   Weighted Avg.
Exercise
Price
   Shares
Exercisable
   Weighted Avg.
Exercise
Price
 
$0.05 - $0.07   1,750,000    0.01   $0.0600    1,750,000   $0.0600 
    1,750,000    0.01   $0.0600    1,750,000   $0.0600 

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of future minimum lease payments
   Operating Lease 
For the fiscal years ending December 31, 2022:    
2022  $30,752 
2023   143,325 
2024   168,577 
2025   191,779 
2026   66,536 
Thereafter   
-
 
Total undiscounted lease payments   600,969 
Present value discount, less interest   71,512 
Lease Liability  $529,426 

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Accounting Policies [Abstract]    
Net loss $ 4,265,136  
Negative cash flows from operations 2,742,953  
Total current assets 1,492,695  
Current liability 1,786,868  
Working capital 294,173  
Total cash 1,155,349  
Subscription amount received $ 585,000  
Earning per share antidilutive (in Shares) 24,424,550 32,019,604
Cash uninsured $ 905,349  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable (Details) - USD ($)
1 Months Ended 6 Months Ended 9 Months Ended
Apr. 12, 2022
Apr. 08, 2022
Jun. 30, 2021
Apr. 28, 2020
May 24, 2019
Jun. 30, 2022
Jun. 30, 2020
Sep. 30, 2022
Dec. 31, 2021
Nov. 19, 2021
May 24, 2021
Feb. 10, 2021
Notes Payable (Details) [Line Items]                        
Promissory note issued         $ 2,500,000              
Payments           $ 1,000,000   $ 100,000   $ 500,000 $ 500,000 $ 500,000
Maturity date by one year               The Promissory Note was amended on May 23, 2022 as modification of debt to extend the maturity date by one year to, May 24, 2023, and restructure the payment to time up to the adjusted maturity date.        
Paid amount           $ 100,000            
Aggregate amount             $ 23,553 $ 300,000        
Outstanding Principle Amount               700,000        
Payment, description       the company entered into a loan agreement with Alliance Bank of Arizona, N.A. for a loan in the amount of $132,760 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act enacted on March 27, 2020 (the “CARES Act”). This loan is evidenced by a promissory note, dated April 27, 2020, and matured two years from the disbursement date. This loan bears interest at a rate of 1.00% per annum, with the first six-months ended of interest deferred. Principal and interest are payable monthly commencing six-months ended after the disbursement date and may be prepaid by the company at any time prior to maturity with no prepayment penalties.                
Proceeds amount     $ 81,550                  
Financial amount   $ 234,367                    
Interest fixed rate   5.00%                    
Current asset   $ 58,932           117,728 $ 43,391      
Principal amount $ 19,901                      
Interest payments $ 175,435                      
Notes payable outstanding balance               38,985        
Note payable balance               738,985        
Outstanding notes payable               700,000        
Installments               100,000        
PPP Forgiveness [Member]                        
Notes Payable (Details) [Line Items]                        
PPP principal amount               80,594        
PPP interest amount               $ 956        
AOS [Member]                        
Notes Payable (Details) [Line Items]                        
Promissory note issued         $ 2,500,000              
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable (Details) - Schedule of reconciles notes payable - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Schedule Of Reconciles Notes Payable Abstract    
Beginning balance $ 1,024,190 $ 2,681,157
Notes payable 175,435 117,209
Accrued interest (640) 1,385
Payments on notes payable (460,002) (1,646,513)
Extinguishment of debt (81,550)
Converted into common stock (47,498)
Total 738,985 1,024,190
Less-Notes payable – current 738,985 1,024,190
Notes payable – non-current
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable (Details) - Schedule of future principal payments
Sep. 30, 2022
USD ($)
Schedule Of Future Principal Payments Abstract  
2022 $ 338,985
2023 400,000
Thereafter
Total $ 738,985
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Deferred Compensation (Details) - USD ($)
1 Months Ended 9 Months Ended
May 24, 2019
Sep. 30, 2022
Sep. 30, 2021
Deferred Compensation [Abstract]      
Promissory note issued $ 2,500,000    
Deferred compensation $ 2,500,000    
Amortization of deferred compensation   $ 416,666 $ 625,000
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Due to Related Parties (Details)
1 Months Ended
Jul. 31, 2018
USD ($)
CEO [Member]  
Due to Related Parties (Details) [Line Items]  
Deposited $ 50,000
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 01, 2022
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Stockholders’ Equity (Details) [Line Items]                
Restricted shares value (in Dollars)   $ 0       $ 0    
Subscription payable, description           As a result, the company received $13,000 in cash proceeds as part of the transaction.During the nine months ended September 30, 2022, the company issued 25,000 shares of common stock upon result of the two warrant exercises of 12,500 shares each, or 25,000 shares of common stock in the aggregate, at an exercise price of $0.05 a share.    
Cash proceeds (in Dollars)           $ 1,250    
Shares granted (in Dollars per share) $ 1,000,000              
Exercise price (in Dollars per share) $ 2.36              
Restricted shares           400,000    
Forfeited shares           950,000    
Compensation expense (in Dollars)           $ 176,000    
Sale of current liability (in Dollars)   585,000       585,000    
Cash proceeds (in Dollars)           585,000    
Recognized stock based compensation expense (in Dollars)   $ 1,261,626 $ 848,277     $ 1,261,626 $ 848,277  
Series A convertible preferred stock, issued   13,602       13,602   13,602
Accrued dividends (in Dollars)           $ 314,546    
Series A convertible preferred stock, liquidation preference (in Dollars per share)   $ 25       $ 25    
Series A convertible preferred stock, dividend rate           6.50%    
Weighted average of the last sales prices           95.00%    
Dividend rate increase           10.00%    
Preferred stock conversion price per share (in Dollars per share)           $ 12    
Stockholders equity, description           If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.    
Common stock discount shares description           The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.    
Preferred stock, annual dividend (in Dollars)           $ 34,000 34,000  
Reserved a total possible issuance under the plan           50,000,000    
Total stock-based compensation expense for grants (in Dollars)           $ 1,261,626 848,277  
Share based compensation of restricted stock agreement shares               140,000
Restricted stock awards value (in Dollars)             84,000  
Recognized restricted stock awards value (in Dollars)           $ 580,000 $ 84,000  
Restricted stock, grants description           The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.    
Shares issued   250,000       250,000    
Restricted stock amount (in Dollars)           $ 42,297    
Shares vest portably years           4 years    
Percentage of vested           25.00%    
Remaining expensed percentage           50.00%    
Remaining expensed period           3 years    
Stock based compensation description           The $1,261,626 stock-based compensation for the nine months ended September 30, 2022, was comprised of $930,077 option expense, $108,549 expense from the vesting of the restricted stock and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.     
Unrecognized stock based compensation (in Dollars)           $ 4,998,280    
Stock based compensation restricted stock agreements (in Dollars)   $ 1,414,923       $ 1,414,923   $ 15,355
Common Stock [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares   25,000 600,000 450,010 600,000   158,329  
Shares issued for convertible notes             47,499  
Warrant [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             800,000  
Stock value issued for exercise of warrants     800,000       800,000  
Warrant exercise price per share (in Dollars per share)     $ 0.07       $ 0.07  
Warrant One [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             250,000  
Stock value issued for exercise of warrants     250,000       250,000  
Warrant exercise price per share (in Dollars per share)     $ 0.06       $ 0.06  
Options [Member]                
Stockholders’ Equity (Details) [Line Items]                
Warrant exercise price per share (in Dollars per share)     $ 0.37       $ 0.37  
Common stock option exercise     259,741       259,741  
Stock option exercise price Per share (in Dollars per share)             $ 500,000  
Restricted Stock Agreement [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares           130,417    
Warrant exercise price per share (in Dollars per share)     $ 0.4       $ 0.4  
Common stock option exercise     1,760,000       1,760,000  
Options vest over a period           3 years    
Warrant Two [Member]                
Stockholders’ Equity (Details) [Line Items]                
Stock value issued for exercise of warrants     50,000       50,000  
Warrant exercise price per share (in Dollars per share)     $ 0.06       $ 0.06  
Common stock option exercise     50,000       50,000  
Warrant Three [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             100,000  
Stock value issued for exercise of warrants     100,000       100,000  
Warrant exercise price per share (in Dollars per share)     $ 0.07       $ 0.07  
Warrant Four [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             200,000  
Stock value issued for exercise of warrants     200,000       200,000  
Warrant exercise price per share (in Dollars per share)     $ 0.06       $ 0.06  
Warrant Five [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             125,000  
Stock value issued for exercise of warrants     125,000       125,000  
Warrant exercise price per share (in Dollars per share)     $ 0.06       $ 0.06  
Options Two [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares           100,000    
Net cash proceeds (in Dollars)           $ 13,000    
Common stock option exercise   100,000 500,000     100,000 500,000  
Stock option exercise price Per share (in Dollars per share)           $ 0.13    
Common stock withheld with exercise     25,000       25,000  
Preferred Stock [Member]                
Stockholders’ Equity (Details) [Line Items]                
Liquidation preference           101.00%    
Minimum [Member]                
Stockholders’ Equity (Details) [Line Items]                
Liquidation preference           1.00%    
Vested Period           1 year    
Maximum [Member]                
Stockholders’ Equity (Details) [Line Items]                
Liquidation preference           6.50%    
Vested Period           2 years    
Warrant Six [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             60,000  
Stock value issued for exercise of warrants     60,000       60,000  
Warrant exercise price per share (in Dollars per share)     $ 0.06       $ 0.06  
Warrant Seven [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             65,000  
Stock value issued for exercise of warrants     65,000       65,000  
Warrant exercise price per share (in Dollars per share)     $ 0.06       $ 0.06  
Options Two [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             475,000  
Options Three [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             482,143  
Common stock option exercise     500,000       500,000  
Common stock withheld with exercise     17,857       17,857  
Private Placement [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             7,056,250  
Price per share (in Dollars per share)             $ 0.32  
Net cash proceeds (in Dollars)             $ 2,258,000  
Private Placement One [Member]                
Stockholders’ Equity (Details) [Line Items]                
Net cash proceeds (in Dollars)             $ 3,041,000  
Warrant exercise price per share (in Dollars per share)     $ 0.75       $ 0.75  
Common stock option exercise     4,054,665       4,054,665  
Series A Preferred Stock [Member]                
Stockholders’ Equity (Details) [Line Items]                
Series A convertible preferred stock, issued   13,602       13,602   13,602
Liquidation preference           7.50%    
Business Combination [Member]                
Stockholders’ Equity (Details) [Line Items]                
Issuable in acquisition, description           As of September 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $501,750, respectively, was amortized for the nine months ended September 30, 2022, and 2021.     
Chief Financial Officer [Member]                
Stockholders’ Equity (Details) [Line Items]                
Shares issued   400,000       400,000    
Restricted Stock [Member]                
Stockholders’ Equity (Details) [Line Items]                
Common stock shares             31,250  
Stock value issued for restricted stock agreement (in Dollars)             $ 4,550  
Recognized restricted stock awards value (in Dollars)           $ 928,000    
Restricted stock amount (in Dollars)           50,780    
Statements of operations [Member]                
Stockholders’ Equity (Details) [Line Items]                
Preferred stock, annual dividend (in Dollars)           $ 25,004 $ 25,504  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details) - Schedule of stock options
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Schedule Of Stock Options Abstract  
Shares Outstanding, Beginning Balance | shares 28,415,000
Weighted Average Exercise Price Outstanding, Beginning Balance | $ / shares $ 0.1859
Weighted Average Contractual Term Outstanding, Beginning Balance 5 years 10 months 2 days
Intrinsic Value Outstanding, Beginning Balance | $ $ 50,673,665
Shares Outstanding, Ending Balance | shares 22,755,000
Weighted Average Exercise Price Outstanding, Ending Balance | $ / shares $ 0.3378
Weighted Average Contractual Term Outstanding, Ending Balance 6 years 7 months 28 days
Intrinsic Value Outstanding, Ending Balance | $ $ 208,131,088
Shares Outstanding and exercisable, Ending Balance | shares 20,308,888
Weighted Average Exercise Price Outstanding and exercisable, Ending Balance | $ / shares $ 0.1751
Weighted Average Contractual Term Outstanding and exercisable, Ending Balance 6 years 4 months 2 days
Intrinsic Value Outstanding and exercisable, Ending Balance | $ $ 189,061,250
Shares, Granted | shares 2,390,000
Weighted Average Exercise Price, Granted | $ / shares $ 2.213
Weighted Average Contractual Term Outstanding, Granted 9 years 5 months 23 days
Intrinsic Value, Granted | $ $ 17,378,564
Shares, Exercised | shares (100,000)
Weighted Average Exercise Price, Exercised | $ / shares $ (0.13)
Weighted Average Contractual Term Outstanding, Exercised 6 years 1 month 2 days
Exercised | $ $ (961,438)
Shares, Forfeited or expired | shares (7,950,000)
Weighted Average Exercise Price, Forfeited or expired | $ / shares
Weighted Average Contractual Term Outstanding, Forfeited or expired
Intrinsic Value, Forfeited or expired | $ $ (75,400,831)
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Assumptions:    
Risk-free interest rate 0.00% 0.00%
Expected dividend yield 0.00% 0.00%
Expected volatility 0.00% 0.00%
Expected life (in years) 0 years 0 years
Fair Value of Option [Member]    
Assumptions:    
Expected dividend yield 0.00% 0.00%
Expected volatility 126.00%  
Expected life (in years) 5 years  
Minimum [Member] | Fair Value of Option [Member]    
Assumptions:    
Risk-free interest rate 1.26% 5.00%
Expected volatility   128.00%
Expected life (in years)   2 years
Maximum [Member] | Fair Value of Option [Member]    
Assumptions:    
Risk-free interest rate 1.30% 0.07%
Expected volatility   130.00%
Expected life (in years)   3 years
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details) - Schedule of fair value of restricted stock and restricted stock units - Restricted Stock Outstanding [Member]
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Stockholders’ Equity (Details) - Schedule of fair value of restricted stock and restricted stock units [Line Items]  
Shares, Outstanding beginning balance | shares 215,000
Weighted Average Fair Value per Share at Grant Date, Outstanding beginning balance | $ / shares $ 0.52
Shares, Granted – restricted stock units and awards | shares 650,000
Weighted Average Fair Value per Share at Grant Date, Granted – restricted stock units and awards | $ / shares $ 2.32
Shares, Granted – performance based stock units | shares
Weighted Average Fair Value per Share at Grant Date, Granted – performance based stock units | $ / shares
Shares, Canceled | shares
Weighted Average Fair Value per Share at Grant Date, Canceled | $ / shares
Shares, Vested and converted to shares | shares
Weighted Average Fair Value per Share at Grant Date, Vested and converted to shares | $ / shares
Shares, Outstanding ending balance | shares 865,000
Weighted Average Fair Value per Share at Grant Date, Outstanding ending balance | $ / shares $ 1.8708
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement - Warrant Activity [Member]
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Stockholders’ Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement [Line Items]  
Shares Outstanding | shares 1,775,000
Weighted Average Exercise Price | $ / shares $ 0.0599
Weighted Average remaining Contractual Term (years) 7 years 5 months 4 days
Shares, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average remaining Contractual Term (years), Granted
Shares, Exercised | shares (25,000)
Weighted Average Exercise Price, Exercised | $ / shares $ 0.05
Weighted Average remaining Contractual Term (years), Exercised
Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average remaining Contractual Term (years), Forfeited
Shares, Outstanding and exercisable | shares 1,750,000
Weighted Average Exercise Price, Outstanding and exercisable | $ / shares $ 0.06
Weighted Average Remaining Contractual Term (years), Outstanding and exercisable 6 years 9 months 10 days
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details) - Schedule of range exercise prices warrants outstanding and exercisable
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Warrants Outstanding, Shares Outstanding | shares 1,750,000
Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years 3 days
Warrants Outstanding, Weighted Avg. Exercise Price | $ / shares $ 0.06
Warrants Exercisable, Shares Exercisable | shares 1,750,000
Warrants Exercisable, Weighted Avg. Exercise Price | $ / shares $ 0.06
Range of Exercise Prices $0.05 - $0.07 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Warrants Outstanding, Shares Outstanding | shares 1,750,000
Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years 3 days
Warrants Outstanding, Weighted Avg. Exercise Price | $ / shares $ 0.06
Warrants Exercisable, Shares Exercisable | shares 1,750,000
Warrants Exercisable, Weighted Avg. Exercise Price | $ / shares $ 0.06
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition (Details)
9 Months Ended
Sep. 30, 2022
USD ($)
Revenue Recognition (Details) [Line Items]  
Accounts receivable $ 219,618
One Customer [Member]  
Revenue Recognition (Details) [Line Items]  
Earned revenue $ 648,905
Earned revenue recognized percentage 85.00%
Accounts receivable $ 162,226
Accounts receivable percentage 74.00%
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Details)
3 Months Ended 9 Months Ended
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
Commitments and Contingencies (Details) [Line Items]    
Operating Lease, Expense   $ 193,326
Cash lease payments   166,501
Future minimum lease payments   $ 128,000
Square Food Laboratory [Member]    
Commitments and Contingencies (Details) [Line Items]    
Lease square foot 13,000  
Base rent $ 6.7626  
Minimum lease payment sale lease back transactions within two year 9.2009  
Minimum lease payment sale leaseback transactions within three years 11.4806  
Minimum lease payment sale leaseback transactions, within four years 13.174  
Minimum lease payment sale leaseback transactions within five years $ 14.9306  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Details) - Schedule of future minimum lease payments
Sep. 30, 2022
USD ($)
Schedule Of Future Minimum Lease Payments Abstract  
2022 $ 30,752
2023 143,325
2024 168,577
2025 191,779
2026 66,536
Thereafter
Total undiscounted lease payments 600,969
Present value discount, less interest 71,512
Lease Liability $ 529,426
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details) - USD ($)
9 Months Ended
Sep. 30, 2022
Nov. 04, 2022
Oct. 20, 2022
Subsequent Events (Details) [Line Items]      
Cash proceeds $ 2,931,000    
Common stock price per share $2.20    
Share issued 250,000    
Subsequent Event [Member]      
Subsequent Events (Details) [Line Items]      
Share issued   50,000 50,000
Price per share   $ 2.24 $ 2.3
XML 47 f10q0922_appliedener_htm.xml IDEA: XBRL DOCUMENT 0000879911 2022-01-01 2022-09-30 0000879911 2022-11-08 0000879911 2022-09-30 0000879911 2021-12-31 0000879911 2022-07-01 2022-09-30 0000879911 2021-07-01 2021-09-30 0000879911 2021-01-01 2021-09-30 0000879911 us-gaap:PreferredStockMember 2021-12-31 0000879911 us-gaap:CommonStockMember 2021-12-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000879911 us-gaap:RetainedEarningsMember 2021-12-31 0000879911 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000879911 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000879911 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000879911 2022-01-01 2022-03-31 0000879911 us-gaap:PreferredStockMember 2022-03-31 0000879911 us-gaap:CommonStockMember 2022-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000879911 us-gaap:RetainedEarningsMember 2022-03-31 0000879911 2022-03-31 0000879911 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0000879911 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000879911 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000879911 2022-04-01 2022-06-30 0000879911 us-gaap:PreferredStockMember 2022-06-30 0000879911 us-gaap:CommonStockMember 2022-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000879911 us-gaap:RetainedEarningsMember 2022-06-30 0000879911 2022-06-30 0000879911 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0000879911 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000879911 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000879911 us-gaap:PreferredStockMember 2022-09-30 0000879911 us-gaap:CommonStockMember 2022-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000879911 us-gaap:RetainedEarningsMember 2022-09-30 0000879911 us-gaap:PreferredStockMember 2020-12-31 0000879911 us-gaap:CommonStockMember 2020-12-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000879911 us-gaap:RetainedEarningsMember 2020-12-31 0000879911 2020-12-31 0000879911 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000879911 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000879911 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000879911 2021-01-01 2021-03-31 0000879911 us-gaap:PreferredStockMember 2021-03-31 0000879911 us-gaap:CommonStockMember 2021-03-31 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000879911 us-gaap:RetainedEarningsMember 2021-03-31 0000879911 2021-03-31 0000879911 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000879911 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000879911 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000879911 2021-04-01 2021-06-30 0000879911 us-gaap:PreferredStockMember 2021-06-30 0000879911 us-gaap:CommonStockMember 2021-06-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000879911 us-gaap:RetainedEarningsMember 2021-06-30 0000879911 2021-06-30 0000879911 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000879911 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000879911 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000879911 us-gaap:PreferredStockMember 2021-09-30 0000879911 us-gaap:CommonStockMember 2021-09-30 0000879911 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000879911 us-gaap:RetainedEarningsMember 2021-09-30 0000879911 2021-09-30 0000879911 aerg:AppliedOpticalSciencesMember 2019-05-01 2019-05-24 0000879911 2021-02-10 0000879911 2021-05-24 0000879911 2021-11-19 0000879911 2022-01-01 2022-06-30 0000879911 2020-04-01 2020-04-28 0000879911 2021-06-01 2021-06-30 0000879911 aerg:PPPForgivenessMember 2022-09-30 0000879911 aerg:PPPForgivenessMember 2022-01-01 2022-09-30 0000879911 2020-01-01 2020-06-30 0000879911 2022-04-01 2022-04-08 0000879911 2022-04-08 0000879911 2022-04-12 0000879911 2022-04-01 2022-04-12 0000879911 2021-01-01 2021-12-31 0000879911 2019-05-01 2019-05-24 0000879911 srt:ChiefExecutiveOfficerMember 2018-07-01 2018-07-31 0000879911 us-gaap:PrivatePlacementMember 2021-01-01 2021-09-30 0000879911 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000879911 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0000879911 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000879911 us-gaap:WarrantMember 2021-09-30 0000879911 aerg:WarrantsOneMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantsOneMember 2021-09-30 0000879911 aerg:OptionsMember 2021-09-30 0000879911 aerg:OptionsMember 2021-01-01 2021-09-30 0000879911 aerg:OptionsOneMember 2021-09-30 0000879911 aerg:OptionsOneMember 2022-01-01 2022-09-30 0000879911 aerg:PrivatePlacement1Member 2021-09-30 0000879911 aerg:PrivatePlacement1Member 2021-01-01 2021-09-30 0000879911 aerg:WarrantTwoMember 2021-09-30 0000879911 aerg:WarrantThreeMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantThreeMember 2021-09-30 0000879911 aerg:WarrantFourMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantFourMember 2021-09-30 0000879911 aerg:WarrantFiveMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantFiveMember 2021-09-30 0000879911 aerg:WarrantSixMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantSixMember 2021-09-30 0000879911 aerg:WarrantSevenMember 2021-01-01 2021-09-30 0000879911 aerg:WarrantSevenMember 2021-09-30 0000879911 aerg:OptionsTwoMember 2021-01-01 2021-09-30 0000879911 aerg:OptionsTwoMember 2021-09-30 0000879911 aerg:OptionsThreeMember 2021-01-01 2021-09-30 0000879911 aerg:OptionsThreeMember 2021-09-30 0000879911 aerg:OptionsTwoMember 2022-01-01 2022-09-30 0000879911 aerg:OptionsTwoMember 2022-09-30 0000879911 2022-08-01 0000879911 2022-07-25 2022-08-01 0000879911 us-gaap:ConvertiblePreferredStockMember 2022-09-30 0000879911 us-gaap:ConvertiblePreferredStockMember 2021-12-31 0000879911 srt:MinimumMember 2022-01-01 2022-09-30 0000879911 srt:MaximumMember 2022-01-01 2022-09-30 0000879911 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-09-30 0000879911 us-gaap:PreferredStockMember 2022-01-01 2022-09-30 0000879911 us-gaap:OperatingIncomeLossMember 2022-01-01 2022-09-30 0000879911 us-gaap:OperatingIncomeLossMember 2021-01-01 2021-09-30 0000879911 srt:ChiefFinancialOfficerMember 2022-09-30 0000879911 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0000879911 aerg:BusinessCombinationMember 2022-01-01 2022-09-30 0000879911 srt:MinimumMember aerg:FairValueOfOptionMember 2022-01-01 2022-09-30 0000879911 srt:MaximumMember aerg:FairValueOfOptionMember 2022-01-01 2022-09-30 0000879911 srt:MinimumMember aerg:FairValueOfOptionMember 2021-01-01 2021-09-30 0000879911 srt:MaximumMember aerg:FairValueOfOptionMember 2021-01-01 2021-09-30 0000879911 aerg:FairValueOfOptionMember 2022-01-01 2022-09-30 0000879911 aerg:FairValueOfOptionMember 2021-01-01 2021-09-30 0000879911 aerg:RestrictedStockOutstandingMember 2021-12-31 0000879911 aerg:RestrictedStockOutstandingMember 2022-01-01 2022-09-30 0000879911 aerg:RestrictedStockOutstandingMember 2022-09-30 0000879911 aerg:WarrantActivityMember 2022-09-30 0000879911 aerg:WarrantActivityMember 2022-01-01 2022-09-30 0000879911 aerg:ZeropoinzerofivetozeropointzerosevenMember 2022-01-01 2022-09-30 0000879911 aerg:ZeropoinzerofivetozeropointzerosevenMember 2022-09-30 0000879911 aerg:OneCustomerMember 2022-01-01 2022-09-30 0000879911 aerg:OneCustomerMember 2022-09-30 0000879911 aerg:SquareFoodLaboratoryMember 2021-01-01 2021-03-31 0000879911 aerg:SquareFoodLaboratoryMember 2021-03-31 0000879911 us-gaap:SubsequentEventMember 2022-10-20 0000879911 us-gaap:SubsequentEventMember 2022-11-04 shares iso4217:USD iso4217:USD shares pure 10-Q true 2022-09-30 2022 false 001-14015 APPLIED ENERGETICS, INC. DE 77-0262908 9070 S. Rita Road Suite 1500 Tucson AZ 85747 (520) 628-7415 Yes Yes Non-accelerated Filer true false false Common Stock, par value $0.001 per share AERG 207817878 1155349 3662615 219618 117728 43391 1492695 3706006 220765 206810 416666 460705 544670 17004 17004 698474 1185150 2191169 4891156 249880 195381 738985 1000001 24189 50000 50000 104117 76227 10807 21870 48079 48079 585000 1786868 1415747 425339 507188 425339 507188 2212207 1922935 0.001 0.001 2000000 2000000 13602 13602 13602 13602 340050 340050 14 14 0.001 0.001 500000000 500000000 207817878 207817878 207562461 207562461 207817 207562 101728483 100452862 -101957353 -97692217 -21038 2968221 2191169 4891156 572766 763688 127668 142835 445098 620853 1249132 1304875 4365823 3412603 56416 83173 231528 235897 65364 61968 286365 192783 1370912 1450016 4883716 3841283 -925813 -1450016 -4262863 -3841283 637 637 81218 1227 1794 2910 3542 -590 -1794 -2273 77676 -926404 -1451810 -4265136 -3763607 -926404 -1451810 -4265136 -3763607 8501 8502 25504 25504 -934905 -1460312 -4290640 -3789111 0 -0.01 -0.02 -0.01 207794526 203857408 207726711 198786305 13602 14 207562461 207562 100452862 -97692217 2968221 130417 130 -130 554877 554877 -1781190 -1781190 13602 14 207692878 207692 101007609 -99473407 1741908 449508 449508 100000 100 12900 13000 -1557542 -1557542 13602 14 207792878 207792 101470017 -101030949 646874 257241 257241 25000 25 1225 1250 -926404 -926404 13602 14 207817878 207817 101728483 -101957353 -21038 13602 14 190529320 190529 93778591 -92266764 1702370 31250 31 4519 4550 170029 170029 1005682 1006 -1006 600000 600 41400 42000 158329 158 47340 47498 7056250 7056 2250944 2258000 -1086438 -1086438 13602 14 199380821 199380 96291817 -93353202 3138010 318818 318818 259741 260 -260 450010 450 28550 29000 -1225360 -1225360 13602 14 200090572 200090 96638926 -94578562 2260468 354880 354880 957143 957 -957 600000 600 36400 37000 4054665 4054 3036946 3041000 -1451810 -1451810 13602 14 205702380 205701 100066194 -96030372 4241539 -4265136 -3763607 -1261626 -848277 83965 50499 18021 -81550 416666 625000 162760 122660 -14540 219618 -2880 53959 -24216 237097 48218 53863 -28051 696 -11063 29 -2742953 -2279649 78996 206198 -78996 -206198 460002 1102113 5299000 175435 585000 14250 108000 314682 4304887 -2507267 1819042 3662615 3323290 1155349 5142332 1683 1421 175435 117209 617569 81449 64107 47499 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 – ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2021, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going Concern</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the nine months ended September 30, 2022, the company incurred a net loss of $4,265,136, had negative cash flows from operations of $2,742,953 and may incur additional future losses due to limited contract activity. At September 30, 2022, the company had total current assets of $1,492,695 and total current liabilities of $1,786,868, resulting in a working capital deficit of $294,173. At September 30, 2022, the company had cash of $1,155,349.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from a government grant and contract, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ongoing COVID-19 pandemic and pandemic-related trade conditions, such as exacerbated port congestion, supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company’s financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the company will be successful in its effort to secure additional equity financing. During the three months ended September 30, 2022, the company received funds in the amount of $585,000 as part of a pending placement of equity which it has recognized as a subscription payable. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other relevant matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities and valuation of debt discount related to beneficial conversion features.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Loss Attributable to Common Stockholders</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 24,424,550 and 32,019,604 for the nine months ended September 30 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Significant Concentrations and Risks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2022, $905,349 was uninsured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2021, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 4265136 2742953 At September 30, 2022, the company had total current assets of $1,492,695 and total current liabilities of $1,786,868, resulting in a working capital deficit of $294,173. At September 30, 2022, the company had cash of $1,155,349.<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from a government grant and contract, will be sufficient to meet its anticipated cash requirements for the near term. However, there can be no assurance that the current business plan will be achievable. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that management’s efforts will result in profitable operations or enable it to overcome future liquidity concerns. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ongoing COVID-19 pandemic and pandemic-related trade conditions, such as exacerbated port congestion, supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the company’s financial position and results of operations are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the company will be successful in its effort to secure additional equity financing. During the three months ended September 30, 2022, the company received funds in the amount of $585,000 as part of a pending placement of equity which it has recognized as a subscription payable. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1492695 1786868 294173 1155349 585000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other relevant matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, analysis of fair value transferred upon debt extinguishment, valuation and calculation of measurements of income tax assets and liabilities and valuation of debt discount related to beneficial conversion features.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Loss Attributable to Common Stockholders</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 24,424,550 and 32,019,604 for the nine months ended September 30 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 24424550 32019604 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Significant Concentrations and Risks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2022, $905,349 was uninsured.</p> 905349 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 – NEW ACCOUNTING STANDARDS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company has reviewed all issued accounting pronouncements and plans to adopt those that are applicable to it. The company does not expect the adoption of any other pronouncements to have an impact on its results of operations or financial position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">In December 2019, the FASB issued amended guidance in the form of ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU is intended to simplify various aspects of accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarifying certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for annual periods beginning after December 15, 2020, and interim periods within those annual periods, with early adoption permitted. An entity that elects early adoption must adopt all the amendments in the same period. Most amendments within this ASU are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The company has evaluated the impact of this new standard and notes the guidance did not have a material impact on our financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">On August 5, 2020, the FASB issued ASU No. 2020-06 which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 simplifies the guidance in U.S. GAAP on the issuer’s accounting for convertible debt instruments and preferred stock. Such guidance includes multiple disparate sets of classification, measurement, and derecognition requirements whose interactions are complex. ASU 2020-06 is effective for annual periods beginning after December 15, 2021, and interim periods within those annual periods, with early adoption permitted. An entity that elects early adoption must adopt all the amendments in the same period. Most amendments within this ASU are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The company adopted this standard on January 1, 2022. The adoption of this standard did not have a material impact on the company’s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 – NOTES PAYABLE</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">On May 24, 2019, the company entered into an Asset Purchase Agreement (the “APA”) with Applied Optical Sciences, LLC (“AOS”) to acquire certain assets. As consideration for the APA, the company entered into a promissory note issued to the shareholders of AOS for $2,500,000. The note is non-interest bearing and payable in equal installments. The company made the first three payments of $500,000 on February 10, 2021, May 24, 2021, and November 19, 2021, respectively. The Promissory Note was amended on May 23, 2022 as modification of debt to extend the maturity date by one year to, May 24, 2023, and restructure the payment to time up to the adjusted maturity date. The remaining balance of $1,000,000 as of June 30, 2022 is to be paid in ten equal installments of $100,000 over a period of ten month with the final installment to paid on April 24, 2023. In accordance with the terms of the promissory note, the company made three payments of $100,000, for an aggregate total repayment of $300,000. As of September 30, 2022, $700,000 in principle was outstanding on this loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Paycheck Protection Program</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 28, 2020, the company entered into a loan agreement with Alliance Bank of Arizona, N.A. for a loan in the amount of $132,760 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act enacted on March 27, 2020 (the “CARES Act”). This loan is evidenced by a promissory note, dated April 27, 2020, and matured two years from the disbursement date. This loan bears interest at a rate of 1.00% per annum, with the first six-months ended of interest deferred. Principal and interest are payable monthly commencing six-months ended after the disbursement date and may be prepaid by the company at any time prior to maturity with no prepayment penalties. This loan contains customary events of default relating to, among other things, payment defaults or breaches of the terms of the loan. Upon the occurrence of an event of default, the lender may require immediate repayment of all amounts outstanding under the note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the PPP, up to the entire amount of principal and accrued interest may be forgiven to the extent loan proceeds are used for qualifying expenses as described in the CARES Act and applicable implementing guidance issued by the U.S. Small Business Administration (“SBA”) under the PPP. The company partially used the loan amount for designated qualifying expenses and received notice from the SBA on June 30, 2021, that the company would not be required to repay $81,550 in proceeds. As a result, the company received partial forgiveness of the PPP amounting to $80,594 in principal and $956 in interest which is reflected within PPP forgiveness and other income on the statements of operations. During the six months ended June 30, 2020, the company paid the remaining balance of the loan in the aggregate of $23,553 in four equal payments, with loan formally repaid on April 20, 2022. As a result, as of September 30, 2022, no principal or interest was outstanding on this loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Premium Financing </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 8, 2022, the company entered into an agreement with Oakwood D&amp;O Insurance to provide financing in an amount of $234,367 for the insurance premium associated with two D&amp;O policies. Both policies commenced March 12, 2022, and provided coverage for the next 12 months, expiring March 12, 2023. The loan bears interest at a fixed rate of 5% per annum and required the company to prepay $58,932 and appears on the balance sheet as a current asset. On April 12, 2022, the company commenced monthly principal and interest payments of $19,901, which was the first payment of nine remaining months due of $175,435, the last payment of which is scheduled to be made on December 31, 2022. As of September 30, 2022, the outstanding balance on the note was $38,985 and was recorded as notes payable, a currently liability, in the company’s condensed consolidated balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Notes Payable Reconciliation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following reconciles notes payable as of September 30, 2022, and December 31, 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Beginning balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,024,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,681,157</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,209</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(640</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,385</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Payments on notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(460,002</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,646,513</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Extinguishment of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(81,550</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Converted into common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,498</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,985</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,024,190</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less-Notes payable – current</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,985</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,024,190</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Notes payable – non-current</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Future principal payments for the company’s Notes as of September 30, 2022, are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">338,985</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2023</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">400,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">738,985</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">The company’s note payable balance of $738,985 is due within the next twelve months, in accordance with the terms of note payable. $700,000 of the outstanding notes payable balance at September 30, 2022 will be paid in seven equal installments of $100,000 over the next seven months, with the final installment to paid on April 24, 2023.</p> 2500000 500000 500000 500000 The Promissory Note was amended on May 23, 2022 as modification of debt to extend the maturity date by one year to, May 24, 2023, and restructure the payment to time up to the adjusted maturity date. 1000000 100000 100000 300000 700000 the company entered into a loan agreement with Alliance Bank of Arizona, N.A. for a loan in the amount of $132,760 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act enacted on March 27, 2020 (the “CARES Act”). This loan is evidenced by a promissory note, dated April 27, 2020, and matured two years from the disbursement date. This loan bears interest at a rate of 1.00% per annum, with the first six-months ended of interest deferred. Principal and interest are payable monthly commencing six-months ended after the disbursement date and may be prepaid by the company at any time prior to maturity with no prepayment penalties. 81550 80594 956 23553 234367 0.05 58932 19901 175435 38985 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Beginning balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,024,190</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,681,157</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,209</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(640</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,385</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Payments on notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(460,002</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,646,513</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Extinguishment of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(81,550</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Converted into common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,498</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,985</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,024,190</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less-Notes payable – current</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,985</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,024,190</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Notes payable – non-current</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1024190 2681157 175435 117209 640 -1385 460002 1646513 -81550 -47498 738985 1024190 738985 1024190 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">338,985</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2023</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">400,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">738,985</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 338985 400000 738985 738985 700000 100000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 – DEFERRED COMPENSATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 24, 2019, the company entered into the APA with AOS to acquire certain assets. As consideration for the APA, the company entered into a promissory note issued to the shareholders of AOS for $2,500,000. The company also recorded a debt discount, which is reported on the balance sheet as deferred compensation, in the amount of $2,500,000, in relation to the transaction which is being amortized over the life of the loan as compensation expense. The amortization of deferred compensation for the nine months ended September 30, 2022, and 2021 was $416,666 and $625,000, respectively.</p> 2500000 2500000 416666 625000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 – DUE TO RELATED PARTIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It has come to the board’s attention that on July 31, 2018, our now deceased CEO deposited $50,000 into the company’s account. Although it has been suggested that the funds may have been intended for use toward Mr. Dearmin’s healthcare, the board does not know for certain what the purpose of the funds were or the nature of any intended investment. Accordingly, the board is investigating the appropriate disposition of the funds which will likely be to the estate of Mr. Dearmin. Until such a determination is made, the board does not intend to use these funds for any corporate purpose. For reporting purposes, the company has treated the deposit as a due to related party.</p> 50000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6 – STOCKHOLDERS’ EQUITY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Authorized Capital Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 7,056,250 shares of common stock in a private placement to accredited investors for $0.32 per share or $2,258,000 of net cash proceeds, in the aggregate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 158,329 shares of common stock upon the conversion of $47,499 of convertible notes (see Note 3).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 31,250 shares of common stock in relation to a restricted stock agreement with a value of $4,550.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 800,000 shares of common stock upon the exercise of 800,000 warrants at an exercise price of $0.07 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 250,000 shares of common stock upon the exercise of 250,000 warrants at an exercise price of $0.06 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 259,741 shares of common stock upon the exercise of 500,000 options at an exercise price of $0.37 a share. This exercise was performed on a cashless basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 1,760,000 options to purchase common stock at an exercise price of $0.40 a share. The options vest over a period of three years from the date of the amendment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 4,054,665 shares of common stock in a private placement to accredited investors for $0.75 per share or $3,041,000 of net cash proceeds, in the aggregate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 50,000 shares of common stock upon the exercise of 50,000 warrants at an exercise price of $0.06 a share. During the nine months ended September 30, 2021, the company issued 100,000 shares of common stock upon the exercise of 100,000 warrants at an exercise price of $0.07 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 200,000 shares of common stock upon the exercise of 200,000 warrants at an exercise price of $0.06 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 125,000 shares of common stock upon the exercise of 125,000 warrants at an exercise price of $0.06 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 60,000 shares of common stock upon the exercise of 60,000 warrants at an exercise price of $0.06 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 65,000 shares of common stock upon the exercise of 65,000 warrants at an exercise price of $0.06 a share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued 475,000 shares of common stock with an exercise of 500,000 options. 25,000 shares of common stock were withheld with the exercise. This exercise was performed on a cashless basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2021, the company issued the company issued 482,143 shares of common stock with an exercise of 500,000 options. 17,857 shares of common stock were withheld with the exercise. This exercise was performed on a cashless basis</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2022, the company issued 130,417 shares of common stock for previously vested and expensed shares in relation to a restricted stock agreement. For the nine months ended September 30, 2022, the Company recorded $0 in relation to these shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2022, the company issued 100,000 shares of common stock upon the exercise of 100,000 options at an exercise price of $0.13 a share. As a result, the company received $13,000 in cash proceeds as part of the transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2022, the company issued 25,000 shares of common stock upon result of the two warrant exercises of 12,500 shares each, or 25,000 shares of common stock in the aggregate, at an exercise price of $0.05 a share. The company received $1,250 in cash proceeds as part of the transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span>Effective August 1, 2022, the Company entered into an Executive Employment Agreement with </span>Mr. Donaghey <span>who was appointed the Company’s </span>Chief Financial Officer ("CFO"). As part of the Executive Employment Agreement, the Company granted 1,000,000 options to purchase shares of common stock at an exercise price of $2.36 per share. The options vest over a period of four years and expire ten years from the date of the grant.  Mr. Donaghey was also granted 400,000 shares of restricted to units as part of his Executive Employment Agreement (see “Share-Based Payments” below). Further, Mr. Donaghey forfeited unvested options to purchase 950,000 shares of common stock which he had previously received for his service on the Company’s Board of Advisors. The forfeiture of the unvested options resulted in the reversal of previously recorded stock-based compensation expense in the amount of approximately $176,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">As of nine months ended, September 30, 2022, the company recognized a subscription payable for $585,000 from the sale of common stock as a current liability on its balance sheet, reflecting the receipt of $585,000 in cash proceeds as part of a pending private equity placement transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2022 and 2021, the company recognized stock-based compensation in the amount of $1,261,626 and $848,277, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Preferred Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30, 2022, and December 31, 2021, there were 13,602 shares of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Stock”) issued and outstanding, respectively. The company has not paid the dividends commencing with the quarterly dividend due August 1, 2013. Dividend arrearages as of June 30, 2022, including previously accrued dividends included in our balance sheet are approximately $314,546. Our Board of Directors suspended the declaration of the dividend, commencing with the dividend payable as of February 1, 2015, since we did not have a surplus (as such term is defined in the Delaware general corporation Law) as of December 31, 2014, until such time as we have a surplus or net profits for a fiscal year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Series A Preferred Stock has a liquidation preference of $25.00 per Share. The Series A Preferred Stock bears dividends at the rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. Dividends may be paid in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement and the company’s common stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance or (iii) any combination of the foregoing. If the company fails to make a dividend payment within five business days following a dividend payment date, the dividend rate shall immediately and automatically increase by 1% from 6.5% of the liquidation preference per offered share of Series A preferred stock to 7.5% of such liquidation preference. If a payment default shall occur on two consecutive dividend payment dates, the dividend rate shall immediately and automatically increase to 10% of the liquidation preference for as long as such payment default continues and shall immediately and automatically return to the Initial dividend rate at such time as the payment default is no longer continuing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each share of Series A Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the liquidation preference (plus any unpaid dividends for periods prior to the dividend payment date immediately preceding the date of conversion by the holder) divided by the conversion price (initially $12.00 per share, subject to adjustment in the event of a stock dividend or split, reorganization, recapitalization or similar event). If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a change of control occurs, each holder of shares of Series A Convertible Preferred Stock that are outstanding immediately prior to the change of control shall have the right to require the corporation to purchase, out of legally available funds, any outstanding shares of Series A Convertible Preferred Stock at the defined purchase price. The purchase price is defined as: per share of Preferred Stock, 101% of the liquidation preference thereof, plus all unpaid and accumulated dividends, if any, to the date of purchase thereof. The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Corporation pays all or a portion of the Purchase Price in Common Stock, no fractional shares of Common Stock will be issued; instead, the company will round the applicable number of shares of Common Stock up to the nearest whole number of shares; provided that the Corporation may pay the Purchase Price (or a portion thereof), whether in cash or in shares of Common Stock, only if the Corporation has funds legally available for such payment and may pay the Purchase Price (or a portion thereof) in shares of its Common Stock only if (i) the Common Stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance and (ii) a shelf registration statement covering the issuance by the Corporation and/or resales of the Common Stock issuable as payment of the Purchase Price is effective on the Payment Date unless such shares are eligible for immediate resale in the public market by non-affiliates of the Corporation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company pays an annual dividend on its preferred stock of approximately $34,000. For the nine months ended September 30, 2022 and 2021, the company has recorded $25,004 and $25,504 respectively as preferred stock dividends on its condensed consolidated statements of operations in relation to its annual dividend. Dividends on our Preferred Stock are payable quarterly on the first day of February, May, August and November, in cash or shares of Common Stock, at our discretion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Share-Based Payments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective November 12, 2018, the Board of Directors of Applied Energetics, Inc. adopted the 2018 Incentive Stock Plan. The plan provides for the allocation and issuance of stock, restricted stock purchase offers and options (both incentive stock options and non-qualified stock options) to officers, directors, employees and consultants of the company. The board reserved a total of 50,000,000 shares for possible issuance under the plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have, from time to time, also granted non-plan options to certain officers, directors, employees and consultants. Total stock-based compensation expense for grants to officers, employees and consultants was $1,261,626 and $848,277 for the nine months ended September 30, 2022, and 2021, respectively, which was charged to general and administrative expense.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stock-based compensation for the year ended December 31, 2021, was comprised of 140,000 shares under a restricted stock agreement the company entered into in May of 2021. The restricted stock awards were valued at $84,000 of which the full $84,000 was recognized as of September 30, 2022. The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of his Executive Employment Agreement dated July 13, 2022 the company granted 400,000 shares issued as restricted stock units to the Chief Financial Officer. The restricted stock units were valued at $928,000 of which $50,780 was recognized as of September 30, 2022. The shares vest in equal annual installments over four years. If either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date. The Restricted Stock Units are issued pursuant to a Restricted Stock Unit Agreement, dated as of July 13, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Stock based compensation for the nine months ended September 30, 2022, was comprised of 250,000 shares issued pursuant to the restricted stock unit agreement, dated July 13, 2022. The restricted stock units were valued at $580,000 of which $42,297 was recognized as of September 30, 2022. The shares vest with 25% being vested at the end of year one and two respectively, with the remaining 50% being expensed at the end of year <span style="-sec-ix-hidden: hidden-fact-120">three</span>. If either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The $1,261,626 stock-based compensation for the nine months ended September 30, 2022, was comprised of $930,077 option expense, $108,549 expense from the vesting of the restricted stock and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company recognized no related income tax benefit because our deferred tax assets are fully offset by a valuation allowance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30, 2022, the company has $4,998,280 of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of approximately six years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes the activity of our stock options for the nine-months ended September 30:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Contractual Term<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intrinsic<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">28,415,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">0.1859</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 9%; font-weight: bold; text-align: right">5.84</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">50,673,665</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,390,000</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">2.2130</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">9.48</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,378,564</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(100,000</td><td style="text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(0.1300</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">6.09</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(961,438</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Forfeited or expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,950,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">(75,400,831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,755,000</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">0.3378</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">6.66</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,131,088</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Outstanding and exercisable at September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">20,308,888</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold; text-align: right">0.1751</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold; text-align: right">6.34</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right">189,061,250</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model applying the assumptions in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine-Months Ended<br/> September 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26-1.30</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.05-0.07</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128-130</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life (in years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2-3</span></td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the nine months ended September 30, 2022, was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Fair Value<br/> per Share<br/> at Grant Date</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">215,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.52</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Granted – restricted stock units and awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">650,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.32</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Granted – performance-based stock units</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Canceled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Vested and converted to shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Outstanding at September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">865,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1.8708</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30, 2022, and December 31, 2021, there was $1,414,923 and $15,355 respectively in unrecognized stock-based compensation related to unvested restricted stock agreements, net of estimated forfeitures.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $501,750, respectively, was amortized for the nine months ended September 30, 2022, and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrant stock activity for the nine-months ended September 30, 2022, was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant Activity</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average remaining Contractual Term (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -9pt; padding-left: 9pt">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,775,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.0599</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">7.43</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Outstanding and exercisable at September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,750,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.0600</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6.78</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Range of Exercise Prices</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Avg.<br/> Remaining<br/> Contractual<br/> Life in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Avg.<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Avg.<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">$0.05 - $0.07</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,750,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">0.01</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">$</td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">0.0600</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,750,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">$</td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">0.0600</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,750,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right">0.01</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.0600</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,750,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.0600</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option-Pricing Model applying the assumptions in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine-months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assumptions:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected life (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td></tr> </table> 7056250 0.32 2258000 158329 47499 31250 4550 800000 800000 0.07 250000 250000 0.06 259741 500000 0.37 1760000 0.4 P3Y 4054665 0.75 3041000 50000 50000 0.06 100000 100000 0.07 200000 200000 0.06 125000 125000 0.06 60000 60000 0.06 65000 65000 0.06 475000 500000 25000 482143 500000 17857 130417 0 100000 100000 0.13 As a result, the company received $13,000 in cash proceeds as part of the transaction.During the nine months ended September 30, 2022, the company issued 25,000 shares of common stock upon result of the two warrant exercises of 12,500 shares each, or 25,000 shares of common stock in the aggregate, at an exercise price of $0.05 a share. 13000 1250 1000000 2.36 400000 950000 176000 585000 585000 1261626 848277 13602 13602 314546 25 0.065 0.95 0.01 0.065 0.075 0.10 12 If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions. 1.01 The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof. 34000 34000 25004 25504 50000000 1261626 848277 140000 84000 84000 The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date. 400000 928000 50780 P4Y 250000 580000 42297 0.25 P1Y P2Y 0.50 The $1,261,626 stock-based compensation for the nine months ended September 30, 2022, was comprised of $930,077 option expense, $108,549 expense from the vesting of the restricted stock and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.  4998280 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Contractual Term<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intrinsic<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">28,415,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">0.1859</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 9%; font-weight: bold; text-align: right">5.84</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">50,673,665</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,390,000</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">2.2130</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">9.48</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,378,564</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(100,000</td><td style="text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(0.1300</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">6.09</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(961,438</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Forfeited or expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,950,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">(75,400,831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,755,000</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">0.3378</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">6.66</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,131,088</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Outstanding and exercisable at September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">20,308,888</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold; text-align: right">0.1751</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold; text-align: right">6.34</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right">189,061,250</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 28415000 0.1859 P5Y10M2D 50673665 2390000 2.213 P9Y5M23D -17378564 100000 0.13 P6Y1M2D 961438 7950000 75400831 22755000 0.3378 P6Y7M28D 208131088 20308888 0.1751 P6Y4M2D 189061250 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine-Months Ended<br/> September 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26-1.30</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.05-0.07</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128-130</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life (in years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2-3</span></td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine-months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assumptions:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Risk-free interest rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected life (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td></tr> </table> 0.0126 0.013 0.05 0.0007 0 0 1.26 1.28 1.30 P5Y P2Y P3Y <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Fair Value<br/> per Share<br/> at Grant Date</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">215,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.52</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Granted – restricted stock units and awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">650,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.32</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Granted – performance-based stock units</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Canceled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Vested and converted to shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Outstanding at September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">865,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1.8708</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 215000 0.52 650000 2.32 865000 1.8708 1414923 15355 As of September 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $501,750, respectively, was amortized for the nine months ended September 30, 2022, and 2021.  <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant Activity</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average remaining Contractual Term (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -9pt; padding-left: 9pt">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,775,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.0599</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">7.43</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Outstanding and exercisable at September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,750,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.0600</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6.78</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1775000 0.0599 P7Y5M4D -25000 0.05 1750000 0.06 P6Y9M10D <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Range of Exercise Prices</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Avg.<br/> Remaining<br/> Contractual<br/> Life in Years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Avg.<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Avg.<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">$0.05 - $0.07</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,750,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">0.01</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">$</td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">0.0600</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,750,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">$</td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">0.0600</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,750,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right">0.01</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.0600</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,750,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.0600</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1750000 P0Y3D 0.06 1750000 0.06 1750000 P0Y3D 0.06 1750000 0.06 0 0 0 0 0 0 P0Y P0Y <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 – REVENUE RECOGNITION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company derives revenue from technical research detailing the findings of its investigations to its customers under contract for specific projects. Under Topic 606, revenue is recognized when control of promised goods and services is transferred to customers, and the amount of revenue recognized reflects the consideration to which an entity expects to be entitled to in exchange for the goods and services transferred. A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The Company’s contracts require significant integrated services and are accounted for as a single performance obligation, and revenue is recognized by the Company over the contract term at a fixed contract price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentrations</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the nine months ended September 30, 2022, the company earned revenue from two contracts with two separate customers. One customer accounted for $648,905 or 85% of revenue recognized during the period. As of September 30, 2022. The company has $219,618 of accounts receivable recorded as current assets on the balance sheet. As of September 30, 2022, one customer accounted for $162,226 or 74% of accounts receivable. The company had no revenue during the nine months ended, September 30, 2021.</p> 648905 0.85 219618 162226 0.74 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 – COMMITMENTS AND CONTINGENCIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Operating Leases</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In March 2021, the company signed a five-year lease for a 13,000 square foot laboratory/office space in Tucson. The initial base rent was $6.7626 per rentable square foot for year one, and escalated to $9.2009 in year two, $11.4806 in year three, $13.1740 in year four and $14.9306 in year five, plus certain operating expenses and taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company incurred lease expense for its operating leases of $193,326 which was included in general and administrative expenses in the statements of operation for the periods ended September 30, 2022. During the nine months ended September 30, 2022, the company made cash lease payments in the amount of $166,501.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At September 30, 2022, we had approximately $128,000 in future minimum lease payments due in less than a year. The below table presents the future minimum lease payments due reconciled to lease liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">For the fiscal years ending December 31, 2022:</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">30,752</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,325</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,577</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191,779</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total undiscounted lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">600,969</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Present value discount, less interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">71,512</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Lease Liability</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">529,426</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Guarantees</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company agrees to indemnify its officers and directors for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The maximum amount of future payments that the company could be required to make under these indemnification agreements is unlimited. However, the company maintains a director’s and officer’s liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. As a result, it believes the estimated fair value of these indemnification agreements is minimal because of its insurance coverage, and it has not recognized any liabilities for these agreements as of September 30, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Litigation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 3, 2019, Gusrae, Kaplan &amp; Nusbaum and its partner, Ryan Whalen filed a complaint in the United States District Court for the Southern District of New York against the company, its directors, officers, attorneys and a consultant. The action alleged libel, securities fraud and related claims. The company filed a motion to dismiss the complaint on October 24, 2019. On December 13, 2019, Gusrae Kaplan and Mr. Whalen filed an opposition to the company’s motion. On January 10, 2020, the company filed a reply brief. On August 5, 2021, the plaintiffs filed a Notice of Voluntary Dismissal of the action without prejudice.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan &amp; Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan &amp; Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan &amp; Nusbaum and Mr. Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties are currently engaged in discovery. No trial date has been set.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 7, 2021, Gusrae Kaplan &amp; Nusbaum and its partner Ryan Whalen filed a complaint in the New York Supreme Court against the company, its directors, officers, attorneys and a consultant, alleging a single claim for defamation per se based on the same conduct underlying their claim of libel in their voluntarily dismissed federal court action. The company filed a motion to dismiss the complaint on October 29, 2021, to which Gusrae Kaplan &amp; Nusbaum and Mr. Whalen filed an opposition on January 13, 2022, and the company filed its reply brief on February 17, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 23, 2022, the New York Supreme Court held a hearing on the motion to dismiss, and Judge Hagler ruled from the bench, granting all defendants’, including Applied Energetics’, motions to dismiss the claim, in its entirety, with prejudice. While he noted that defendants’ arguments regarding the claim being time-barred and the court lacking personal jurisdiction over certain defendants may have merit, he elected not to rule on those issues as he believed it appropriate to reach the merits. The judge declined to award sanctions requested by the defendants in this claim. The plaintiffs have filed a notice of intent to appeal the dismissal but have not filed their actual appeal brief, which is due on December 21, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may, from time to time, be involved in legal proceedings arising from the normal course of business.</p> 13000 6.7626 9.2009 11.4806 13.174 14.9306 193326 166501 128000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">For the fiscal years ending December 31, 2022:</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">30,752</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,325</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,577</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191,779</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total undiscounted lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">600,969</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Present value discount, less interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">71,512</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Lease Liability</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">529,426</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 30752 143325 168577 191779 66536 600969 71512 529426 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 – SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The company’s management has evaluated subsequent events occurring after September 30, 2022, the date of our most recent balance sheet, through the date our financial statements were issued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">Subsequent to September 30, 2022, the Company received $2,931,000 in cash proceeds from a pending placement of common stock at a price of $2.20 per share, as amended in November 2022 per agreement between the company and the investors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As of October 20, 2022, the Company issued incentive stock options to purchase up to 50,000 shares of common stock to an employee. The options are exercisable at a price of $2.30 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As of November 4, 2022, the Company issued incentive stock options to purchase up to 50,000 shares of common stock to an employee. The options are exercisable at a price of $2.24 per share.</p> 2931000 $2.20 50000 2.3 50000 2.24 NONE 0.00 -0.01 -0.01 -0.02 P3Y false --12-31 Q3 0000879911 EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 49 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 152 318 1 false 36 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://aergs.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://aergs.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://aergs.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) Sheet http://aergs.com/role/ConsolidatedIncomeStatement_Parentheticals Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Sheet http://aergs.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://aergs.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Organization of Business, Going Concern and Summary of Significant Accounting Policies Sheet http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPolicies Organization of Business, Going Concern and Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - New Accounting Standards Sheet http://aergs.com/role/NewAccountingStandards New Accounting Standards Notes 9 false false R10.htm 009 - Disclosure - Notes Payable Notes http://aergs.com/role/NotesPayable Notes Payable Notes 10 false false R11.htm 010 - Disclosure - Deferred Compensation Sheet http://aergs.com/role/DeferredCompensation Deferred Compensation Notes 11 false false R12.htm 011 - Disclosure - Due to Related Parties Sheet http://aergs.com/role/DuetoRelatedParties Due to Related Parties Notes 12 false false R13.htm 012 - Disclosure - Stockholders??? Equity Sheet http://aergs.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 013 - Disclosure - Revenue Recognition Sheet http://aergs.com/role/RevenueRecognition Revenue Recognition Notes 14 false false R15.htm 014 - Disclosure - Commitments and Contingencies Sheet http://aergs.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 15 false false R16.htm 015 - Disclosure - Subsequent Events Sheet http://aergs.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://aergs.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPolicies 17 false false R18.htm 017 - Disclosure - Notes Payable (Tables) Notes http://aergs.com/role/NotesPayableTables Notes Payable (Tables) Tables http://aergs.com/role/NotesPayable 18 false false R19.htm 018 - Disclosure - Stockholders??? Equity (Tables) Sheet http://aergs.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://aergs.com/role/StockholdersEquity 19 false false R20.htm 019 - Disclosure - Commitments and Contingencies (Tables) Sheet http://aergs.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://aergs.com/role/CommitmentsandContingencies 20 false false R21.htm 020 - Disclosure - Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details) Sheet http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details) Details 21 false false R22.htm 021 - Disclosure - Notes Payable (Details) Notes http://aergs.com/role/NotesPayableDetails Notes Payable (Details) Details http://aergs.com/role/NotesPayableTables 22 false false R23.htm 022 - Disclosure - Notes Payable (Details) - Schedule of reconciles notes payable Notes http://aergs.com/role/ScheduleofreconcilesnotespayableTable Notes Payable (Details) - Schedule of reconciles notes payable Details http://aergs.com/role/NotesPayableTables 23 false false R24.htm 023 - Disclosure - Notes Payable (Details) - Schedule of future principal payments Notes http://aergs.com/role/ScheduleoffutureprincipalpaymentsTable Notes Payable (Details) - Schedule of future principal payments Details http://aergs.com/role/NotesPayableTables 24 false false R25.htm 024 - Disclosure - Deferred Compensation (Details) Sheet http://aergs.com/role/DeferredCompensationDetails Deferred Compensation (Details) Details http://aergs.com/role/DeferredCompensation 25 false false R26.htm 025 - Disclosure - Due to Related Parties (Details) Sheet http://aergs.com/role/DuetoRelatedPartiesDetails Due to Related Parties (Details) Details http://aergs.com/role/DuetoRelatedParties 26 false false R27.htm 026 - Disclosure - Stockholders??? Equity (Details) Sheet http://aergs.com/role/StockholdersEquityDetails Stockholders??? Equity (Details) Details http://aergs.com/role/StockholdersEquityTables 27 false false R28.htm 027 - Disclosure - Stockholders??? Equity (Details) - Schedule of stock options Sheet http://aergs.com/role/ScheduleofstockoptionsTable Stockholders??? Equity (Details) - Schedule of stock options Details http://aergs.com/role/StockholdersEquityTables 28 false false R29.htm 028 - Disclosure - Stockholders??? Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions Sheet http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable Stockholders??? Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions Details http://aergs.com/role/StockholdersEquityTables 29 false false R30.htm 029 - Disclosure - Stockholders??? Equity (Details) - Schedule of fair value of restricted stock and restricted stock units Sheet http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable Stockholders??? Equity (Details) - Schedule of fair value of restricted stock and restricted stock units Details http://aergs.com/role/StockholdersEquityTables 30 false false R31.htm 030 - Disclosure - Stockholders??? Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement Sheet http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable Stockholders??? Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement Details http://aergs.com/role/StockholdersEquityTables 31 false false R32.htm 031 - Disclosure - Stockholders??? Equity (Details) - Schedule of range exercise prices warrants outstanding and exercisable Sheet http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable Stockholders??? Equity (Details) - Schedule of range exercise prices warrants outstanding and exercisable Details http://aergs.com/role/StockholdersEquityTables 32 false false R33.htm 032 - Disclosure - Revenue Recognition (Details) Sheet http://aergs.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details http://aergs.com/role/RevenueRecognition 33 false false R34.htm 033 - Disclosure - Commitments and Contingencies (Details) Sheet http://aergs.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://aergs.com/role/CommitmentsandContingenciesTables 34 false false R35.htm 034 - Disclosure - Commitments and Contingencies (Details) - Schedule of future minimum lease payments Sheet http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable Commitments and Contingencies (Details) - Schedule of future minimum lease payments Details http://aergs.com/role/CommitmentsandContingenciesTables 35 false false R36.htm 035 - Disclosure - Subsequent Events (Details) Sheet http://aergs.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://aergs.com/role/SubsequentEvents 36 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: aerg:RemainingExpensedPeriod, dei:SecurityExchangeName, us-gaap:EarningsPerShareDiluted - f10q0922_appliedener.htm 3600, 3616, 3617, 3618, 3619, 3720 f10q0922_appliedener.htm aerg-20220930.xsd aerg-20220930_cal.xml aerg-20220930_def.xml aerg-20220930_lab.xml aerg-20220930_pre.xml f10q0922ex31-1_applied.htm f10q0922ex31-2_applied.htm f10q0922ex32-1_applied.htm f10q0922ex32-2_applied.htm http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 54 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0922_appliedener.htm": { "axisCustom": 0, "axisStandard": 13, "contextCount": 152, "dts": { "calculationLink": { "local": [ "aerg-20220930_cal.xml" ] }, "definitionLink": { "local": [ "aerg-20220930_def.xml" ] }, "inline": { "local": [ "f10q0922_appliedener.htm" ] }, "labelLink": { "local": [ "aerg-20220930_lab.xml" ] }, "presentationLink": { "local": [ "aerg-20220930_pre.xml" ] }, "schema": { "local": [ "aerg-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 444, "entityCount": 1, "hidden": { "http://aergs.com/20220930": 25, "http://fasb.org/us-gaap/2022": 96, "http://xbrl.sec.gov/dei/2022": 5, "total": 126 }, "keyCustom": 93, "keyStandard": 225, "memberCustom": 21, "memberStandard": 14, "nsprefix": "aerg", "nsuri": "http://aergs.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://aergs.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Notes Payable", "role": "http://aergs.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "aerg:DeferredCompensationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Deferred Compensation", "role": "http://aergs.com/role/DeferredCompensation", "shortName": "Deferred Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "aerg:DeferredCompensationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Due to Related Parties", "role": "http://aergs.com/role/DuetoRelatedParties", "shortName": "Due to Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Stockholders\u2019 Equity", "role": "http://aergs.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "aerg:RevenueRecognitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Revenue Recognition", "role": "http://aergs.com/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "aerg:RevenueRecognitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Commitments and Contingencies", "role": "http://aergs.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Subsequent Events", "role": "http://aergs.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccounting", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://aergs.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccounting", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Notes Payable (Tables)", "role": "http://aergs.com/role/NotesPayableTables", "shortName": "Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Stockholders\u2019 Equity (Tables)", "role": "http://aergs.com/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://aergs.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://aergs.com/role/CommitmentsandContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "aerg:NetIncomeLoss1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details)", "role": "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails", "shortName": "Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "aerg:NetIncomeLoss1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c88", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesIssued1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Notes Payable (Details)", "role": "http://aergs.com/role/NotesPayableDetails", "shortName": "Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c30", "decimals": "0", "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "aerg:BeginningBalanceNotesPayable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Notes Payable (Details) - Schedule of reconciles notes payable", "role": "http://aergs.com/role/ScheduleofreconcilesnotespayableTable", "shortName": "Notes Payable (Details) - Schedule of reconciles notes payable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "aerg:BeginningBalanceNotesPayable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "aerg:FutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Notes Payable (Details) - Schedule of future principal payments", "role": "http://aergs.com/role/ScheduleoffutureprincipalpaymentsTable", "shortName": "Notes Payable (Details) - Schedule of future principal payments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "aerg:FutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c88", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesIssued1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Deferred Compensation (Details)", "role": "http://aergs.com/role/DeferredCompensationDetails", "shortName": "Deferred Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c88", "decimals": "0", "lang": null, "name": "us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c89", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Due to Related Parties (Details)", "role": "http://aergs.com/role/DuetoRelatedPartiesDetails", "shortName": "Due to Related Parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c89", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherRestrictedAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Stockholders\u2019 Equity (Details)", "role": "http://aergs.com/role/StockholdersEquityDetails", "shortName": "Stockholders\u2019 Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "lang": "en-US", "name": "aerg:SubscriptionPayableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of stock options", "role": "http://aergs.com/role/ScheduleofstockoptionsTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of stock options", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions", "role": "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c139", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of fair value of restricted stock and restricted stock units", "role": "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of fair value of restricted stock and restricted stock units", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c139", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c142", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement", "role": "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c142", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "aerg:WarrantsOutstandingSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of range exercise prices warrants outstanding and exercisable", "role": "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of range exercise prices warrants outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "aerg:WarrantsOutstandingSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ReceivablesFromCustomers", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Revenue Recognition (Details)", "role": "http://aergs.com/role/RevenueRecognitionDetails", "shortName": "Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ReceivablesFromCustomers", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Commitments and Contingencies (Details)", "role": "http://aergs.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Commitments and Contingencies (Details) - Schedule of future minimum lease payments", "role": "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable", "shortName": "Commitments and Contingencies (Details) - Schedule of future minimum lease payments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Subsequent Events (Details)", "role": "http://aergs.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://aergs.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)", "role": "http://aergs.com/role/ConsolidatedIncomeStatement_Parentheticals", "shortName": "Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c39", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "role": "http://aergs.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c46", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://aergs.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "aerg:NoncashStockBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Organization of Business, Going Concern and Summary of Significant Accounting Policies", "role": "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPolicies", "shortName": "Organization of Business, Going Concern and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - New Accounting Standards", "role": "http://aergs.com/role/NewAccountingStandards", "shortName": "New Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_appliedener.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 36, "tag": { "aerg_AccountsReceivablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts receivable percentage.", "label": "Accounts Receivable Percentage", "terseLabel": "Accounts receivable percentage" } } }, "localname": "AccountsReceivablePercentage", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "percentItemType" }, "aerg_AccruedIncomeTaxeCurrent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Less notes payable current.", "label": "Accrued Income Taxe Current", "terseLabel": "Less-Notes payable \u2013 current" } } }, "localname": "AccruedIncomeTaxeCurrent", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_AccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued interest.", "label": "Accrued Interest", "negatedLabel": "Accrued interest" } } }, "localname": "AccruedInterest", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_AggregateAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of aggregate value.", "label": "Aggregate Amount", "terseLabel": "Aggregate amount" } } }, "localname": "AggregateAmount", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "aerg_AmortizationOfFutureCompensationPayabl": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of future compensation payable.", "label": "Amortization Of Future Compensation Payabl", "terseLabel": "Amortization of future compensation payable" } } }, "localname": "AmortizationOfFutureCompensationPayabl", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_AmortizationOfPrepaidExpenses": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of prepaid expenses", "label": "Amortization Of Prepaid Expenses", "terseLabel": "Amortization of prepaid assets" } } }, "localname": "AmortizationOfPrepaidExpenses", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_AppliedOpticalSciencesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Applied Optical Sciences", "label": "Applied Optical Sciences Member", "terseLabel": "AOS [Member]" } } }, "localname": "AppliedOpticalSciencesMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "aerg_AssumptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assumptions Abstract", "terseLabel": "Assumptions:" } } }, "localname": "AssumptionsAbstract", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "stringItemType" }, "aerg_BeginningBalanceNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Beginning balance of notes payable.", "label": "Beginning Balance Notes Payable", "terseLabel": "Beginning balance" } } }, "localname": "BeginningBalanceNotesPayable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_BusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Member", "terseLabel": "Business Combination [Member]" } } }, "localname": "BusinessCombinationMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_CashProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds refers to the cash received from the sale of goods or assets during a particular period. The total is obtained by multiplying the quantities sold by the selling price per unit.", "label": "Cash Proceeds", "terseLabel": "Cash proceeds (in Dollars)" } } }, "localname": "CashProceeds", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_CommitmentsandContingenciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "localname": "CommitmentsandContingenciesDetailsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "aerg_CommitmentsandContingenciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "localname": "CommitmentsandContingenciesDetailsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "aerg_CommitmentsandContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "localname": "CommitmentsandContingenciesLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingencies" ], "xbrltype": "stringItemType" }, "aerg_CommitmentsandContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Table]" } } }, "localname": "CommitmentsandContingenciesTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingencies" ], "xbrltype": "stringItemType" }, "aerg_CommonStockDiscountOnSharesDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Discount On Shares Description.", "label": "Common Stock Discount On Shares Description", "terseLabel": "Common stock discount shares description" } } }, "localname": "CommonStockDiscountOnSharesDescription", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "aerg_CommonStockIssuedOnCashlessExerciseOfOptionsAndWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued on cashless exercise of options and warrants.", "label": "Common Stock Issued On Cashless Exercise Of Options And Warrant", "terseLabel": "Common stock issued on cashless exercise of options and warrant (in Shares)" } } }, "localname": "CommonStockIssuedOnCashlessExerciseOfOptionsAndWarrant", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "aerg_CommonStockIssuedOnCashlessExerciseOfOptionsAndWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued on cashless exercise of options and warrants.", "label": "Common Stock Issued On Cashless Exercise Of Options And Warrants", "terseLabel": "Common stock issued on cashless exercise of options and warrant" } } }, "localname": "CommonStockIssuedOnCashlessExerciseOfOptionsAndWarrants", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "aerg_CommonStockIssuedOnExerciseOfOptionsAndWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued on exercise of options and warrants.", "label": "Common Stock Issued On Exercise Of Options And Warrant", "terseLabel": "Common stock issued on exercise of option (in Shares)" } } }, "localname": "CommonStockIssuedOnExerciseOfOptionsAndWarrant", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "aerg_CommonStockValueIssuedInRelationToRestrictedStockAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common Stock value Issued In Relation To Restricted Stock Agreement", "label": "Common Stock Value Issued In Relation To Restricted Stock Agreement", "terseLabel": "Stock value issued for restricted stock agreement (in Dollars)" } } }, "localname": "CommonStockValueIssuedInRelationToRestrictedStockAgreement", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_ConvertedintoCommonStocksValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Convertedinto Common Stocks Value", "terseLabel": "Converted into common stock" } } }, "localname": "ConvertedintoCommonStocksValue", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_DeferredCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Compensation [Abstract]" } } }, "localname": "DeferredCompensationAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_DeferredCompensationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for deferred compensation.", "label": "Deferred Compensation Text Block", "terseLabel": "DEFERRED COMPENSATION" } } }, "localname": "DeferredCompensationTextBlock", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/DeferredCompensation" ], "xbrltype": "textBlockItemType" }, "aerg_DividendRateIncreasePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dividend rate increase percentage", "label": "Dividend Rate Increase Percentage", "terseLabel": "Dividend rate increase" } } }, "localname": "DividendRateIncreasePercentage", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "aerg_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_DuetoRelatedPartiesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Due to Related Parties (Details) [Line Items]" } } }, "localname": "DuetoRelatedPartiesDetailsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/DuetoRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "aerg_DuetoRelatedPartiesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Due to Related Parties (Details) [Table]" } } }, "localname": "DuetoRelatedPartiesDetailsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/DuetoRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "aerg_ExtinguishmentOfDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment Of Debt", "terseLabel": "Extinguishment of debt" } } }, "localname": "ExtinguishmentOfDebt", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_FairValueOfOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Option Member", "terseLabel": "Fair Value of Option [Member]" } } }, "localname": "FairValueOfOptionMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "domainItemType" }, "aerg_ForgivenessOfPPPLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forgiveness of PPP loan amount.", "label": "Forgiveness Of PPPLoan", "terseLabel": "Forgiveness of PPP loan" } } }, "localname": "ForgivenessOfPPPLoan", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_FutureMinimumLeasePayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of future minimum lease payments.", "label": "Future Minimum Lease Payments", "terseLabel": "Future minimum lease payments" } } }, "localname": "FutureMinimumLeasePayments", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_FutureMinimumPaymentsDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Due.", "label": "Future Minimum Payments Due", "terseLabel": "Total" } } }, "localname": "FutureMinimumPaymentsDue", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffutureprincipalpaymentsTable" ], "xbrltype": "monetaryItemType" }, "aerg_FutureMinimumPaymentsDueCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Due, Next Twelve Months.", "label": "Future Minimum Payments Due Current", "terseLabel": "2022" } } }, "localname": "FutureMinimumPaymentsDueCurrent", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffutureprincipalpaymentsTable" ], "xbrltype": "monetaryItemType" }, "aerg_FutureMinimumPaymentsDueNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "future minimum payments due next twelve months.", "label": "Future Minimum Payments Due Next Twelve Months", "terseLabel": "2023" } } }, "localname": "FutureMinimumPaymentsDueNextTwelveMonths", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffutureprincipalpaymentsTable" ], "xbrltype": "monetaryItemType" }, "aerg_FutureMinimumPaymentsDueThereafter": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments, Due Thereafter.", "label": "Future Minimum Payments Due Thereafter", "terseLabel": "Thereafter" } } }, "localname": "FutureMinimumPaymentsDueThereafter", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffutureprincipalpaymentsTable" ], "xbrltype": "monetaryItemType" }, "aerg_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Going Concern Policy Text Block.", "label": "Going Concern Policy Text Block", "terseLabel": "Going Concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "aerg_ImplementationOfASC842": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Implementation of ASC 842.", "label": "Implementation Of ASC842", "terseLabel": "Implementation of ASC 842" } } }, "localname": "ImplementationOfASC842", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_IncreaseDecreaseROUliabilities": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of ROU liabilities.", "label": "Increase Decrease ROUliabilities", "negatedLabel": "ROU liabilities" } } }, "localname": "IncreaseDecreaseROUliabilities", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_InstallmentsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installments amount.", "label": "Installments Amount", "terseLabel": "Installments" } } }, "localname": "InstallmentsAmount", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "aerg_InsuranceFinancingForPrepaidInsurance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Insurance financing for prepaid insurance.", "label": "Insurance Financing For Prepaid Insurance", "terseLabel": "Insurance financing for prepaid insurance" } } }, "localname": "InsuranceFinancingForPrepaidInsurance", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_IssuanceOfStockForConversionOfNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of stock for conversion of notes payable.", "label": "Issuance Of Stock For Conversion Of Notes Payable", "terseLabel": "Common stock issued for repayment of convertible notes" } } }, "localname": "IssuanceOfStockForConversionOfNotesPayable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_LeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease liability.", "label": "Lease Liability", "terseLabel": "Lease Liability" } } }, "localname": "LeaseLiability", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "aerg_LeaseSquareFoot": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease square foot.", "label": "Lease Square Foot", "terseLabel": "Lease square foot" } } }, "localname": "LeaseSquareFoot", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "aerg_LiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liability Current", "terseLabel": "Current liability" } } }, "localname": "LiabilityCurrent", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_LiquidationPreferencePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidation preference.", "label": "Liquidation Preference Percentage", "terseLabel": "Liquidation preference" } } }, "localname": "LiquidationPreferencePercentage", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "aerg_LongRwemInvestmentUtilizedForCancellationOfShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-cash accrual for payment on settlement.", "label": "Long Rwem Investment Utilized For Cancellation Of Shares", "terseLabel": "Equipment investing in accounts payable" } } }, "localname": "LongRwemInvestmentUtilizedForCancellationOfShares", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_LongTermLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Liabilities Abstract", "terseLabel": "Long-term liabilities" } } }, "localname": "LongTermLiabilitiesAbstract", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "aerg_MinimumLeasePaymentSaleLeaseBackTransactionsWithinOneYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum lease payment sale lease back transactions within one year.", "label": "Minimum Lease Payment Sale Lease Back Transactions Within One Year", "terseLabel": "Base rent" } } }, "localname": "MinimumLeasePaymentSaleLeaseBackTransactionsWithinOneYear", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_MinimumLeasePaymentSaleLeaseBackTransactionsWithinTwoYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum lease payment sale lease back transactions within two year.", "label": "Minimum Lease Payment Sale Lease Back Transactions Within Two Year", "terseLabel": "Minimum lease payment sale lease back transactions within two year" } } }, "localname": "MinimumLeasePaymentSaleLeaseBackTransactionsWithinTwoYear", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_MinimumLeasePaymentSaleLeasebackTransactionsWithinFiveYears": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum lease payment sale leaseback transactions within five years.", "label": "Minimum Lease Payment Sale Leaseback Transactions Within Five Years", "terseLabel": "Minimum lease payment sale leaseback transactions within five years" } } }, "localname": "MinimumLeasePaymentSaleLeasebackTransactionsWithinFiveYears", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_MinimumLeasePaymentSaleLeasebackTransactionsWithinFourYears": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum lease payment sale leaseback transactions, within four years.", "label": "Minimum Lease Payment Sale Leaseback Transactions Within Four Years", "terseLabel": "Minimum lease payment sale leaseback transactions, within four years" } } }, "localname": "MinimumLeasePaymentSaleLeasebackTransactionsWithinFourYears", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_MinimumLeasePaymentSaleLeasebackTransactionsWithinThreeYears": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum lease payment sale leaseback transactions within three years.", "label": "Minimum Lease Payment Sale Leaseback Transactions Within Three Years", "terseLabel": "Minimum lease payment sale leaseback transactions within three years" } } }, "localname": "MinimumLeasePaymentSaleLeasebackTransactionsWithinThreeYears", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_NetCashProvidedByUsedInOperatingActivities1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities1", "terseLabel": "Negative cash flows from operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities1", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_NetIncomeLoss1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss1", "terseLabel": "Net loss" } } }, "localname": "NetIncomeLoss1", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_NoncashStockBasedCompensationExpense": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash stock based compensation expense.", "label": "Noncash Stock Based Compensation Expense", "negatedLabel": "Noncash stock-based compensation expense" } } }, "localname": "NoncashStockBasedCompensationExpense", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_NotesPayableDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Line Items]" } } }, "localname": "NotesPayableDetailsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "aerg_NotesPayableDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Table]" } } }, "localname": "NotesPayableDetailsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "aerg_NotesPayableNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes payable non-current", "label": "Notes Payable Noncurrent", "terseLabel": "Notes payable \u2013 non-current" } } }, "localname": "NotesPayableNoncurrent", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_NotesPayableTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes payable total.", "label": "Notes Payable Total", "terseLabel": "Total" } } }, "localname": "NotesPayableTotal", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Customer Member", "terseLabel": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "aerg_OptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Member", "terseLabel": "Options [Member]" } } }, "localname": "OptionsMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_OptionsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options One Member", "terseLabel": "Options One [Member]", "verboseLabel": "Restricted Stock Agreement [Member]" } } }, "localname": "OptionsOneMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_OptionsThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Three Member", "terseLabel": "Options Three [Member]" } } }, "localname": "OptionsThreeMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_OptionsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Two Member", "terseLabel": "Options Two [Member]" } } }, "localname": "OptionsTwoMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_OutstandingPrincipleAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of outstanding principle amount.", "label": "Outstanding Principle Amount", "terseLabel": "Outstanding Principle Amount" } } }, "localname": "OutstandingPrincipleAmount", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "aerg_PPPForgivenessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PPPForgiveness Member", "terseLabel": "PPP Forgiveness [Member]" } } }, "localname": "PPPForgivenessMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "aerg_PaymentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of payment.", "label": "Payment Description", "terseLabel": "Payment, description" } } }, "localname": "PaymentDescription", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "aerg_PaymentsOnNotesPayable1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments on notes payable.", "label": "Payments On Notes Payable1", "negatedLabel": "Payments on notes payable" } } }, "localname": "PaymentsOnNotesPayable1", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "aerg_PercentOfWeightedAverageOfTheLastTenTradingDaysEndingOnTheThirdTradingDayPriorToApplicableDividendDividendPaymentDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation of dividends payable in shares, percent of the weighted average of common stock sales price on the last ten trading days ending on the third trading day prior to applicable dividend payment date.", "label": "Percent Of Weighted Average Of The Last Ten Trading Days Ending On The Third Trading Day Prior To Applicable Dividend Dividend Payment Date", "terseLabel": "Weighted average of the last sales prices" } } }, "localname": "PercentOfWeightedAverageOfTheLastTenTradingDaysEndingOnTheThirdTradingDayPriorToApplicableDividendDividendPaymentDate", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "aerg_PercentageOfVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of vested.", "label": "Percentage Of Vested", "terseLabel": "Percentage of vested" } } }, "localname": "PercentageOfVested", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "aerg_PreferredStockConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Conversion Price Per Share.", "label": "Preferred Stock Conversion Price Per Share", "terseLabel": "Preferred stock conversion price per share (in Dollars per share)" } } }, "localname": "PreferredStockConversionPricePerShare", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "aerg_PresentValueOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present Value of Lease Liabilities.", "label": "Present Value Of Lease Liabilities", "terseLabel": "Present value discount, less interest" } } }, "localname": "PresentValueOfLeaseLiabilities", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "aerg_PricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per share.", "label": "Price Per Share", "terseLabel": "Price per share (in Dollars per share)" } } }, "localname": "PricePerShare", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "aerg_PrivatePlacement1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement1 Member", "terseLabel": "Private Placement One [Member]" } } }, "localname": "PrivatePlacement1Member", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_ProceedsFromTheExerciseOfStockOptionsAndWarrants": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from the exercise of stock options and warrants.", "label": "Proceeds From The Exercise Of Stock Options And Warrants", "terseLabel": "Proceeds from exercise of stock options and warrants" } } }, "localname": "ProceedsFromTheExerciseOfStockOptionsAndWarrants", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "aerg_RecognizedStockBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Recognized stock based compensation expense.", "label": "Recognized Stock Based Compensation Expense", "terseLabel": "Recognized stock based compensation expense (in Dollars)" } } }, "localname": "RecognizedStockBasedCompensationExpense", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_RemainingBeindExpensedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining beind expensed percentage", "label": "Remaining Beind Expensed Percentage", "terseLabel": "Remaining expensed percentage" } } }, "localname": "RemainingBeindExpensedPercentage", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "aerg_RemainingExpensedPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining expensed period.", "label": "Remaining Expensed Period", "terseLabel": "Remaining expensed period" } } }, "localname": "RemainingExpensedPeriod", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "aerg_RestrictedStockAgreementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock agreement shares.", "label": "Restricted Stock Agreement Shares", "terseLabel": "Share based compensation of restricted stock agreement shares" } } }, "localname": "RestrictedStockAgreementShares", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "aerg_RestrictedStockAwardsValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock awards value", "label": "Restricted Stock Awards Value", "terseLabel": "Restricted stock awards value (in Dollars)" } } }, "localname": "RestrictedStockAwardsValue", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_RestrictedStockDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Description.", "label": "Restricted Stock Description", "terseLabel": "Restricted stock, grants description" } } }, "localname": "RestrictedStockDescription", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "aerg_RestrictedStockOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock Outstanding Member", "terseLabel": "Restricted Stock Outstanding\t[Member]" } } }, "localname": "RestrictedStockOutstandingMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "domainItemType" }, "aerg_RevenueRecognitionDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition (Details) [Line Items]" } } }, "localname": "RevenueRecognitionDetailsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "aerg_RevenueRecognitionDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition (Details) [Table]" } } }, "localname": "RevenueRecognitionDetailsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "aerg_RevenueRecognitionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for revenue recognition.", "label": "Revenue Recognition Text Block", "terseLabel": "REVENUE RECOGNITION" } } }, "localname": "RevenueRecognitionTextBlock", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "aerg_ReversalOfConvertiblePreferredStockDividendAccrual": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reversal Of Convertible Preferred Stock Dividend Accrual.", "label": "Reversal Of Convertible Preferred Stock Dividend Accrual", "terseLabel": "Accrued dividends (in Dollars)" } } }, "localname": "ReversalOfConvertiblePreferredStockDividendAccrual", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_SaleOfCurrentLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale of current liability.", "label": "Sale Of Current Liability", "terseLabel": "Sale of current liability (in Dollars)" } } }, "localname": "SaleOfCurrentLiability", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_ScheduleOfBlackScholesMertonOptionPricingModelApplyingTheAssumptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Black Scholes Merton Option Pricing Model Applying The Assumptions Abstract" } } }, "localname": "ScheduleOfBlackScholesMertonOptionPricingModelApplyingTheAssumptionsAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfFairValueOfRestrictedStockAndRestrictedStockUnitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of Restricted Stock And Restricted Stock Units Abstract" } } }, "localname": "ScheduleOfFairValueOfRestrictedStockAndRestrictedStockUnitsAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfFutureMinimumLeasePaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Lease Payments Abstract" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfFuturePrincipalPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Future Principal Payments Abstract" } } }, "localname": "ScheduleOfFuturePrincipalPaymentsAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfRangeExercisePricesWarrantsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Range Exercise Prices Warrants Outstanding And Exercisable Abstract" } } }, "localname": "ScheduleOfRangeExercisePricesWarrantsOutstandingAndExercisableAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfReconcilesNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles Notes Payable Abstract" } } }, "localname": "ScheduleOfReconcilesNotesPayableAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfStockOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Stock Options Abstract" } } }, "localname": "ScheduleOfStockOptionsAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ScheduleOfUnrecognizedStockBasedCompensationRelatedToALockupAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Unrecognized Stock Based Compensation Related To ALockup Agreement Abstract" } } }, "localname": "ScheduleOfUnrecognizedStockBasedCompensationRelatedToALockupAgreementAbstract", "nsuri": "http://aergs.com/20220930", "xbrltype": "stringItemType" }, "aerg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestedperiod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vestedperiod", "terseLabel": "Vested Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestedperiod", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "aerg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options intrinsic value exercised.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value Exercised", "negatedLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueExercised", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "monetaryItemType" }, "aerg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value Granted", "negatedLabel": "Intrinsic Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueGranted", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "monetaryItemType" }, "aerg_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares outstanding and exercisable, ending balance.", "label": "Share Based Compensation Arrangement By Shares Based Payment Award Options Outstanding Number", "terseLabel": "Shares Outstanding and exercisable, Ending Balance" } } }, "localname": "ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "aerg_ShareBasedCompensationArrangementBySharesBasedPaymentWeightedAverageExercisePriceEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price, Ending Balance", "label": "Share Based Compensation Arrangement By Shares Based Payment Weighted Average Exercise Price Ending Balance", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementBySharesBasedPaymentWeightedAverageExercisePriceEndingBalance", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "perShareItemType" }, "aerg_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIntrinsicValueForfeitedOrExpired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options intrinsic value, forfeited or expired.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Intrinsic Value Forfeited Or Expired", "negatedLabel": "Intrinsic Value, Forfeited or expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIntrinsicValueForfeitedOrExpired", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "monetaryItemType" }, "aerg_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageContractualTermOutstandingExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Contractual Term Outstanding, Exercised.\r \n.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Contractual Term Outstanding Exercised", "terseLabel": "Weighted Average Contractual Term Outstanding, Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageContractualTermOutstandingExercised", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "aerg_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageContractualTermOutstandingForfeitedorexpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Contractual Term Outstanding, Forfeited or expired.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Contractual Term Outstanding Forfeitedorexpired", "terseLabel": "Weighted Average Contractual Term Outstanding, Forfeited or expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageContractualTermOutstandingForfeitedorexpired", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "aerg_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageContractualTermOutstandingGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Contractual Term Outstanding Granted", "terseLabel": "Weighted Average Contractual Term Outstanding, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageContractualTermOutstandingGranted", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "aerg_SharesGrantedRestrictedStockUnitsAndAwards": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares, Granted \u2013 restricted stock units and awards.", "label": "Shares Granted Restricted Stock Units And Awards", "terseLabel": "Shares, Granted \u2013 restricted stock units and awards" } } }, "localname": "SharesGrantedRestrictedStockUnitsAndAwards", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "sharesItemType" }, "aerg_SharesIssuedForConvertibleNotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for convertible notes.", "label": "Shares Issued For Convertible Notes", "terseLabel": "Shares issued for convertible notes" } } }, "localname": "SharesIssuedForConvertibleNotes", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "aerg_SharesVestPortablyYears": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares vest portably years.", "label": "Shares Vest Portably Years", "terseLabel": "Shares vest portably years" } } }, "localname": "SharesVestPortablyYears", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "aerg_SquareFoodLaboratoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Square Food Laboratory Member", "terseLabel": "Square Food Laboratory [Member]" } } }, "localname": "SquareFoodLaboratoryMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "aerg_StockOptionExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option exercise price per share.", "label": "Stock Option Exercise Price Per Share", "terseLabel": "Stock option exercise price Per share (in Dollars per share)" } } }, "localname": "StockOptionExercisePricePerShare", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "aerg_StockholdersEquityDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders Equity Description.", "label": "Stockholders Equity Description", "terseLabel": "Stockholders equity, description" } } }, "localname": "StockholdersEquityDescription", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) [Line Items]" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of black-scholes- merton option-pricing model applying the assumptions [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsScheduleoffairvalueofrestrictedstockandrestrictedstockunitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of fair value of restricted stock and restricted stock units [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleoffairvalueofrestrictedstockandrestrictedstockunitsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of fair value of restricted stock and restricted stock units [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of unrecognized stock-based compensation related to a lockup agreement [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "stringItemType" }, "aerg_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "aerg_SubscriptionPayable": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Subscription payments, or recurring payments, are repeated transactions that are scheduled on a regular basis.", "label": "Subscription Payable", "terseLabel": "Subscription payable" } } }, "localname": "SubscriptionPayable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "aerg_SubscriptionPayableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription payable description.", "label": "Subscription Payable Description", "terseLabel": "Subscription payable, description" } } }, "localname": "SubscriptionPayableDescription", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "aerg_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "aerg_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "aerg_TotalCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Total Cash", "terseLabel": "Total cash" } } }, "localname": "TotalCash", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_TotalCurrentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Current Assets.", "label": "Total Current Assets", "terseLabel": "Total current assets" } } }, "localname": "TotalCurrentAssets", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_UnrecognizedStockBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The Amount of unrecognized stock based compensation.", "label": "Unrecognized Stock Based Compensation", "terseLabel": "Unrecognized stock based compensation (in Dollars)" } } }, "localname": "UnrecognizedStockBasedCompensation", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aerg_WarrantActivityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Activity Member", "terseLabel": "Warrant Activity [Member]" } } }, "localname": "WarrantActivityMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "domainItemType" }, "aerg_WarrantFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Five Member", "terseLabel": "Warrant Five [Member]" } } }, "localname": "WarrantFiveMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Four Member", "terseLabel": "Warrant Four [Member]" } } }, "localname": "WarrantFourMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Seven Member", "terseLabel": "Warrant Seven [Member]" } } }, "localname": "WarrantSevenMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Six Member", "terseLabel": "Warrant Six [Member]" } } }, "localname": "WarrantSixMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Three Member", "terseLabel": "Warrant Three [Member]" } } }, "localname": "WarrantThreeMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Two Member", "terseLabel": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantsExercisableSharesExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Exercisable, Shares Exercisable.", "label": "Warrants Exercisable Shares Exercisable", "terseLabel": "Warrants Exercisable, Shares Exercisable" } } }, "localname": "WarrantsExercisableSharesExercisable", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "aerg_WarrantsExercisableWeightedAvgExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Warrants Exercisable Weighted Avg Exercise Price", "terseLabel": "Warrants Exercisable, Weighted Avg. Exercise Price" } } }, "localname": "WarrantsExercisableWeightedAvgExercisePrice", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "aerg_WarrantsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants One Member", "terseLabel": "Warrant One [Member]" } } }, "localname": "WarrantsOneMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aerg_WarrantsOutstandingSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Outstanding, Shares Outstanding.", "label": "Warrants Outstanding Shares Outstanding", "terseLabel": "Warrants Outstanding, Shares Outstanding" } } }, "localname": "WarrantsOutstandingSharesOutstanding", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "aerg_WeightedAverageContractualTermOutstandingEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average contractual term outstanding, ending balance .", "label": "Weighted Average Contractual Term Outstanding Ending Balance", "terseLabel": "Weighted Average Contractual Term Outstanding, Ending Balance" } } }, "localname": "WeightedAverageContractualTermOutstandingEndingBalance", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "aerg_WeightedAverageFairValuePerShareAtGrantDateGrantedPerformanceBasedStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Fair Value per Share at Grant Date, Granted \u2013 performance based stock units", "label": "Weighted Average Fair Value Per Share At Grant Date Granted Performance Based Stock Units", "terseLabel": "Weighted Average Fair Value per Share at Grant Date, Granted \u2013 performance based stock units" } } }, "localname": "WeightedAverageFairValuePerShareAtGrantDateGrantedPerformanceBasedStockUnits", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "perShareItemType" }, "aerg_WeightedAverageFairValuePerShareAtGrantDateOutstandingEndingBalancein": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Fair Value per Share at Grant Date, Outstanding, ending balance.", "label": "Weighted Average Fair Value Per Share At Grant Date Outstanding Ending Balancein", "terseLabel": "Weighted Average Fair Value per Share at Grant Date, Outstanding ending balance" } } }, "localname": "WeightedAverageFairValuePerShareAtGrantDateOutstandingEndingBalancein", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "perShareItemType" }, "aerg_WeightedAverageFairValuePerShareAtGrantDateOutstandingendingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Fair Value per Share at Grant Date, Outstanding, ending balance", "label": "Weighted Average Fair Value Per Share At Grant Date Outstandingending Balance", "terseLabel": "Weighted Average Fair Value per Share at Grant Date, Outstanding beginning balance" } } }, "localname": "WeightedAverageFairValuePerShareAtGrantDateOutstandingendingBalance", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "perShareItemType" }, "aerg_WeightedAverageRemainingContractualTermyearsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average remaining Contractual Term (years), Exercised.", "label": "Weighted Average Remaining Contractual Termyears Exercised", "terseLabel": "Weighted Average remaining Contractual Term (years), Exercised" } } }, "localname": "WeightedAverageRemainingContractualTermyearsExercised", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "durationItemType" }, "aerg_WeightedAverageRemainingContractualTermyearsForfeitedOrExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average remaining Contractual Term (years), Forfeited or expired.", "label": "Weighted Average Remaining Contractual Termyears Forfeited Or Expired", "terseLabel": "Weighted Average remaining Contractual Term (years), Forfeited" } } }, "localname": "WeightedAverageRemainingContractualTermyearsForfeitedOrExpired", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "durationItemType" }, "aerg_WeightedAverageRemainingContractualTermyearsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term", "label": "Weighted Average Remaining Contractual Termyears Granted", "terseLabel": "Weighted Average remaining Contractual Term (years), Granted" } } }, "localname": "WeightedAverageRemainingContractualTermyearsGranted", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "durationItemType" }, "aerg_WeightedAverageRemainingContractualsTermyearsOutstandingBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term .", "label": "Weighted Average Remaining Contractuals Termyears Outstanding Beginning Balance", "terseLabel": "Weighted Average remaining Contractual Term (years)" } } }, "localname": "WeightedAverageRemainingContractualsTermyearsOutstandingBeginningBalance", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "durationItemType" }, "aerg_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "working capital.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "aerg_ZeropoinzerofivetozeropointzerosevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Zeropoinzerofivetozeropointzeroseven Member", "terseLabel": "Range of Exercise Prices $0.05 - $0.07 [Member]" } } }, "localname": "ZeropoinzerofivetozeropointzerosevenMember", "nsuri": "http://aergs.com/20220930", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aergs.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]", "terseLabel": "CEO [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/DuetoRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief financial officer.", "label": "Chief Financial Officer [Member]", "terseLabel": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r74", "r164", "r169", "r175", "r280", "r281", "r282", "r283", "r324", "r387", "r399", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r74", "r164", "r169", "r175", "r280", "r281", "r282", "r283", "r324", "r387", "r399", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of future minimum lease payments" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r140", "r212", "r214", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r159", "r160", "r161", "r162", "r177", "r193", "r219", "r221", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r368", "r370", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r159", "r160", "r161", "r162", "r177", "r193", "r219", "r221", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r368", "r370", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r140", "r212", "r214", "r369" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r154", "r159", "r160", "r161", "r162", "r177", "r193", "r216", "r219", "r221", "r256", "r257", "r258", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r368", "r370", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r154", "r159", "r160", "r161", "r162", "r177", "r193", "r216", "r219", "r221", "r256", "r257", "r258", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r368", "r370", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r141", "r320" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/DuetoRelatedPartiesDetails", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r26", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r19", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r76", "r77", "r78", "r263", "r264", "r265", "r287" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, after Tax", "terseLabel": "Compensation expense (in Dollars)" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDeferredCharges": { "auth_ref": [ "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of amortization of deferred charges applied against earnings during the period.", "label": "Amortization of Deferred Charges", "terseLabel": "Amortization of deferred compensation" } } }, "localname": "AmortizationOfDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/DeferredCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Earning per share antidilutive (in Shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r12", "r71", "r127", "r130", "r136", "r147", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r280", "r282", "r293", "r325", "r327", "r346", "r357" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r25", "r71", "r147", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r280", "r282", "r293", "r325", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r71", "r147", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r280", "r282", "r293", "r325" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total long-term assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Long-term assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r226", "r227", "r228", "r230", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r251", "r252", "r255", "r256", "r257", "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails", "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccounting": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccounting", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r218", "r220", "r278" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r218", "r220", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableDescription": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Description of equity interests issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Description", "terseLabel": "Issuable in acquisition, description" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r10", "r327", "r380", "r381" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash proceeds" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r10", "r62" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r55", "r62", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r55", "r297" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash, Uninsured Amount", "terseLabel": "Cash uninsured" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesOutstandingBalance": { "auth_ref": [ "r145", "r146" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The undiscounted sum of all amounts, including amounts deemed principal, interest, fees, penalties, and other under the loan, owed to the investor at the reporting date, whether or not currently due and whether or not any such amounts have been written or charged off by the investor. This relates to loans accounted for as debt securities, with evidence of deterioration of credit quality since origination that were acquired by completion of a transfer for which it is probable, at acquisition, that the investor will be unable to collect all contractually required payments receivable.", "label": "Certain Loans Acquired in Transfer Accounted for as Debt Securities, Outstanding Balance", "terseLabel": "Notes payable outstanding balance" } } }, "localname": "CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesOutstandingBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r15", "r16", "r17", "r69", "r71", "r98", "r99", "r100", "r103", "r106", "r112", "r113", "r114", "r147", "r164", "r169", "r170", "r171", "r175", "r176", "r191", "r192", "r195", "r199", "r205", "r293", "r396" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant exercise price per share (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Stock value issued for exercise of warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r156", "r157", "r158", "r163", "r386" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r76", "r77", "r287" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding", "terseLabel": "Common stock option exercise" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r17", "r205" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r17", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.001 par value, 500,000,000 shares authorized; 207,817,878 and 207,562,461 shares issued and outstanding at September 30, 2022 and at December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r117", "r356" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Significant Concentrations and Risks" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r213" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Earned revenue" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of reconciles notes payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r191", "r192", "r195" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r45", "r71", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r293" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r68", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r187", "r188", "r189", "r190" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r13" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Debt Instrument, Annual Principal Payment", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Maturity date by one year" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense": { "auth_ref": [ "r215", "r224" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The compensation expense recognized during the period pertaining to the deferred compensation arrangement.", "label": "Deferred Compensation Arrangement with Individual, Compensation Expense", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredCompensationArrangementWithIndividualCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/DeferredCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r11" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds": { "auth_ref": [ "r379" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The price per share or unit times the number of shares or units issued in an insurance entity stock offering in connection with its conversion from a mutual form of ownership to a stock entity. Amount is gross, before offering costs.", "label": "Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds", "terseLabel": "Net cash proceeds (in Dollars)" } } }, "localname": "DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAverageFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average fixed interest rate related to the group of interest rate derivatives.", "label": "Derivative, Average Fixed Interest Rate", "terseLabel": "Interest fixed rate" } } }, "localname": "DerivativeAverageFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DividendsAndInterestPaid": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The contractual amount of dividends (or interest on participating income bonds) that must be paid for the current period (for example, unpaid cumulative dividends).", "label": "Dividends and Interest Paid", "terseLabel": "Paid amount" } } }, "localname": "DividendsAndInterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Accrued dividends" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockStock": { "auth_ref": [ "r208", "r355" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.", "label": "Dividends, Preferred Stock, Stock", "negatedLabel": "Preferred stock dividends" } } }, "localname": "DividendsPreferredStockStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromOtherRelatedParties": { "auth_ref": [ "r73", "r319", "r362" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount receivable from related parties classified as other.", "label": "Due from Other Related Parties", "terseLabel": "Subscription amount received" } } }, "localname": "DueFromOtherRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r26", "r73", "r167", "r169", "r170", "r174", "r175", "r176", "r319" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r43", "r85", "r86", "r87", "r88", "r89", "r96", "r98", "r103", "r105", "r106", "r109", "r110", "r288", "r289", "r351", "r364" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss attributable to common stockholders per common share - basic and diluted (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r43", "r85", "r86", "r87", "r88", "r89", "r98", "r103", "r105", "r106", "r109", "r110", "r288", "r289", "r351", "r364" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss attributable to common stockholders per common share - basic and diluted (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r107", "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Attributable to Common Stockholders" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareSubsequentEvents": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "For the latest period for which an income statement is presented, this element represents a description of any transaction that occurs after the end of the most recent period but before issuance of the financial statements that would have changed materially the number of common shares or potential common shares outstanding at the end of the period, if the transaction had occurred before the end of the period. Examples of those transactions include the issuance or acquisition of common shares (including stock splits and stock dividends); the issuance of warrants, options, or convertible securities; the resolution of a contingency pursuant to a contingent stock agreement; and the conversion or exercise of potential common shares outstanding at the end of the period into common shares.", "label": "Earnings Per Share, Subsequent Events", "terseLabel": "Common stock price per share" } } }, "localname": "EarningsPerShareSubsequentEvents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Stock based compensation restricted stock agreements (in Dollars)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r37", "r38", "r39", "r76", "r77", "r78", "r82", "r90", "r92", "r111", "r148", "r205", "r208", "r263", "r264", "r265", "r269", "r270", "r287", "r298", "r299", "r300", "r301", "r302", "r303", "r314", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "http://aergs.com/role/ShareholdersEquityType2or3", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfNotesReceivable": { "auth_ref": [ "r337" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale of financing receivable.", "label": "Gain (Loss) on Sale of Financing Receivable", "terseLabel": "Financial amount" } } }, "localname": "GainLossOnSaleOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r60" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r47" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r44", "r71", "r127", "r129", "r132", "r135", "r137", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r293" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r41", "r127", "r129", "r132", "r135", "r137", "r344", "r349", "r353", "r365" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r153", "r155" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r72", "r91", "r92", "r126", "r268", "r274", "r275", "r366" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r57", "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued interest" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Prepaids and deposits" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued expenses and compensation" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInSecuritiesLoanedTransactions": { "auth_ref": [ "r59" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the liability arising from securities loaned transactions.", "label": "Increase (Decrease) in Securities Loaned Transactions", "terseLabel": "PPP loan forgiveness" } } }, "localname": "IncreaseDecreaseInSecuritiesLoanedTransactions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOtherLongTermDebt": { "auth_ref": [ "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense incurred on long-term debt classified as other, including, but not limited to, interest on long-term notes and amortization of issuance costs.", "label": "Interest Expense, Other Long-Term Debt", "terseLabel": "PPP interest amount" } } }, "localname": "InterestExpenseOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r54", "r56", "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "auth_ref": [ "r382", "r383" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For investments which are quantified by principal amount, the principle balance held at close of period.", "label": "Investment Owned, Balance, Principal Amount", "terseLabel": "PPP principal amount" } } }, "localname": "InvestmentOwnedBalancePrincipalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Total undiscounted lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffutureminimumleasepaymentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r29", "r71", "r131", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r281", "r282", "r283", "r293", "r325", "r326" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r23", "r71", "r147", "r293", "r327", "r348", "r360" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders\u2019 Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r31", "r71", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r281", "r282", "r283", "r293", "r325", "r326", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r7", "r8", "r9", "r13", "r14", "r71", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r281", "r282", "r283", "r293", "r325", "r326" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r55", "r58", "r61" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r35", "r36", "r39", "r42", "r61", "r71", "r81", "r85", "r86", "r87", "r88", "r91", "r92", "r101", "r127", "r129", "r132", "r135", "r137", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r289", "r293", "r350", "r363" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow", "http://aergs.com/role/ConsolidatedIncomeStatement", "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r85", "r86", "r87", "r88", "r96", "r97", "r102", "r106", "r127", "r129", "r132", "r135", "r137" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Accounting Standards [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r1", "r79", "r80", "r83", "r84", "r93", "r94", "r95", "r143", "r144", "r149", "r150", "r271", "r272", "r273", "r286", "r290", "r291", "r292", "r294", "r295", "r296", "r305", "r306", "r313", "r315", "r341", "r342", "r343", "r374", "r375", "r376", "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "NEW ACCOUNTING STANDARDS" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NewAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing and financing activities" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r48" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income/(expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansPayable": { "auth_ref": [ "r13", "r347", "r358" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Notes and Loans Payable", "terseLabel": "Outstanding notes payable" } } }, "localname": "NotesAndLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r64", "r65", "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Notes Issued", "terseLabel": "Promissory note issued" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/DeferredCompensationDetails", "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r13", "r347", "r358" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable", "terseLabel": "Notes payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Payments" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableFairValueDisclosure": { "auth_ref": [ "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of notes payable.", "label": "Notes Payable, Fair Value Disclosure", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofreconcilesnotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r127", "r129", "r132", "r135", "r137" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing operating income (loss).", "label": "Operating Income (Loss) [Member]", "terseLabel": "Statements of operations [Member]" } } }, "localname": "OperatingIncomeLossMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r308" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liability - current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r308" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liability - non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r307" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of use asset - operating" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r60" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of ROU assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r3", "r75", "r123", "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "terseLabel": "ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/OrganizationofBusinessGoingConcernandSummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r24", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other assets", "verboseLabel": "Current asset" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet", "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r46", "r60", "r151" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r367" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLoansPayable": { "auth_ref": [ "r13", "r347", "r358" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term loans payable classified as other.", "label": "Other Loans Payable", "terseLabel": "Notes payable CARES Act PPP Loan" } } }, "localname": "OtherLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income/(expense)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNotesPayable": { "auth_ref": [ "r13", "r347", "r358" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes payable classified as other.", "label": "Other Notes Payable", "terseLabel": "Note payable balance" } } }, "localname": "OtherNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r18" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestrictedAssets": { "auth_ref": [ "r11", "r384", "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total assets that cannot be used for operating purposes because of contract or regulatory requirements that are in effect for a period that extends beyond one year.", "label": "Other Restricted Assets", "terseLabel": "Restricted shares value (in Dollars)" } } }, "localname": "OtherRestrictedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash outflow or inflow associated with the acquisition or sale of a business segment during the period.", "label": "Payments for (Proceeds from) Businesses and Interest in Affiliates", "terseLabel": "Interest payments" } } }, "localname": "PaymentsForProceedsFromBusinessesAndInterestInAffiliates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r50" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": { "auth_ref": [ "r207" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of cumulative preferred dividends in arrears.", "label": "Preferred Stock, Amount of Preferred Dividends in Arrears", "terseLabel": "Preferred stock, annual dividend (in Dollars)" } } }, "localname": "PreferredStockAmountOfPreferredDividendsInArrears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Series A convertible preferred stock, dividend rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r69", "r195" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred Stock, Liquidation Preference, Value", "terseLabel": "Series A convertible preferred stock, liquidation preference (in Dollars)" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock", "verboseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r16", "r191" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Series A convertible preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Series A convertible preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r16", "r191" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Series A convertible preferred stock, shares issued", "verboseLabel": "Series A convertible preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Series A convertible preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r16", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at September 30, 2022 and December 31, 2021 (Liquidation preference $340,050 and $340,050, respectively)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r49" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Cash proceeds (in Dollars)" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r51" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLeasePayments": { "auth_ref": [ "r311", "r312" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from lease payment, classified as operating activity.", "label": "Proceeds from Lease Payment, Operating Activity", "terseLabel": "Cash lease payments" } } }, "localname": "ProceedsFromLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r52" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from note payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r52" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Proceeds from subscription payable" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSecuredNotesPayable": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds from Secured Notes Payable", "terseLabel": "Proceeds amount" } } }, "localname": "ProceedsFromSecuredNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r152", "r327", "r354", "r361" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment - net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesFromCustomers": { "auth_ref": [ "r345" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers for fees and charges arising from transactions related to the entity's brokerage activities and operations.", "label": "Receivables from Customers", "terseLabel": "Accounts receivable" } } }, "localname": "ReceivablesFromCustomers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r318", "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Deposited" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/DuetoRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r217", "r318", "r319", "r321" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r316", "r317", "r319", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "DUE TO RELATED PARTIES" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/DuetoRelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r53" ], "calculation": { "http://aergs.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Repayment on note payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r267", "r339", "r390" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Recognized restricted stock awards value (in Dollars)" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Restricted shares" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings", "terseLabel": "Restricted stock amount (in Dollars)" } } }, "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r208", "r327", "r359", "r374", "r378" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r76", "r77", "r78", "r82", "r90", "r92", "r148", "r263", "r264", "r265", "r269", "r270", "r287", "r371", "r373" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition [Abstract]" } } }, "localname": "RevenueRecognitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Earned revenue recognized percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/RevenueRecognitionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r40", "r71", "r124", "r125", "r128", "r133", "r134", "r138", "r139", "r140", "r147", "r164", "r165", "r166", "r169", "r170", "r171", "r172", "r173", "r175", "r176", "r293", "r353" ], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Series A convertible preferred stock, liquidation preference (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of future principal payments" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r240", "r247", "r250" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Activity [Table Text Block]", "terseLabel": "Schedule of unrecognized stock-based compensation related to a lockup agreement" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of fair value of restricted stock and restricted stock units" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of range exercise prices warrants outstanding and exercisable" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of black-scholes- merton option-pricing model applying the assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "terseLabel": "Schedule of stock options" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r11" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://aergs.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Selling and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Options vest over a period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r223", "r225" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Description", "terseLabel": "Stock based compensation description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "Forfeited shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "terseLabel": "Shares, Outstanding and exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r230", "r232" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Shares, Outstanding ending balance", "periodStartLabel": "Shares, Outstanding beginning balance", "terseLabel": "Shares Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price Outstanding and exercisable, Ending Balance", "verboseLabel": "Weighted Average Exercise Price, Outstanding and exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Shares, Forfeited or expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value", "terseLabel": "Weighted Average Fair Value per Share at Grant Date, Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "terseLabel": "Shares, Canceled", "verboseLabel": "Shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares, Granted", "verboseLabel": "Shares, Granted \u2013 performance based stock units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable", "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Fair Value per Share at Grant Date, Granted \u2013 restricted stock units and awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r262" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Intrinsic Value Outstanding, Ending Balance", "periodStartLabel": "Intrinsic Value Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r230", "r232" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Shares Outstanding, Ending Balance", "periodStartLabel": "Shares Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r230", "r232" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r226", "r227", "r228", "r230", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r251", "r252", "r255", "r256", "r257", "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/NotesPayableDetails", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted Average Exercise Price, Exercised", "terseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Forfeited or expired", "verboseLabel": "Weighted Average Exercise Price, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Shares granted (in Dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r262" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Intrinsic Value Outstanding and exercisable, Ending Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Term (years), Outstanding and exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Term Outstanding, Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Term Outstanding and exercisable, Ending Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Shares, Vested and converted to shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Fair Value per Share at Grant Date, Vested and converted to shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleoffairvalueofrestrictedstockandrestrictedstockunitsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Warrants Outstanding, Weighted Avg. Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofrangeexercisepriceswarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares issued", "verboseLabel": "Share issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails", "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r15", "r16", "r17", "r69", "r71", "r98", "r99", "r100", "r103", "r106", "r112", "r113", "r114", "r147", "r164", "r169", "r170", "r171", "r175", "r176", "r191", "r192", "r195", "r199", "r205", "r293", "r396" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r34", "r37", "r38", "r39", "r76", "r77", "r78", "r82", "r90", "r92", "r111", "r148", "r205", "r208", "r263", "r264", "r265", "r269", "r270", "r287", "r298", "r299", "r300", "r301", "r302", "r303", "r314", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofblackscholesmertonoptionpricingmodelapplyingtheassumptionsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable", "http://aergs.com/role/ShareholdersEquityType2or3", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r76", "r77", "r78", "r111", "r340" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "auth_ref": [ "r222", "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Total stock-based compensation expense for grants (in Dollars)" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r33", "r186", "r205", "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Common stock issued on exercise of convertible note (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r16", "r17", "r205", "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "RSU restricted Stock (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r16", "r17", "r205", "r208" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Sale of common stock (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Common stock issued on exercise of stock options and warrants (in Shares)", "verboseLabel": "Common stock shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r16", "r17", "r205", "r208" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Reserved a total possible issuance under the plan" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r16", "r17", "r205", "r208", "r236" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Shares, Exercised", "terseLabel": "Shares, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ScheduleofstockoptionsTable", "http://aergs.com/role/ScheduleofunrecognizedstockbasedcompensationrelatedtoalockupagreementTable" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r34", "r205", "r208" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Common stock issued on exercise of convertible note" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Sale of common stock" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Common stock issued on exercise of option" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r16", "r17", "r205", "r208" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "RSU restricted Stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r34", "r205", "r208" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Common stock issued on exercise of stock options and warrants" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionExercisePriceDecrease": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Per share decrease in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option, Exercise Price, Decrease", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePriceDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r17", "r21", "r22", "r71", "r142", "r147", "r293", "r327" ], "calculation": { "http://aergs.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet", "http://aergs.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r70", "r192", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r208", "r210", "r285" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r304", "r329" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r304", "r329" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r304", "r329" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r328", "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/CommitmentsandContingenciesDetails", "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Common stock withheld with exercise" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r115", "r116", "r118", "r119", "r120", "r121", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r96", "r106" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of common shares outstanding (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://aergs.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "30", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123409700&loc=d3e13503-111538" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=121614798&loc=d3e15032-111544" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919320-209978" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919327-209978" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r345": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "310", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176284" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.8)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "805", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124505872&loc=d3e30785-158569" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r391": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r392": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r393": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r394": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r395": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r396": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r397": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r398": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r399": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r400": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r401": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r402": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r75": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693" }, "r95": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" } }, "version": "2.1" } ZIP 55 0001213900-22-072004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-072004-xbrl.zip M4$L#!!0 ( ,=Q;E46GY O_A0 +KJ 1 865R9RTR,#(R,#DS,"YX M76?SYIVM\^_GU[6[L $&#=!:;6FVHGR!EU#$OK8AV2 M/L*.]LYU?M&VM:'KC@XKEX>-AG;7/='JU7K=[_*WCQ-R2(PA<'0-V, !T#VGPYZ" MON[9[M'6@Z?;5M\"YI9&^8*T+7:WW>D(D*.M %-?)[WW" \JLUL51G]+;OJ0:,:$K#]KQGB=]+#-:=>KU4:%W>[I!(3- M)ZGVCPW>NG9P<%#A=\.F'A&A#N\$H /*)(LL!5&K_'%]U>'S-6M+,9KNK'T4 M\F[%OQDV-5V!U"Y.HNU=1/_L7@\FADP3[Z%%RB%]E4'H;3?POZ&I_<0P;Y:(M8SLAFX_-K M0PSZ1UMLX.UPS+]LO?>>H@N;Z-C R 9RR55&&(T =BTJFHC@.8%4[_B4L-L5 M.B:PK^:0MRJ?5L7."(-G9X>.2>C#R865X&IE8C)!_]GYHF-:T,K@:D4\&;K] M[#S1,0W/SA15C"O6N$OYT-@?=[>7&8\MIW>"($&V93*CWM1M]K1WA@!0LV*9 M/K]_X;^$C693&0X[G_)/U*!1Y]*A:L5-/_V;DC$!)-0=10EJ 46-DR0?*TE" MVEP+PV$\2J0%/_&_D]H;$ B:2+O&%23943YL0A")SJ$L*C%AI)ZG9:7T5UO' ME/)8WA'#";9:$4D^W24Q$3 M7:.8Z&9-B(;Z6FO$(D9*@ KQ#NJ>:=$V&_F5D5_1AS*G6XYT=U8GW2*/ZYLW MP9TAG:,ALDVZ_#I[\"QWRGK5$6[$!"QIELE/3*:[B\CT9*C# 2":!>D-9-P' M@__S'_OUVMZ_-1]$SL/\YJ4;G=\3G0S/;?0H?'!G#3(F+B;/#PO)DU+7&/F- M!9:*K(4'.K2>^&BHW_2(!0$A%\B" SJ[!L!0AV;'@NQ1I3BUB&$CXF% _XD.SI0A'/Y?&@>@!0@T M"D$+,+!F$13:'(86XMC$U!GZYU-%'T%HZMB,JX*@28YGWD\*E9*)2F5& M*$LL;UTHR 6DK4_U'EMZ1T41O9$C@(.4 %AG+>B]L:3)23\%?8 Q]6O(&5'W MQ$>-37YF@QS;5JLFI1!2T:)D-J8I2R ><-$ML%ET0$-S-^FBLNY+E_&U6DH8 M'M!NCBB8;4?3L=#_O3M+"6.R:.>E(LG!S'O!?[#R 3U%[%U[,S@N]=9%%UQU=]H,( MER7![5Q'DUKTQY8GVCN?CD <;UT>Z6 K0RK"1O(@.;5PE^5395)ZXS*2N/H, M8>6WSGVB4@M^:8 @D]T;E]P*VVIU9"\/'2LIY(0ZTFP:N\"/!LG MFN=$L_0BZ[[45-=3^8R$#Y6(XXW+@ATP-#T;H#ZFZUIJ$*DEA&SR1I$H)NY- M"_7(>1!3"0^!P)C7#<9CS]U\1(T/J8V$2=S-G\/$F]=5&EUXE9DA*WRMD"JZ=R,;(%Y>:A*N39")M" M-&+#2MU9NEV.\4NE98H(*^'.^*!:,.HF$2T18\_6C7MBT.D%Q '8I0M"/FLT M$C#HRLI!)C5EHY$]I?^X0Z 3XCGY0E^6:FZ84RI%)% 2#G([0+FM^3@#I=D. MD&H(UE:Y:0(D8,(TC\Y=)(9+ !+'T1>HB![A1';'J>!#[>[U/@4C9ZS6F$8E] ML1]@N4BWF<1'^@ #?G13ID1+DY6J4R.5XUI G:(0?6W9YB"U*$HM@,DB35WS MD6HSJ!O%DJ1:V!%M, '8L A;8AN /.J87G4)\ESVDB5[AY?^#-KD)F(6IBGA?BT"$!NIB(0-Q%3@8,N64L4<:N<)4HCE9?+./4B M7YO\1 +B;[C_]]OUU]W__?G7J/%WOX8._W^H^[ M[I38>V/CJ6I_=BMN!WQ^VFO<3VK&E5O]?GY>[_Q>&4^:)W]6QV8']R;?OUFN MW?QR\_39OAG9]8?/3P/4O*Q4_JCO7)U;UX][I'[S87#9O+W8NSK[?>"8;>O; MR<6/2K>V]]MP=_]V;U3[\D/?K;3O]KZ8^V?-Q_JOSJHM]OX M;?#X\+V"OW[WOEP][>Y5_Z>==&[#T@"+:+9DWR]+Q0LTE[O)5(8R9Y/PC>C\ MO)[\?S(#4D [LDO^%)1(V(&)8G<^:F$I)*LN M%1,#[141P8Q&7 9%62? >#] XPJQC"(@DLW9'[&!@T&#>E1\U*.M,"1H]6]G MYPVB9U*.>\3%ND$GWB\-P^LF';+L&AQ9[.PA\5&0W#ZI(M%F[X>KP)T47?TQ$,N0)FI:_+: .8SGX"FEGD^V3=/QM MDFN^2>*3:?M;)-=LA^0XV"#I#L'Q?'M$Q7E8 3?YYNM<2 MH%%:XLH=VPU0<:869R+JW413=!?)=',239;GCCZ P2&*+CJ^XBGNXS##K>)D MK8*=(M-VRY*Z9T%.M\U3NM^"C&YKGM!EZXIY.E?%^5J*CQ).]=I/*5RQC(+Z M?E6*-A(RQWF^@[P0(C#582P-2:S4YRN[9;A0$7'7/M0A@,5_7)MKPP'*KKEVGX9 M#E3TRK6#$AS45?3)]3(^N:ZB3ZZ7\*3E=Q[$&PA%.9 @0 794FVN%R,IIIZ4@2X./UZ@Z!!"63OAIU-V)^KL IK MTXY"^,6&W$'8#0K@YRF8S;&!D F.0<(Z<[!'-3$3MP M\CS^8$FQEV9%-B^7D%"8%-:Y!>DO&K*=(QRHTNR>PI-1#+_8^E^RK[8YX5GB M5O^X<[*_4U>9X6S 8@[I? RL,6!5RZB1:+>OD Y5?L@S\>9M"=\^ N<2C@'A M[W3,CUB.P#(P @L'W8%O]^+<3 MU-7WXDR(9R+KX&073-PF>RLY9-YT\:$;7GSFJ%8.4+*$3;_*J11?,GAYRQ-9 ME<]GSS68[N&0]L2&UP.7Z16)%*M8+R5=KRS(!R(OGU8IA%)TVC1:KM.O(:V4 M@LK@R12T"086A+1O\"G+%5O3=>60I+"E:R3#H /1D,H%K%"(PBPFD4J,9WAV ML06C\U!;(W/+AOX"P!(>SR;L:?4L,F076_U3T%NG])9D,!.MS'ZR4,"E"@-= M%,D,$7X@7%TV1F5G7@YC&*N9K]M"R;YQV]0DX\3#[QNA* M ].E+4H2G,Q@1KEG*;J5\?,,B<7)5B MG_6P*WDI;>T2#C/P;T6CY_P*7S%=J8P%\_OS*G5L@E]*J\\1[@/*IHDPF(PL M_&;4.X-QV1FB1?%D2GXV=@N?94VZ,X%_DI,\:F)(]QZ*R_2LL0J[.GL4S<"O5UW4.K]#.R3/Q M*0E^\P$L6@#]52GS@DR*PZ\U#/FZ]'8)]DKX]5EQES; W-@?NWS%=ZJ[(&+> M09:39]N*HZ#;R[KXA;C(BSE)L/3-+'$#3>X(DZKT8FZ\&%@)RR5F-!B*WN'E M)>E<\@!A/N#K4I!\=H16:C$UC(6=%GQ=LR7A8RDON?RW'EZ5OUR:W64\YQ*# MORX?NA)&5[XN3#QML>I7F:OI%[0,:V90;#(2-&Z!HUO0/TH4KN8)6\Y/@8ZC M"]'D 1P5,Q*+,R/*!Q<88$9?I=VA17 7#V*DY-3:5%@,^5*/SXQ>7D[T%4Q) M=G(S>V;2Y05]"Q:YH$!47PBF.# ->D>J)OJ](Q<48E(*LPR3;72E\O6=5 B![C$JL?:3A5F,0%4J+@WP/7/ MNETA0E9Q&G9][[[&D4K.30*7O27T MZOP69D/D8/A1S."DVS$A8"7O.JYIBS$#J^Q!#%5;_1.(*:C"< #A>Q94Z"-+ M[=.^":!"X^*+E"JQPN^2M^%#YBA^C)%096Y%0._C2A?T*.)2@%NIED+@Y!;,".$6U<8VK@PQ0 M(BM^R8RN;?/#M^N7T/*OU"?!RK3PU ,N"KX:T-:Q.__"HG(&,0^J\*LPPGX* M6<NB>6: M%%+F7(CE"@VJ%KLPS#!.O8UI,$$@"5O&?LI%UYT2>&X+093S,UM MS@>@5E?R;DU)H:(,B&P-JTF"B6Y3'9@;\C8.*K!PFJ<6RZ]!D[_YNY*TR[J$ MO@ SLH((U*[Q]^X3FUNM?G<(KG3B=@'L8IVMW4[U*?$WRUN0WNP.+6S.;U'+ MB' 7L2_460:W)@&(\'>X>*+1:L*V,P#/':>\"-OB1_3*HH&?Z9OD)RP,H7$@%TW!+^0^+^:G$5PX^V9,3>^3F):I4BV**X2RYAE(JDI'B MDY=B"H):]EEYEO9H03_P5XO!@D#%WB\[-,\JC?52F8 MU7,6@2>M\!;KI98R2L#)7UTE7VG/-L(N'77Z)SLCH\2A'A$VL=V8NX=6G_6; MGTYZ\7@FBFD5IT13[]GQ'_X /@/JR' U[,B-37#@JPDL&)9=-E6*9G(1RA:) M0==(+U7D*\(F^\)FWE>/%5[A%0 O-+7I\INJ)O5SD):J@*I>4K\ 1G&%?H/' M>(1V!M:8C;XZ&[/TL4$I.(G0)"5%5=70HI"EFP%R @II;!FPTN+<; G=>?"H MOSU'*+&M84$7# !^[N1% I)HI93QE7.6.N;_-W7CODL#"D+!TN'(-\L=6K % M 0L7%@!C]B8&([$M8@"#\VIP8G(EABH=#X[L0C+G( 5H.%-"!1 M@!Z4^5($=@R,9+Z#VF00*(5[CD<2D@5M>?RF%/HHHMRIIY&Z6N!G>&3[R^UV MY,-8:N#/Q"0[G#K67="V=8-?KBG"A "6+#<>V_.*O,^@!D>Y^(2',,.AS0#G0 M.RQQKQ3V*"))?8V@L351"_P,3[["*Q1E9"#*G7IEHHP4GORI5R)#(\?6X#F&:1C3B\A+P[(#SH$ M++Q\]J,02L;BQPKED!A#X.C\L?H_4$L#!!0 ( ,=Q;E5?'I)(M H /IS M 5 865R9RTR,#(R,#DS,%]C86PN>&UL[5U;<]JZ%G[?O\*'\W+.="BW MI"29I'N 7$I* N'2VYX]'6&+H,181+*YY-=OR=C4!@MC(\?0V2]MZMIK+7V? MM-;2TB7G?\Y&NC*!A")L7&0*[_,9!1HJUI#Q>)'I=;*53JU>S_SY45'^./]/ M-JO<0 ,28$)-Z<^5&AZ-.RI2N@08=(#)2/F?.?J_DE6&ICD^R^6FT^E[E;U# M540@Q191(>4/E&R6"71%U@CD L^4.VPH]WBB%(Z4PLE9OGQ6*BF];DTIYHO% MQ2=_G.O(>.X#"A5FMT$O,AY-LS[1WV/RF"OF\Z6<^V)F\>;9C#_PO3\MV6\7 M3D]/<_;_+E^E*.A%)K:0^W;7Z*A#. )99% 3&"I70-$9M1\VL I,&\E0NQ3A M&_Q?6?>U+'^4+12SI<+[&=4R"]P4Y9Q@';;A0+$M/S/G8WB1H6@TUKE!]K,A M@8.+#(#D,!SIO2&4)H9A0NNM>N+QO! M/[!YR_'_R0D_S'U,PK8ZZXXCV#'9SR-H1#-O]=M<,O#5 !U>ZW@:R;;E1PNC M;*M4H*N6;G>A!K/!9QV ,@OL/CP M&]W9.?#'$O5BH0G0F4!:,6N D#GS9U^ ;D')QF^GTQT8?H8KQ-\Z M0%37.O:CC]YU)^&\D:/6:&1+RR+6Q]WO!P2/0M@S<63D,-$@84$BHTPA>AR: M_$?6M#A<-#C>\U[;*@).DZ/^)ACL47P&!)SWF)QPF1N@+N ,0^7]U"V MR1M5[4F'6>?+VV?Q^M]_888:89 MIS\T$.@C'9D()I1G!BC8(;Y65!5;;*;3 G.>=R)_H@\/:#(1B:L2> #0R,A*!>EW\0> ? (C$9N;1@%[>ASJMP M+4"2\XH;%*4:1;)V@ MF &96%!+/(T0ZSD,5C;@Y!#R00XAEVB"-&AHR:9((BVI)]);.C 12 X7Y5VF M6O9R4\?J4Y6@L5W0" K@@F6JH._2+1=L1E3<6 ?*$TF!P&-&8O798!UQ$[A@ M/YR8\>'Z]FEP1BD_!6(GN7#K,2VY3K4WN5T0YAM"TW[52D+:L7W?D;56US&Q M^CS$.A-*^>J".9==Q5Q7L(.Y+>(4W6VQ2:RQ!VE(-XB)*?(O%04@(QP#L78\ MX-$(&XD!OR8^58>S'>CKD$@>GA5-0]Q2H+< TNIR1"739$Q2!EM3=Y78L M"$&2N;S>AB9 !M2N #&8@Z9L4F2-++N,< D'2)6^_+.%PD/P2]O@)JR[[)@- M50PM\?@6JFY_2I,;X1"D4YORJ,-J5-!;XIKW>6YE=^3'Q+9,KFX;C1\M;@BF MM$7P0+HS\DJ..:=LPPDT+.E3E*78U(-5 /I^1^BV7_+TKX:IV1PXXJ4G95[9 M^P[Q"A+KHSL;?TG+G9E=S?AF'_E[2-?DQPZ BT,3.G.,%6V$#$1-+GD"'"%KWEX3BE=8!(RZ:4AGCQ^9NCM GJ''.NG[AX2*]I^432B)YUB+ M(SY_?;W[/WN=&[M*8W97):_EQ\ZG7G5"]/U->\ M?FOFS Z\?2V7GF<%M6'F?UQ?%SN?O7A_O56OQ_K MQ9?;UT==RWXI'C6MT-RW3XOV'QWJU?5-N7'U^'&DM]+5V\Y3K%LJ?AL.[OK:I#MO/WU]T*ZO7X>? M)L,2>M >Z%WI0V_4UM4;_=V[^]'-\XL^G[T[+3Z_D"ZYG==.9J!/C>(/\G*3 M?[K!A6KSB_FC#FIWKVIS=/1ZU*W\Z'5&X]=6DQY/KSZU+.VZ<7Q2?L(SLSKX M6ZEUVN[9J%@!G4+&.]_+?\EPW)9E!+=83/[K: M>VP6PI+8=.1(3K6;A-*SMN?(Q4.4R,0!NFZ8D$#JNC!;CV3$ U6D77J(A'XP M2,+1&H\'UU=<,SMKV&"&6*\+9I!>S5B&RXQ !B#S.FNI MO:+)OF0@Z':S%E9+IS,Y2U,=D&] 0:#_]X:)O0MF;PS*AF$I\QS./303RZK\ MLE.OM00VU>_<$F1844_[Q(/4OS:A>C;=V#_D=A^S0!5^S6T MXK&T&(;KE(M+Q#98>QS&6SVS5NK5><]RM>^EME,1349#@EL8HN@6(YC M^^WS@H@\OHU'VGCLMS+"Q$2O=MN2*69$5G_@1$:'6_8!LTLX)E!%"] ,S:LS MB=+/)G7I9PJ[,!D*IJ@Z'3\9)[S37,+%WW7#.3;.#.3'XZ!F7_$&5'L2(3]' MCZ(\W4K?3KQ&A5E\^BWR"1)O]VD.KBW3(M!W389]T,+/K.!0R9:B#M2;1D)+ M>/IM1WY8VCD&2 O>V; 5+:L2TET,DD;%&C!RC[NM#]"5$_")N[Y5?0'QL5-;?Z>PW.BMV=W>TL.T>-*8<#I M#*<[GWKEE6C6!KOJ4F56^.[U"IPS"D+C5H(.<)!&0,F=UN?EE(UO #)XO:!I M=( .>5SV7(NWO!-/]L;&[90>>,C<%EJ7T8(<1L61^M?%I&^6_7A4'N"PC :I MRZ.43=$"Q_W+X"0N;-M2Z8&/RVVA=?DL[38N;=^^JK/=[.FB9$<0^T)$I+YY M)W[@"P/')>)(UJZ>%?J=&Q4]MP@G/JX"5/Y6_C$(4I?&8QG^46!PW9A FL:2 M5Y#BV"&4\-:!=7%%9GD"@\+)BR8V+H'@_Z_(;^/>=Z(\ \/HZFO1>>XT, M8*@I]-H@Q?%[+<$JA)J]9:E.J<5_645SX%FLE]U90_7M:Z*R@>^5*\K# )6X MR.O5EN!=GD(U>UEFB<'45E=_[LR0L[+83^!B_P =^YB;Q*#& YIXW35R;N_5 MT!W"JQDD*J)LI-ICM&E??\;/TG\%A+#HLEVV'UGH@?JZF A*O=:B#<=./M < M).CYA&H.V?.)L5M?4MVEJL5-7/FU1FV6Z1&D.AOH6/?P/_"\V8($86UUEG(U M4W5+LP][J4-@/,(V,.'58 !5V4[UC8U/NQ20#EIY&Z-WKS*D36*)">;;&VE* YFAC&''(/D2.-?OP!(SO -Q L;!"GK MPSFQ91'=>+K1:#0:W3_]Q]/*/]@@''EA\/.K-]^\?G6 C><><'BYU7EZ_^X_\?'/S;3_]^>'CP'@4(.S&:'3QL#T[#U?K.]0[NL1-$\Q"O#OYO MO/I_!X<'RSA>_WAT]/CX^(U+?B=R/8RB,,$NBN@/#@X/R8#YD*<8T0%_//@0 M!@?7X>;@S;<';[[_\?6[']^^/?AX?WIP_/KX./WDWW[RO>#3@Q.A \)W$/W\ MJD#IZ0'[WX1X<73\^O7;H_P77Z6_^>,3_4'I]Q_?LM]^\\,//QRQ?]W]:N0U M_2(9]LW1?WVXNG.7:.4<>D$4.X%+"43>CQ'[X57H.C%#4LC7 ?'%(H7[]P]O7E-;_H3_Y"_]U&@91Z'LS*J03 MQZ=SOELB%+\ZH$-_O+W0&*HO!M.+_S%H$W)Y(+XHGKADD0D]^[(0RZ'A*K M!20M2 RNT>.> M'48.;@F7@ZG,\ -?HZC%%TXVR=!_J)B)WB+P,R<8;F"&.B M?F1K1T'$I"=DIO$C2)F=)2@.;Y%/%P8Q*;&,_C5] V?B[^+0_52R(6*S4_^$ M\ /"S2W:H" A8[@A6492,FOX!(H;H@8K+Z;V/R++A"QVNF2(YRDCM;9O(7>/ MY"%"GQ-"YGQ#:8F%5_T ;*>HF[N3+?N36*-:/@5CKVAH[NG_29C*^B=0JE5? M0Y(\<3^$]/JXJBO)I'@$,!S)D6:6^"B<8V( " 4R>$#%MBZ(30RJU"B0RW9' M<)[$"49K[!&J:\3G\91F,0T_$/C9.3_L]_1 MLHK:- S:S)47>*MDY9,%A;J93?Y(8-X'X"'R#,6.)Q'.,$#2T"%1=D9-W\ M MJ:;#GRQG;=]"'FKK1T%I#OF?@BEYW3>5Y8[_)>3INWY4E.6/_R4D?RUNLRRC M$D, ;D*5LZ2TM#G?=7:$SD(WH7.?!+-S,O-X>QG0&Q_)X$_;Q_M%[&!7ED'. M[4E^^4&O3;YC?,\\0IC>;AW.T-Q)_/C504:FR.]N#"^(C\@G1]GO'-4_SY T MS&NXT.&.L!J_30,4EKP1@!DPARNT>D!8$=W2I[N% M;H)+Q_?5>*,?[#@B>NJE=O2*T"YQA9YB1!S)6Z?S"(]Z1ZSG^31@Q/BE=),V:5P>_AHHA&= [2+*MT_]0[W+C^-3MF,2GY!!+ MHS*_T5 &L$SD:!:F9$E*',TL"DL2/J'P=$0WC9<($[\;$;)I[!E42K7A;2\: M"7'4(@+X3H,W!YV\@8RHW6PFB 3KQ,M&=W@D)S6XNV-[Z3'>+)9K2GCUPA: M3JVDAF#!^)I:%%$[8A+>F)Z@FL*EE(64=6!1"8CM A!#EY4(-#-V;[JFJ=3$ MR;NBMR.WWF))S,#'"#&JT,Y *RV+%E!%3 + A*9/*W"!"&,L:+ZF=ADZ1E$9 M?30KI@9+!OY;LZZ!89? ^A%%#OPZ*AGZWQH)L!@!?510[P#^#AC@*\]Y\'R/ M7AD2%Z%^56?(%98F:]4>Z3K'\J"*C59GL9J-3K80LK>^5)6:(SN="*:>E4N3 M,O+T!T/1@&8B-H.48BTM64(.2D9"D^5W#J""J+^*& 7\942$!Q+MB.15Z 2& MD*^//Q[X&[ QSL (?VG.&MH1!^.S&K MWIGB^A' )G& T=W;R0"S.K/PVSN'SHB$U *6Q/E'S]YY&V^&@IE9YXM'Q6XT M6=':\9#*1/-/F,@+RS^D680N]MA+BD9?@).WV/2=Q=BB',#\&6?(O@/?1(R; M(ZX=&K8HVO#)A/$]H)I?A<'B'N%5\<#:>$[GJ'O;]P-Q;:4/X&) ^K@$V3D& MQD*^8GIV%HJL0DHX50V!8?A[Q@*+QF353*/_XXF.;#CX2*03=92&.1F,#WEC MZ1"]1>K;8_,C"\Q+A.);#X":F2O9Y3ZC;B(=M8F"U9PBE8![(SRF;70:GSMJ+'1\Z&L*A8O<,PE._4@B$ MAX]X2>B(XY8^SPO0[-S! ?'CHHGK)JN$133/"#PN>,*)!$&+IDM&0C*0&?*R MF@HZ&=[M1[!DFE QDZTM.M?VG"5A]8RO?:W.04[F-NNGH_+CPOUC3<./#JLU M(E_>(-8\-X+0%#-R,[92;Q!F-2R-^KIZ!K+/8N"X+/[<#1%9&G!4>E7$>#;B8B7-$0$1DSDEI M)?5,A-7DHK0GDO0:ZJCV\-"VPI6!# 4U>%0Z>'=9$4#HR^O=L';U6""6H5$"\!(69 MRX)=HI0$$8+4L+CO-8Z8#WD_$DPF\QH?6A*+/8V M*",/O38$U.RM%Z&&EE:,"#13^\4=\LF/%X3P!P=_0@5^H>]*^(1&(J,VJ$QM M*KK+1ET@S M7$9J*7#Y Q8/GX[ETR=?,B480=+W#P]I*89/:BAWQ)T/ 9X^EDC819S7 ZBB"145'!OIHN MLTQ8R=3XA)S:X<-]/"JC<5JX,,F\N-8RQR@VYNZ7QQZ-#"J0B&_%NA9X**<. MT?\#%D0KJ='(I1VP3$P_&%T@DXWC^:S18%BX2LT2QD^Y+69 U)_\=+IO#/"E)#JFCSS_"0&SU+C41F- MN\"%23)^;ES)&5>EQV;W9(SC$+]]I?\.,P.&,(;8*0_Z*K).H(,F[T:[-U!4 MLS*XJ7L&UI.P257YLBB_$2U#4%=.,15JI&5*3(U-.5O%5M+)1I$U@V4FH%VA=9:U084U^8TT3/FI MM9:NK=)H4\R2U6_&R4@MYD9:?[WN2RJ&-N%Z6V!S@J%@]?/X\$/)J3#R!NI# MH0.N+?^HU4SP'SCEZ)A+K=V=ZXT(HCZ^S4"(M! :8#%RY\:IW6)$%.VT+&9[ M2$M%@):APFG5ZBU&A,,A,HK%P@/(2";NUU?01O:XPBV0 KZ!FW[?Q7G4-6S\ MN:^VC!1R3-_RG2684+I!V O35[-Y*+C<%Y ]73"Q3#2X&,8[9?%2T@$8U."Q M.J(%/R1E:!K0OML^BJ+S)W)L]B(TG4]9"7!:)>EW!V,GJ+8_XY2"UAU[P!+L MAAEP1[H.S!B4G]TRGX:$)Y,K"FUJ3\-@0_9:PLATGOXY]AY\E'69A*]JW(V7 M =1MT;:Y$DB;28WB,)5N]0.1ORPS(_"@.J(MD8@%;0/2'U^$^ [AC>?VNN;K MM"UOS!!K1=8D- !OK&U Z\RNT2/[IUY7^YZH[9-I3S*O86VR6BY'Y4R\5!#3 MLRW@KGMW^<$"6*HFSU462W,.MZDBP1'*KH27L>X5;8ISBZ(8 M>VZ\^1 MIL'+"S]\?-4U_X\HPD+>18X !:(43D;-Y@]B9^(>8R?68T'UUBJG)G M*/WO9;"_J;D*G0#-[K%#C)/+PES LE+/FVIY28JR.8-'GMB"Z&GX2 MU0JU*D^3N5/^I\&=XR-*EU8?B[>]7E4E(,Y! ]N: M=S/(7L"8*Y$@2W@0Z662)VX5/ WE\-=9F+ANF!!5)HJ,O(V!5_=2)*V6OE%4 M\G:1-N%I),36P#AUXO=&AI[1K*&)O"KIE;*9,39%<]0FA%EE>3S69)-> H/F8 >3$63:"2R?PG+ M-32*S^USFS+='X=QLC0.9E+QN[+ M#DTE+Y>GX@%HIB H8==%:,8ZP-#L=<(KHD]@=Z_QH/=9(;U!9LLJ2E$"52,5 M^HIT#2X_+IG1+S\^@&9BQ45Z63K5 [AKVTC#7N@)7E(%Y"1RB]1O6(JT[I=H M_S"Y^)A2M:*5\J!C-HR:,!H*!\O/Q9H?.L2CA^(*54%9IGNJ7LE@P@']'SW1 M;AP?L4OV_*DE_0>B;^4?%'XS?<)7C9Z=/[E^,F.]E-VE$RS0+7'6S^=S!'YL MZ9EYJT<>&)WK6]P2$>W>M79(2CAZ-Z.C)$SU6[Q+UNNTE8?CYQ&"RV >XE6: MB&_HT:TDU1$]:),&TM@.E;=,I57"BD.H"B%;(18'DO8 M\J19(EZ48!H$V]&\"''V*&'W;U*G9KF1K!Z>5+6VD*XHA1)PX_:4]"JW!>F# MDTH7E^YG,TY(]4I)0']5FA%Q; M2!K@R<1A-Z=-\XDE$^YTMTR#'WWF2T9D749DGF.9OMB)[ M3R1ZXL/?#O?.OM4R#4(U*Q5;Z%VR,@_0C)N#:_2X9_*.=BMR\*Q#N^[2>#>8 MV)B$&!4&$H'FE 5XH]W#!/8['@&3>(7F=#^WE3"_]"\;-S KE$-%>=.7Q3*TC'A6[2Z-=8$5MYZ(T M$ 4^RSK?%@NBJ'JV,N6@.96Q M\W!:(1B(_:;O)KRT=II#SKDA.]NB( _Q:C;CXHQX56WR(&S!)1Q(1S5;!KZ7 MOM\0#F),21W?+ZNF,NRESF#M2-35E/P24;#S]"KWYU<16F1/A@&S4PI\32I\ MF=]'%8GWOYEJR5L76JGT(_-N9O(0H<\)X?I\P[(_M1L[5@8RELW)(:/=@;@R MH#$GDDO'.)$73>?[@8$Y MKH\_GHO)!FQ 2U>RG:1X_Y^JH9JGWO;]\*$60V"HQ?!'^CKO/(J]E1.#/X:K M#&ZS(K>2PE=!,51U]]S! >&(ODIB256M:M]9&")J%KL8* E'B!IX8MK>:25+ M,X@QNR2X]:)/IQC-O)C^"=SYYU,:OC&3PDNF.$FO5]3LJ!EUB)&-\J8ZS1:, M/3)W.C0#P=R1MHV6Q=U!_LI: )=D[%?]W.4NT2RAU?Z-"ZF5U%@R"]KQDG.E M+%Q:[4S05WQMM9-C[%R&F+9-[4GXYZG;;3"A?8JEB:ZYE_)X3ZL*Q M=H-9R4+6%[O('VV>G>9P1%&R2G_6EQ) ,&?79G;2$A#9&"F#U<1D,86GTFR= M=>1FW&$"G,E?QM/\_N].TN22W=H"L4 'C9,X?YXWG&8#C'>3/'**#QPG4A7JB9 MG;2W8+M&D5$Q%JGT.$!Z,,W:F"=HX04TY'[B^/2IL?(C[-8![&BZEA1V%W7M MB)BKIU\@<^%XF)Z^"CFHP$9:1,U2QI&.T*0!!#VKIEUZTR8Y>7$KJ?52_<9* MSDNW%5*;-NPA+BTVFY=1#XHLO9&"F/?M&*T1%P736A&IA862LNSL)ML?G#K$"-$7P2*N(JCLAQ*M\1A M[/A2T->_LG%;T WLAIE#=W@K;Q=YU<'3!.-:"RC1=EG]V-8#U.Z[9@T&8979 M3DI-RP\I ,[Y=-SJ7<0@0_M[@8[W> 2=)^34C-9IM0?'SSO(%,Z@70ZA%VST MFWSTW*'0/(6*1M/1UG3,#P345;+*1SQ+E.R$: SK!QI),>PKZXE @4Y'::5Z M333[_A'Y&_0A#.*EW.LJZ<&&X*E R:>.E)'BDQSJ]TMR)'/F\7ZR6A(J#&-K MGU751*%@BM# 9[CSJ'82PP"<'*AE(1DDZ''7C>C!(BRD-70.]Y;ZX.AMKXU# M=$BX:KZ4I?UY%NQQY@[C_!^;.^S[F> M$UXTH%;- )^_(V^Q)(?["3GC.PM4NJ(=KF*UP1"<:R4-[5O"$@_ K.^^EX1I+X@\MR$Z M/"1C6>'3OO]JP396966DIV5%O2M:7>#FG/U_=IF6_H8BR',S.G]:(O@VX#^F/^-/B.6MO!N:. TYL? H]#-QD6G3:T/G"7,K^ MX-!TN(71K^GDV"8OF1MC*WO\>]9G_3)(.Q^_QV$$7>3%!(?C,W70(LH4Z@<3 M-JN-UTB)V2&YC8"= 6M#&EMEF6/J:S*:)*J]^VHV\OW(QAZ^Q; M0+F"@29"=+7/Y69G *8]+<>"!SY4$NAP;FQ/MIXAF9PFF-:Z824S#/<4) MYU81NGFX!@-CT(4N^.:RYD?&K7A!.8>C=(34F!^5AO4LUUP[H2/^1C=;CO6R MY@]5C-FP-:U_&>4ZUGI[8-LITM I [1'I3\FL,]UI?5QCI4PU$6(Y\BC>9]1 M&M/UTJJ@.T,[L*"4F-\1*%N/PLLUSTB,O-[BL_[T#59)IZY M7DG+(D]$M=Y=3S,DWJNN!#8.7QLW-[OI5 MP;V5Z4&BW1ONJ5?L8R48)T^>5(*"H/K>?BQ#.\>2?(G=Y $=DI\22T^&[5M# M2HLOK[Y7 !'Z]?=N^ ](]IV?C)2RT4RF?.02.DSW^[*@&E6O!&<^7[EFJ;IX M_O7: **&X41S)_%C/3SI?,W4!H^=F%FI=,515RP,V(MD2=NB=&771LN4!(9H M?"31-_3NKT+LK+3.H1IH-=(P=3)IM5E*JEYJGM6,DY%GP8VTY*P'CV;MG1>)0K.MW9+%K<:@'WI"=Z\3?A*684+,&^I/)Z5 M>WF."YCO[I49&P'5>8(%M33>($$MS]B(/2BT;U&J2M+TG;5'GG9.XXW0F:QN MH'.1M[-[!6YI&\8+C%!>H_>6[%A#N865YM?:?5?+B@&Y>I67V+!*NC3QG3_A M.O,VW@P%LZ%K6B._7Y6F-4O,S&G=!-^_A3X9QB=[P%ATK<*QK4W4IK)5A6:H MZ[;V)5T;[X-Z>BQFU%Y2KXJ"&1*29+&5/JO[$J8WE&G::R;OCL>*#SK!K/*3 MA/;+RV].3=P&*C,#?EG:@0/M=%@#7(%>CFI2-[6/:%^(=M%C%Q@ M&&&QAUO&E@N0QC4#DV7:)I81Z1#XA8LQ+;)Z86-%D<"OP)EQK318+F2E*MSR M" >Q$0_IP];NW LQC,.*O%V'07JGE6ZHEP%A/V%@#+9$MPK+%M^A]N75]JL" M)GI.5/+C=X?Q&X09QY.8O>(_4YE>3TD@(C'0O3%]]I\5 M=:C8VH]T2L1",Z66#"O(#_>5"%X%8'%(S'[MLHHB[[1VI]%#V=4TN;?UQ&4T MNYNN5H@[8A7='-GO.\W!6CW2TSP MN=L] R(2%G&V7.)A^$4=RF4<7LR9OH1!.]/V5K&BLAX'W3NEXV2H"'[Z]\/# M@__^_<-OW_W/?_^7NTZ>_@B^^V'VY=UF\<;R/_ MW<;]\MK_)3Z*[] O7]Z]_?3TQKV*7_]Y<7%\]Z^CS=/)Z1^O-[,[_/#TY^]> M[)_\>OWE%_]Z[1]__N7+(CRY/#KZK^-OKRZ\#X_OHN/K?RXN3V[?O[LZ_]=B M-;OQ?C]]__?1_9MW_[G\[OO;=^LWO_[M?'=T\_'=K[/OST\>C_]Q\GCT^>_7 MF]M/G]:3;S\\S#;WV]N_?_]U=G'Q9?F?F^5;[]?9K]&'M__\N+KUW??^/_YQ MO7K_Z;._??K'#\>?/N-[_,OV]/LGYR$*CO_$G]^__OM]^.9D^EO\YZ5S^N&+ M.UU]^^7;^\F?'^]6ZZ<__[[Y]-O);>2=_\,[BGZY76TGORS_Y^#T[O;P\"7< MU-=BD^RV;*DG01HNF\[3X_104GS:6+20.S8450),)&I5 I/W?YV9M1(HZ8%K MNP^,GJMJRP=06FX*>KHH*/7;JJ9'@%X55"F]V-1N]PDUR!]R5PGMG#< N@8^61:LSAT?.I9K9T%1DP$)O,Q.[!5<_NZ9B&"\&(P1[.S M".WC--"\34@M5,G@["Y1*[F<+S4H>E^SZD4HP!XFOU2A>*E"\5*%0OT0X% G M-IZXL;^8FOTDD?XE>010GM9X\\HE.6\U(^YK0RT M>K-SPRP,N%Z&&:??L$1E(@M=XU5-S68C^KQTBQQ<7!HG:.$%0;?L5GUB0\YT M-*);<&(:6$9DNB+2YEE#RZYHY.UK4CU#TI7)6WQI FN,\Q<-[J>;+'!C*\FV M\&P'4.GEJ3/N<%,;;>V^=>C-Y#*^M/(ZRIJKFP M>RS-W8U#:QV5>S &0'K(EVZ?2?F=6.VIOG=W5;3Y#F:TBBC[]D8][OPGPN$Z M]((OY+]S;X/B\$OVDYC^(4(;I-(55F&XX54.!]D)=N%C%61E(G3:#ZN*&<[I M% L_D+LYD!G(WK,K\PZ[ IRP53+:8Q>:4RSPFX4V).,9Q[U$M/J?E94HEX7C MYD#@!G^;8V>"I4^J3T?Z"?Y:FMK+>K&@3I+]"O5M/3<6C2AZ4TK,N@J6?F( MP+5.+[BB_>6.^J/L7:SQ@@W_(1W^B@Z?W9_5NKNV/[%6&5#7E;Y"4830=(UH M_;-@P0:_\IP'UG(XIW*6H#^0@^\?0^!]7)6ZO:PK#>$6-T]EF(V$?)6X("*& MOAM3IV^M#D"?\DZ1!BX4H>B(W(8#1TYU M7N2&"7U"?O[DDE^=K.C?^I0XEP>[Q^)^Y,\7@)%*@3?D3$_X9H6FI_,2*UZU M*0/GB"D88MQK5@HDB>"[LF#*K$H)HO*)QHQ'@*9XX03>%Q83 M"^0%9+;OP_1:QD4X<(+97;):.7@;SN^\1>#-/9=5IV3+FI9B"'W/)9J3 M/;K2SP.N#]D<'.ILKUL(Z3S-NT;Q94 015=A%+V14N[*)Q:56PSZ3H.K\S23 ME$"HG#K1\@:'&X\H\V67U86E3 J#;7T>':W9#51R(-D9*N]#V/' M/TTPIH\@B'V4; G9\-EH0&^:LI$JDKM=(B,FMU]6/[)WF:: :7VJL-& ]&XF MQ)_HAN:L/2)!N?NM\B?C,-#5>8)7!BPL V)]%!8\_>UQ8%B8'7CAN9P=XBM> M$/ZF\1+AV_3=^8V#ZT>4SHY."Z&A6P<9K(0UX;0]4<+>S/,3LHFB.^0FF&VE MY #K)V2WI?S0N^0D9F[S='[N8)J*$>UZ&YD(,L#P-/A%""P"0T7@J('X2 A& M"48S(^)NHC :X37"(U>GS/B)]SJ,441.[32M87]D53^FU(>Y4FJCU3J ]N&I M/JA\PRKNQ_UVF9)!=G\0XD[82C^GP@ZUO<=.$)$%0L&"?Y_81LE83HA<,R>1 M$A8M12M@9AY7<4@:>:_73JN'YTXMS^XD=%5"4F8?PK42!7_2)I:6U>=ID (S M\F!LYRS0HACWY!<-V+WRV#9?5"O;N@HLAK*;]*O=[?D+9C3_]=I9]?F*N2.+ M=HUIH\K#%"%L$XO)!N/ S/;T !E BZP:>2N*)+4;*!]&)NNU[R%6'MQK M":&*CIET[#/T$.]+D7YP8AK>W9X1BWJ&(A=[[ D6]%V(%,W1+!E)"&4>A>J) MT*.9!\$L(L;U,H@11E%\XWC0!8*Y9,:RJO@X&7CE.5DL,%H0'6BZDN Y695O M[%7T5 K\UJ9JIDU8X57V#?8"UUO[*N"V?&ZIZ9<2R&VS!VW(E3IAJ>_&W0)X M+FO],XLO*)3P;9JQH1O+&QRZ",TB>G/*[E/1K,@JL-D641NX\DN#)G&GJ26M MRV!#]@FJ&]/' ,VR(@_9&G1\(S?.#SVMG>8O#87Q]_-*>.!FAR.?!#,=J74,1D,&4Q(X9&$L./Z[8CE$L#+-;" M>*/[M^/[:6$3^;ANPVF 0 ][A\[[4WL+7/)OG=BY>79#_>>#/BSA=_*8M'@1^( M.K)C*^2@*M[NN)NIG$]L((ZS"AC3^8[+I8,7X$>E=EICD:0 L6%T-#Q+4!R6 M'XP6-Q+U?80[7FVK;=].),;1]&7X0\N_ 1.-8>A UOP23 'SG7LC!*'WGG<1 MCO^Z]V(:'=\;.-F7$>3C@F$A?]L;%?ZXUE]%2&HB%5H+.M#IEXVDZ+[#.*45 M]Y?>^CX\#V*:227]\$%51 **=MXQ")64*RL1@*!5_S0XD'MW8$"(5IX1F)*C M['LQ56&>+CTT/W]"+GOH/YW//1?AIGQU+;&UC6[!V^I@@'*QM>)E*E^=]_"0 M10^BZ;SP,V"'686RQ0",HJ.BA:O<8=:,(2YC:+9I98'?.=1BT <*CU\JMH*<*[F*P@.OH5 M_64SI1;:*%DNM2"GH.7LJA;8##TGY= T\K:XG9;=1\(2*BLA*K,5%UJ)@K_A M%4O+ZF-<2(&]5%RP9?+4ZRX,YM$\L"A?"B^\%%X8L!:]%%XP$R![WL%F^0U! M'&N&RG5^"36_A)I?0LW#"37G-CQ/VF5)FI%G*&# HS(B4RD$#+K;=!O!-*/6 MC$LLIFJ)S@+#J4D&(S&CS8!2Q.?2>*IG-F M)0R813X=+2&:']XF,F+*2C):,]%1K]*-UM MFPEUB@G:#5P*M;8D+@GXC&7,BXG#AQCEI&?7'L(*4-+%4TZP(D?LT/=F--&$ MG;)IZPZ8>"!W:$-)PB;"@7QX0.M;\4B!A?Y:!K?FQLFH7YL<#-VUM),#B>$) MI&$I6-==%D:N*V[I_0F02=J/-2(;5 ! 6/Q-"URP?-KB:%;-2DUG2E@JY,-V MP!/$4E01M60:9/ $7_RU@V6Z5.CM:ABPY\D&8U"-M$Q)P'@4JADYF>J$6A*K MD#-R@&NF8:H@B%H\JDU1B_+AX 1Z3]E*"_Q@QI7*,$)3G01C\N*1D%J% 5OA M\KNQ2KBP-KZ-=_]2]J$4)JS#8F1Q_.[0-)W8"/3EL>VV)9$&O@((;& V;4:= M4HBF0:/_R>N[7?MJT'K,FREP.E%:C)L5B%9IYE+^8N":V31'Z"2#(@TUO:Q] MU']E,BTDZSH)V6\@T_S[QU!]B>\_&CJ4]5F*>PUH0TF@T["7Q<_&L,Z;9BO3 MS5T7UHLP:7Q5W(YJX:O1[$+%F0*W$BB1\38::EKX:CR %F8JU\)<:SM2LZ&U MCX9N0^NS%!?>UVMSD94C,G?4:B1AI;JBLM??C(ZXG+[NJ?>&51E'-[[CLN.Y M(7DT$K%I8.2S'%XB:O:<8'YZ=CG:+4 +]FT&59P/!(=5 ML@++ "B/9\7KY:0UY#?6E1F;*"+XP7F"!;4TWB!!+<\8^I:,&:[\$0PYQSQX M 7L\6& P5'9BN$29T@D5:OX2V\S)BOOETK(I(JCI1 MJ54$'R\SC^MN411CSXU-[JW--.SMJ":KJ91K\#5B:R+GE)9NO"!+.G ]QS=2 MZI(S^HA+7?+P,O6RBRE!VH3@+,&T[S'"7CACFA:Q'C' ZTZ"H*VZ\&JU E40 M!'[GD,=R7$1H,4*R8:S"%Q;+AVH49:S,5N++5TY\>*J]%A.0%(P$@61;J>4YH7(2X< M;5D?%ZD%*!JC?^]#NT:J" T#R1>%W+G?'#]!*?7+(-]A[\.*;S-9D%-'O:V"HS@1I-,#\RSN.\6WWF(97R=TTM/Y?LF?.KZ/9B?;709:^HO0 M5K02[?]SQ MU;3(^'YZ$!8JC%&3<=D\>9 M YWYTOO6H>!Q=A&]\O?GQZ(5/2':5CBG 0&YD.G8K)MR(BS@LR M4UFU-9ST&_$ =D=9:),*RMHH?&8S0A'G,>DHSCU&#CEQ;=D,,S/"C >P%O#I MC.W(VH)8+B+X(F;,JN\=]4D4(7 _N)G&J%8ESQ$+O:8J=_U M)M[]1&[G:Q]B+.M""HY< BU1&KT,S#0*=$&8/_,VU&+&"2;.:W[-B*)K%$_G M-&*4_ON^#1!8?J8&"R/Q:;K!G,L<*"I4VE695V7"44D''LO::\(DA[TU:J-_ M>]3@W9XAE^Z)X/(0D1O9*A+#EXL..+!2"? 5H[ELV:8_N CQO?-$+S'IS(CG M">U?:+,Q*A=$'^Q<^C#E<3H?0M(I7P9D.@G+2&#.U?W2";(<3#*'.?)B&DQ. M#RE#.3AJ<#XV4]*G4'.]! H=Y7.8^.S?T:QY,N=/](^(K1FR5(!U2Y'XJ"R0 M*K"Y?/DQ*?73$7NLBYD]'LD!;9Y^G,< ^=>+G(_"N M/FL) R/!M?'>_Q@V3?<6N>$B\+YDVS=O]4@!+3O6.#*@U.#)I0,377$C*PX[E M!*\-6RX]Z.C*_IEIRUT>9 7L^FW?\*4F1BL7#WCN3+-:W-)WO@B[Q.%P%M#" MDB(Y8K/( S&7(4R1[#2Q-1U^.O\=T:0*-)N0Y4Z($5=\B:Z<*+Y'P3UV:$3@ MS-E&Y^SR?AJ0?[Q?>GBV_R>B;B&^#R?KM>^Y+-R>32+_;W;J.R-SDK*Q=C@; MD_MI27:Y%K;5N5%7Q"N/3'K&?+9T,:# Y5H0CLJ(QAB%29!#(Q<":&VG3G\<"ZX#OKFPP7O&MCXY;([QF[B) M5^1@%,Y?)XAS@<.VPF2LO*>9]V5>V.,=QLI#'])6Y&!\TE:%.)5WYHM/[1W HI9>[UF1LJQ,#)9ZL&& M:+9NR.)M6P8*\8)8YBC/%&R7A("/9=R01 MR<4 EJ=1IEL@*;NT>-^.R_1Q$<@!;VV$T^]+!^XQQ]X3AE'>C< *(E<4T/X^ M'P,LR&"56J,2PXQH6Y,!)9<&/]J@LV3/5VL_W")TA_#&Z=::1 MJ?LP=OSBOY^&47P=QG^@>)^=#+R.S?$Y#C7I05ZY@K6%5K1TK*%&=?X**D;D M&!2GY\\IIO]M?#O$)\F41RNR"(L]OWNU)BA-J@YZ2S)E]A-'M#AKNNYBK1*^K?OVU!'1:9T MMC+\:<>M$KER5>\.4N"/;>ZDO>\[7YK%OK@Y7]]R[%L@ >UQWDJ+]K0W+0#C M(D!S)_%C4!E07(QT,9D&**>DTFRJ]I6-()+40MXWFJK/U%"#DE.R>V#'C>G- M1TYR]VJX;!#A3S:*Q"U=XZIMXKK *O2<4[UBS&AE,;$;A.6A+5 M_)4WK8G+4K2C/57%.Y'6 2R&9S7.-NU8B.OX]W/FI@GV7LP*U#C!C-IQLK!1 MX-*^D+O#M]:SAO91U0[A*N/IWNN*:TN72'SPP(_X#<_Y!3VVXN=5/W&WLU4%]^A-G/PXS\C MDS5L9M2R7 >J&.SO)X[[J: 4$0U4>,$T0#0=4TH4^J-;.^5WD5D',,4]!'L0 M[?UC:%"T^>A?B6AW8(IC!J"B?6CFA@@3R2>2=R(P3H/;#5.9T$0?]8P-,Z])FVE8 MNA#3E* +W%_O^YM6HJ* U^5A$=G=#NF!'3BCG[JUO(BH8U=&M:XG#%L^7Q< M"T4(AK"/7Q_7)#2X@SXGA*/S#66KD)BH%81I'D[M4D0XB&: J'E8^_*)H?N-)BH&I29WO2&CE-4[C4:XQ+$] M(.F8N<7@TNDE_"VXOFC13X%L5.XL0.4#?U/1)B'+MQ-=Y2-W)0$@GZ;["&C) MV+^T$-F,%IFHW%1H)4HZT1(8?C:DM3=8"DY &0.AOFL]QG,PS9^+\M*N5?: MH1>2L_?07$,N8O#$%Q OM8/ Q-%8.0B^,F>!BM%N&5PZ%A\%=I1*]8@@'5CYDL(*BRMB/1]TF;%%,JY;2 M;)).,FDZ Z0.SS2)H]AA[8 S';K\..0B0Q.XF0 5>E,"'LSRN*%[W03 M1'FD,1CURMR%]_":FH_H@TO_DKC;3_]"6PAEKXQHY;RCJ=Y5,*!OUPND4AMW MB]8AIO>;=[$3)]U.%ZT#CT'CVY$1WIWK">+"\Q$^);O+(L00ZE\>;TS&O8*$ M\+I/''Z@ M:ZDZK53QP^QDM:4= )(#;9YG&''U!H1247 TQYZ8*TE\CWX; O#3<& M8]^$0HXUX%DU9^G7Q,$QPOXV]6!!K'QUS#' SL4CQQZH*50I4$=CD@L JDQS^0AQG0AR;E1.4ME@H_#HZQ#D0+?E>^M"?1FX(5[3!\<> MCY&0VP[2X,PB.-Z+P, I."-T2OXXQ??A8UMFN:( "F..P4'EXI&C#_0ZO4:+;4-3 M?(/#C1>X$)LU9^#12:&&3"X*\!O?C.!-&,6._Z>W!O*:&H<=D??:#$LNA=9G MWNJI#Y0>1DYGZ$L##3\(5)YWCBWY52(.JRS" .(K5!AN%,M;[6A/G]RE[0_6.?DUL8!1^#!-P.1YPF*'E-Q4N-_.J(T M'IP(40#^%U!+ P04 " #'<6Y5PTT8-=&@ #U_ < %0 &%E9T^.?5;R2)H9CR?)YCFMVZP2 MC5J16O8Z/CDY;!(M,<,FVR1;E_GU+VYD@R0 @B )4+O[P1YU-RYU0Z%0*%3] MZ?\]KR/P"-,L3.+_^.;P^X-O (S]) CC^__XYNYV?W9[;6#\$B]>)LE:1K\&V^_@[L@X<\W_SAS9NGIZ?O M?=0F\\,49LDV]6&&OP#[^VC 8LB3%.(!_P ^)S&X2A[!X3MP^.,?#C[\X>U; M<+TR__Y4Q3&7Y9>!@&".\[^XQMNIN=E&GV?I/=OC@X.WKXI&GY# M6_[A&7]1:?_TEK0^_/CQXQOR:]DT"T4-T;"';_[K\^6M_P#7WGX89[D7^WB" M+/Q#1KZ\3'PO)Y1LA0M(6^!/^T6S??S5_N'1_MO#[Y^SX!M*-P#^E"81O($K M0"#_0_ZR@?_Q31:N-Q$&B'SWD,*5&) H3=_@_F]B>(])CR?YB"\N[F0XO2Q,A;M]*:$,\*?+Q$\%4CA;/O?A_A8 :402XX1&@#B1@!X!2"*(DOM_/ M(5+8TQ&#)FN:DE!#[TU/;3"*##CBO)+?T^&RG+<].7H9>LLP"O,0CJ3D!1.X MT/1-,+34?;3KYE8,Y'SB14*"I;'VY\8;;0L0SV%;&PBAT-P,IB@DZFU!CNT@ MFF0\"7$I%VIIF* ,M'"^)[]O\\3_\I!$ 3H%G_VV#?.7@=DNF,#%SM$$0RD( M?//?_^['H\,/?P2T&_CV%*Y"/\R_XR3$B8S(6<>+B@3Q-W\>F ,;F(9)<)M[ M:=Z=#P<"1AQ[$?8P[*C\RDA\4%V5 Q+Y+ ZZD_A0A\2O3Y /A]GK9G$PNB9L MG6[P-=EE7Q2"I-217&?@Q<&KT)FZ+)=LMG(B[2R:3B+X*4VR[#I-5N'0!CD_ MLFUSBYM;(D&D!=B0)FXM+0$'>.;743'7-O,-OCL(X_NSYPV,L\'MZ^;X]O5) M P:E DF*U@"RYJ4H.! $*7]X<1 C:+CXR\$N8C]9PTLD:6/)!#?#FS^[$HH= M$!*Q*%NB8WGF^ 2F8(Y0(&K(5<\XG<0"G>63ZJA,V 86#OD\PQNNK4(B!4:M M0?('F(*0M'_S+=,BW[D5G%;V\>*C1IM;JITD:">+YPBTDR1&PV_1#$Q8DS@[ MAJLDA;3=PGN&V=ESGGI)&H2QE[Y%-:71\A)V(*?*1-:CY.LAY,-02FCUZ M(?H]@HOD)%FODY@_G1][6>B/N<@T9K=_!.L(8I^%RF^-!0)X GPP# M,FZPY'-H64\\UM )G1@?FL I[ X?C0"V MJ",ZP7(^8J_LRU\BN;$Y.K*^9FYT(9&AI2&9Y2)^1(=8!^(IFG@RXBD 3E<\ MPZ+KY,53P7H-\921:%CQ/ ]C9*4X$$_1Q),13P%P;>*Y84/@=TJKHKM81*/?O1-B!WA_X#8AN\0?;)V6H%_:&]ZI:!=W!=9!=#U7(C3?%60!8> MCH,A?\#==([W S>2S*]8!\PR/23V G5*JW@<=T2KWZ<7S))E=B);6'M@">_# M.,9[6[("+]!+73HU!I&=P=9-\Z;*GENJ-^ B%Y9"#"#Z%@D A>U_1:!*R5Y. MCJ>9[R=;?(%ZCPRN&/WI$Y<*CH0\(8HWNXCY-B&RP381S&9+!)0WN&4S!$2# M&_8J_]L $NMCR>PZP9NL9/42P/LK&,=_^'X6G PX:F:_\,0M..YP(/I_3]/ MX0JF*5IGR1H'Z9!8 K&@X^9$>@\^OCT@$MP^P A7]B+); 5$(F]%%\#W<2UL MVFS!(J2'N?G]0CTP_"K)X4AZL&6RX?=]]1V#"AB)."E>"TQ$@>DQ5/U$I4$( M8^G"EV''Z.13%=PTQ?H.:[_CEUV3:^\%?S5[0OO!?$,BGKAKM*OM>@G3H05R M9H1/,QR=4L[ALPU;GD')[BKIW=C(",Z#(G$ MYXS\*Y*=_Q6>;O3N<60:$**?87C_@$YULT>8>O?P[!FF?IA!9,_Z0S\%L 7U M"":N?;VNPE"B[8LN@/4!12= >NEN Z][&>O(\TB+NY5E(\7)V=LNVC 4;2*= MI%*VN_RO3([&L1Y9/88#\R+.TS#.0O\G+]I.>-^IP3ETC)W];::*D&1C*1L! MTNI_QD8B%LF1EJF #:-9,?:VBR96H@U"*5W_/3<$Q[)UT-4OG:7Y/V_PS+I1 MS*@#IYG1IYU6KHXUL/]%Y$"L3"CU$R+Z9GGH>Q'X#+ULFQ(B-T.2K4J>D.Q8 M2IHH6??X724Q%37J@KR(LSS=D@N2R3H!NX \EFMGO+V] W9*;^$>KX"YV(=E MP^/SFG2P@;@.HHZ[#U7'=M26(1P ,K M8\Z+A9.NW=DV?TC2\"L,[N( IN0^G KD-2)@=OQ2\7)U.K?T-D/[06A9"D= M0?;8L^KS),;U(6N M"/3';B$T!AHZ%9+,BJA/+ LE8TV("G7AE)11&HN%$(=>O/S;%ITL81J]W,!- MDJI"P?396A_3GJ6H@**-W65S0-L[,N\T>%,7!!&B!E$"_)#7Q?GOU,N'6>K5 M$4=XE:4C$A4@V@2"-L:N9(";NU8%0I;41:&)8$>7+3_8>9CY7O0+]-)S](W* M$-(7@_J8;E1##8HV2:#- 6X/2 =7QH<&=^H2(4*UIW(@105#;&<,N&=3$@S@-L!VM"E3I!QH&"Y$"F#G8&.

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�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